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ABSTRACT  
Pharmacies are convenient for most people to get to and there is no need for an appointment 
to see pharmacist which makes them natural first port of call1 healthcare providers in the 
society. Worldwide, pharmacists are potentially a vital link in healthcare chain. Since public 
health services do not cater to all the population, pharmacies and private health providers can 
play a major role in the healthcare system. This also applies to India with a population of over 
1.3 billion. Though there is a large presence, pharmacists both in public as well as in private 
sector remain largely an untapped resource in India.2,3,4  
 
Aims and objectives  
The objective of this study was to assess public health and patient care aspects in pharmacy 
education and the role of pharmacists in national public health programs (NPHPs) in India. The 
research goal was to find out possibilities and ways of extending pharmacists involvement in 
national public health programs and how pharmacist education could partly facilitate this shift. 
The research was divided into four studies which were published as separate original 
publications. Two of the studies were programmatic studies (I, II) and two cross-sectional 
surveys (III, IV). 
The studies I-IV had the following specific objectives:  
 to review pharmacy education system in India from public health and patient care 
perspective. 
 to compare curriculum of different Indian pharmacy programs (DPharm, BPharm, and 
PharmD) to see overall differences with a focus on the amount of time devoted for 
pharmaceutical policies and public health, patient care and pharmacy practice aspects in 
the programs (I).  
 to compare Indian pharmacy curriculum at all levels with pharmacy curriculum of USA, 
Finland and Denmark (II). 
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 to explore acquaintance of final year pharmacy students with 11 major National Public 
Health Programs and their attitude on pharmacists’ involvement in public health and 
patient care (III).  
 to characterize physician perceptions on the role of pharmacists in public health and 
patient care (IV).  
 
Comparison of curricula (I,II) 
The programmatic studies (I, II) were conducted between March 2012 and 2014. The curricula 
collected from the statutory agencies were used for the comparison to see the overall 
differences with a focus on the amount of time devoted for pharmaceutical policies and public 
health, patient care and pharmacy practice aspects in the programs. (I) 
Syllabi of courses leading to 1) registered pharmacist title in India (DPharm, BPharm and 
PharmD), 2) USA (PharmD, curriculum from University of Florida), 3) Finland (Master of Science 
in Pharmacy program from University of Helsinki), and 4) Denmark (Master of Science in 
Pharmacy  program from University of Copenhagen) were used for comparison. (II)  
 
The results indicate that Indian DPharm and BPharm programs were industry focused, and only 
PharmD has focus on clinical pharmacy and patient oriented services (I). Indian and US PharmD 
programs contain most and Indian DPharm and BPharm least public health and patient care 
aspects (II). DPharm holders are mainstays of pharmacy practice in India but their degree least 
contains patient care and public health aspects. There is a gap in curriculum, particularly at 
DPharm level. (I) 
 
Pharmacy Students’ Perceived Knowledge and Attitude on their role in NPHPs (III) 
This study was conducted as a classroom survey among final year DPharm, BPharm and PharmD 
students in India to explore acquaintance with 11 major NPHPs and their attitude on 
pharmacists’ involvement in public health and patient care (III). A survey instrument was 
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prepared and distributed in a classroom survey to 326 students from 5 randomly selected 
pharmacy colleges from Southern part of India. (III)  
 
Students had positive attitudes on pharmacists’ involvement in NPHPs, although their attitudes 
varied in different student groups, PharmD and DPharm students being most positive towards 
involvement in NPHPs (III). The study also revealed the need for increasing contents supporting 
NPHPs to all pharmacy programs, particularly to BPharm program.  
 
Physician perceptions on the role of pharmacists in NPHPs (IV) 
A cross-sectional survey was designed to a convenience sample of physicians in Southern part 
of India. This small-scale pilot study was designed to develop a method for characterizing 
physicians’ perceptions on the role of pharmacists in public health and patient care in India. Six 
volunteers visited 800 physicians in Southern region in India and collected data in 2014. Survey 
instrument consisted of 28 structured questions based on NPHPs. The data were collated and 
extracted and descriptive statistical analysis was conducted by SAS (version 9.3). (IV) 
 
Among 129 responding physicians, 98% were comfortable with pharmacists’ roles in general, 
96% comfortable to collaborate and 82% regarded pharmacists as part of health care team (IV). 
Physicians with shorter professional practice experience were more positive on pharmacists’ 
involvement in NPHPs than physicians having at least 11 years’ experience. Overall response of 
accepting pharmacists’ role and involvement in NPHPs was positive, Pulse Polio, HIV/AIDS, 
Tuberculosis and Tobacco control, and Leprosy eradication programs being the top NPHPs 
where physicians perceived pharmacists had a role to play.  
 
Conclusions and recommendations 
Upcoming PharmD graduates with 6 years education (training initiated in 2008) focused mainly 
towards clinical and patient care aspects should be able to change collaborative practice 
models and pharmacists’ involvement in patient care and NPHPs. It also would be useful to 
have an alternative curriculum line focusing on patient care and pharmacy practice aspects in 
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Indian DPharm and BPharm programs. Practicing pharmacists would benefit from easily 
accessible continuing education to cover their knowledge gaps in patient care and enhance 
their contributions to NPHPs.  
 
This study is first of its kind to evaluate pharmacy curriculum contents in India from patient care 
and public health perspective. It will be helpful to statutory authorities and curriculum reform 
committees in India and other countries where pharmacists’ role is continuing to evolve 
towards inclusion of public health and patient care. Further research with a scope of detailed 
national level analysis to identity pharmacists’ potential in NPHPs is needed. 
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DEFINITIONS OF KEY TERMS  
 
Clinical Pharmacy: is defined as that area of pharmacy concerned with the science and practice 
of rational medication use.5 
 
Curriculum: is a detailed plan of syllabus with subjects in a course including theoretical, 
practical lessons and academic content to be learnt to complete a program. Specific curriculum 
shall contain number of hours devoted to each subject for its teaching in theory, practical, 
tutorial, internship(s) and detailed guidelines for group work and project(s). The curriculum is 
typically designed to acquire knowledge and skills that are expected to be met by students. To 
conduct this research, different programs from different countries were used, whose details are 
given in the subsequent chapters.  
 
Dispensing: interpretation and evaluation of a prescription, selection and manipulation or 
compounding of a pharmaceutical product, labeling and supply of the product in an appropriate 
container according to legal and regulatory requirements, and the provision of information and 
instructions by a pharmacist, or under the supervision of a pharmacist, to ensure the safe and 
effective use by the patient.6 
 
Health promotion: the process of enabling people to increase control over, and to improve, 
their health.7 
 
National Public Health Programs in India: National public health programs (NPHPs) in this 
study means one or more of 11 NPHPs run by the government of India.8 The 11 major programs 
as prioritized by the Ministry of Health and Family Welfare, Government of India, were included 
in this study are: (1) HIV/ AIDS Control; (2) Revised National Tuberculosis Control (RNTCP); (3) 
Vector Borne Disease Control (NVBDCP); (4) Leprosy Eradication (NLEP); (5) National Mental 
Health (NMPH); (6) Prevention and Control of Deafness (NPPCD); (7) Control of Blindness 
(NPCB); (8) Pulse Polio; (9) Universal Immunization (UIP); (10) Tobacco Control (NTCP); and (11) 
Health Care of the Elderly (NPHCE).  
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Non-communicable disease: Any disease that can NOT be transmitted from one person to 
another by direct physical contact, by common handling of an object that has picked up 
infective micro-organisms, through a disease carrier, or by spread of infected droplets coughed 
or exhaled into the air.9 
 
Pharmaceutical care: the responsible provision of drug therapy for the purpose of achieving 
definite outcomes that improve a patient’s quality of life. It is a collaborative process that aims 
to prevent or identify and solve medicinal product and health-related problems. This is a 
continuous quality improvement process for the use of medicinal products.10 
 
Pharmaceutical practice: includes the provision of pharmaceutical products, pharmaceutical 
services and pharmaceutical care and covers all those activities and services provided by 
pharmacists in the health care system.11 
 
Pharmaceutical services: all the services rendered by pharmaceutical staff to support provision 
of pharmaceutical care. Beyond the supply of pharmaceutical products, pharmaceutical services 
include information, education and communication to promote public health, the provision of 
drug information and counseling, regulatory services, education and training of staff.12 
 
Pharmacist: a person professionally qualified in pharmacy, the branch of health sciences 
dealing with the preparation, dispensing and use of medicines. The role of the pharmacist has 
evolved from that of a provider of medicines to that of a provider of patient-centered 
pharmaceutical care.13 
 
Prevention (preventive measures): measures which aim to thwart or ward off illness or disease 
prophylactically.14 
 
Public health: According to World Health Organization, WHO, (2014a) “public health refers to 
all organized measures (whether public or private) to prevent disease, promote health, prolong 
life among the population as a whole. Its activities aim to provide conditions in which people 
can be healthy and focus on entire populations, not on individual patients or diseases”.15 
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ABBREVIATIONS  
ACPE : Accreditation Council for Pharmacy Education  
AICTE: All India Council for Technical Education  
AIDS: Acquired Immunodeficiency Syndrome 
APPEs: Advanced Pharmacy Practice Experiences 
ART: Antiretroviral Therapy  
BPharm: Bachelor of Pharmacy  
DPharm: Diploma in Pharmacy  
FIP: International Pharmaceutical Federation  
GPP: Good Pharmacy Practice  
HIV: Human Immunodeficiency Virus 
IPA: Indian Pharmaceutical Association  
MoU: Memorandum of Understanding  
MPharm: Master of Pharmacy  
MPJE: Multistate Pharmacy Jurisprudence Examination 
NAPLEX: North American Pharmacist Licensure Examination 
NPHPs: National Public Health Programs  
NRHM: National Rural Health Mission  
NTCP: National Tobacco Control Program  
PCI: Pharmacy Council of India  
PCOA: Pharmacy Curriculum Outcomes Assessment  
PharmD: Doctor of Pharmacy 
RNTCP: Revised National Tuberculosis Control Program (India) 
TB: Tuberculosis  
WHO: World Health Organization 
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1  INTRODUCTION  
Pharmacies are convenient for most people to get to and there is no need for an appointment 
to see the pharmacist which makes them natural first port of call16 healthcare providers in 
society. Worldwide pharmacists are potentially a vital link in the healthcare chain. Since the 
public health services do not cater to all the population, pharmacies and private health 
providers can play a major role in the healthcare system in India. Having such large presence, 
unfortunately, pharmacists both in public as well as in private sector remain largely an 
untapped resource in India.17,18,19 One of the glaring examples of this is reflected by the fact 
that the term pharmacist does not find even a mention in National Health Policy 2002 and 
National Pharmaceutical Policy of the Ministry of Health, Government of India. Major public 
health programs are covered under the Ministry of Health and Family Welfare, Government of 
India, which are: HIV/AIDS prevention and control, Tuberculosis control, Leprosy and Vector 
Borne Disease control, Mental health, Deafness and Blindness control, Pulse Polio, Universal 
Immunization, Health Care of Elderly and Tobacco Control programs.20  Public health services in 
this study mean active participation of pharmacists in major health programs run by the 
government. However, the public health system in India has a shortage of medical and 
paramedical personnel. Government estimates (based on vacancies in sanctioned posts) 
indicate that 18% of primary health centers are without a doctor, about 38% are without a 
laboratory technician, and 16% are without a pharmacist.21 
 
Worldwide, there are differences in pharmacy education and pharmacists’ role in public health 
and patient care. India has different undergraduate pharmacy education programs with varying 
contents. In 1994, WHO resolution WHA 47.12 recognized the key role of pharmacists in public 
health and particularly in the field of medicines which should reflect to curriculum content.22 
However, little research has focused on assessing how public health and patient care aspects 
have been taken into account in pharmacy education in India and some other countries where 
pharmacists actually are more involved in patient care and public health programs.  
 20 
 
This thesis is a collation of literature review and scientific research results which is leading to 
discussion and conclusions. The literature review provides framework and blueprint for the 
research (Chapter 6) and also provides knowledge about health system (Chapter 2), 
pharmacists and public health (Chapter 3), pharmacy practice in India (Chapter 4), and 
pharmacy education in India (Chapter 5).   
The research work in this thesis was to assess public health and patient care aspects in 
pharmacy education and the role of pharmacists in national health care programs in India (I and 
II). The research goal was to find out possibilities and ways of extending pharmacists 
involvement in national public health programs and how pharmacist education could partly 
facilitate this shift. The research also explored: a) final year DPharm, BPharm and PharmD 
students’ awareness, perceived knowledge and attitude, and acquaintance with 11 major 
National Public Health Programs (NPHPs); b) their attitude towards pharmacists’ involvement in 
public health and patient care (III); c) characterized physicians’ perceptions on pharmacists’ role 
in public health and patient care (IV). This PhD thesis is an attempt to find ways how pharmacy 
education can facilitate pharmacists’ involvement in public health programs and make them 
part of health care team.  
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2 HEALTH SYSTEM IN INDIA 
2.1  Health System Prevailing 
 
To understand this research better, it is important to know briefly about the health system 
prevailing in India. 
 
WHO defines ‘public health’ as the science and art of promoting health, preventing disease and 
prolonging life through the organized efforts of the society.23 Public health is a social and 
political concept aimed at improving health, prolonging life and quality of life among whole 
populations through health promotion, disease prevention and other forms of health 
interventions.24  
 
As per the World Health Organization (WHO), a well-functioning health system working in 
harmony is built on trained and motivated health workers, a well-maintained infrastructure, 
and a reliable supply of medicines and technologies, backed by adequate funding, strong health 
plans and evidence-based policies.25 A health system consists of all organizations, people and 
actions whose primary intent is to promote, restore or maintain health.26 The overall health 
systems goal is to improve population health outcomes in an equitable way without 
overburdening people with health care costs.27  
 
India’s health care system was carefully structured at the time of Independence (1946) to 
provide primary, preventive, and curative health care within a reasonable distance of the 
population even in remote, rural areas.28 The health care system in India, at present, has a 
three-tier structure to provide health care services to its people.29 Networks of health care 
facilities at the primary, secondary and tertiary level, run mainly by State Governments, provide 
free or very low cost medical services. There is also an extensive private health care sector, 
covering the entire spectrum from individual doctors and their clinics, to general hospitals and 
super specialty hospitals. The three tier structure of health system is shown in Figure 1 below.  
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Figure 1. Three tier health care system in India (ANM: Auxiliary Nurse-Midwife and MPW: Multipurpose 
Workers) 
2.1.1 Primary Health Care 
 
Primary health care denotes the first level of contact between individuals and families with the 
health system (Figure 1). According to Alma Ata Declaration of 1978,30 primary health care was 
to serve the community; it included maternal and child health care, also family planning; 
immunization against the major infectious diseases; prevention and control of local endemic 
diseases; appropriate treatment of common diseases and injuries; and provision of essential 
drugs, health education, provision of food and nutrition and adequate supply of safe drinking 
water. In India, primary health care is provided through a network of Sub-centers and primary 
health centers in rural areas, whereas in urban areas, it is provided through Health posts and 
Family Welfare Centers (Figure 1). The Sub-center consists of one auxiliary nurse midwife and 
one multipurpose health worker who serves a population of 5,000 in plains and 3,000 people 
living in hilly and tribal areas. The Primary Health Centre (PHC), staffed by a Medical Officer and 
Primary tier 
• Subcenter (SC), ANM, MPW: covering a population range between 3,000 - 
5,000  
• Primary health care centers (PHC):  covering a population range between 
20,000 - 30,000  
Secondary 
tier  
• Community health centers  (CHC): covering a population range between 
80,000 - 120,000  
• District hospitals: covering population in entire dstrict  
Tertiary tier   
• Special hospitals  
• Regional and Central institutions / teaching hospitals  
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other paramedical staff serves around 30,000 population in the plains or 20,000 population in 
hilly, tribal and backward areas. Each PHC is to supervise 6 Sub-centers. 
 
2.1.2  Secondary Health Care  
 
Secondary Health Care refers to the second tier of health system, in which patients from 
primary health care are referred to specialists in higher hospitals for treatment (Figure 1). In 
India, the health centers for secondary health care include District hospitals and Community 
Health Centers at block level. 
 
2.1.3  Tertiary Health Care  
 
Tertiary Health care refers to the third level of health system, in which specialized consultative 
care is provided usually on referral from primary and secondary medical care (Figure 1). 
Specialized Intensive Care Units, advanced diagnostic support services and medical personnel 
specialization are the key features of tertiary health care. In India, under public health system, 
tertiary care service is provided by medical colleges and advanced medical research institutes. 
 
2.2 Evolution and Development of Public Health System in India 
The Bhore committee report is the first health report in India, i.e. the Health Planning and 
Development Committee's Report, 1946.31 It was a plan equivalent to Britain's National Health 
Service (NHS). The Report was based on a countrywide survey in British India. It is the first 
organized set of health care data for India.  
 
After independence, India embarked on a planned effort to raise standard of living of the 
people and impetus was given to health care, which was made integral part of socio-economic 
development.32 Over the past seven decades (since 1947), public health infrastructure and 
services have undergone remarkable changes and huge expansion in scale and nature based on 
recommendations by a number of expert committees.33 The Alma Ata declaration34 in 1978 led 
to the launch of “Health for All by 2000”signed by 137 countries, including India.35 The strategy 
for health care development shifted from committee to policy-based approach with the 
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formulation of National Health Policy 1983. The major goal of this policy was to provide 
universal and comprehensive primary health services.36  
 
The Alma Ata Declaration on Primary Health Care 1978,37 states that “…health is a fundamental 
human right and that the attainment of the highest possible level of health is the most 
important worldwide social goal”. In addressing main health problems in the community, 
Primary Health Care (PHC) must “…provide promotive, preventive, curative and rehabilitative 
services”. The Declaration states that PHC includes at least “…prevention and control of local 
endemic diseases, appropriate treatment of common diseases and injuries and the provision of 
essential drugs”. The Declaration recognized the role played by all health workers and the need 
for suitable training to enable these people to work as health care team to respond to the 
expressed needs of the community. 
 
2.3 Major milestones in evolution of Primary Health Care in India38 
Over the past seven decades, several governments appointed Committees and Commissions 
examined issues and challenges which health sector is facing. The purpose of these ad hoc 
committees formed from time to time is to review the current situation regarding public health 
status in the country and suggest further course of action in order to accord the best of health 
care to the people. The Table 1 below highlights the salient findings and recommendations of 
the various committees since 1946: 
 
Table 1. Salient findings and recommendations of the various committees of the Government of 
India since 1946  
1946 Bhore Committee Report on Health  Survey and  Development39 
The recommendations of the Bhore Committee report were:  
 integration of preventive and curative services at all administrative levels  
 short term Primary Health Centre for 40,000 population   
 long term (3 million plan) – Primary Health Centers with 75 beds for each 10,000 – 20,000 
population   
 formation of Village Health Committees  
 provision of Social doctor; intersectoral approach to health servicers development   
 three months training in preventive and social medicine to prepare social physicians  for better 
health status of the citizens 
 
 25 
 
1948 Sokhey Committee Report on National Health40 
The National Planning Committee (NPC) set up by the Indian National Congress in 1948 under the 
chairmanship of Colonel S. Sokhey stated that the maintenance of the health of the people was the 
responsibility of the State, and the integration of preventive and curative functions in a single state 
agency was emphasized.41 The Sokhey Committee Report endorsed the recommendations of the 
Bhore Committee Report and commented that it was “of the utmost significance”. 
1952 Community Development Programme42 (CDP) 
CDP was envisaged as a multipurpose programme covering health and sanitation (through the 
establishment of Primary Health Care Centers and Sub-Centers) and other related sectors, including 
agriculture, education, transport, social welfare and industries. Each Community Development Block 
(CDB) consists of 100 villages with an approximate total population of 100,000.  
1962 Mudaliar Committee on Health Survey and Planning43 
The major recommendation of this committee was to limit the population served by primary health 
centers to 40,000 with the improvement in the quality of health care provided by these centers. Also 
provision of one basic health worker per 10,000 population was recommended. 
1966 Mukherji Committee on Basic Health Service44 
The committee also worked out the composition and organization of basic health services, which should 
be provided at the Block level. Also it strongly recommended that importance must be given to due 
strengthening of the supervisory levels to correspond to the strengthening of the base organization.45  
1967 Jungalwalla Committee on Integration of Health  Services46 
The committee recommended integration from the highest to lowest level in the services, organization 
and personnel. That is Medical Care and Public Health programs should be put under charge of a single 
administrator at all levels of hierarchy by adopting  - The Unified Cadre, Common Seniority, recognition 
of  extra qualifications,  equal pay for equal work, special pay for special work, abolition of private 
practice by government doctors, improvement in their service conditions. 
1973 Kartar Singh Committee on Multipurpose Health Workers47 
The committee recommended the amalgamation of peripheral workers into a single cadre of 
multipurpose workers. Also it recommended the organizational change with respect to PHCs and SCs - 
one PHC to be established for every 50,000 population.  Each PHC to be divided into 16 SCs each for a 
population of 3,000–3,500.  Each SC to be staffed by a team of one male and one female health worker.  
The work of 3-4 health workers to be supervised by one Health Assistant. 
1975 Shrivastav Committee on Medical Education and Support Manpower48 
The committee recommended:  
 Creation of bands of paraprofessional and semi-professional health workers from within the 
community (like school teachers, post masters etc).   
 Establishment of 3 cadres of health workers between community level workers and doctors at PHC.   
 Development of “Referral Service Complex” by establishing linkages between the primary health 
center and higher level referral and service centers like taluka (municipality), district, regional and 
medical college hospitals.  
 Establishment of a Medical and Health Education Commission for planning and implementing the 
reforms needed in health and medical education on the lines of University Grants Commission. 
1977 Rural Health Scheme: Community Health Volunteer Scheme-Village Health Guides49 
According to the Village Health Guide (VHG) scheme, the village community selects a volunteer from the 
village, mostly women, who was imparted short term training and small incentive for the work. VHG acts 
as a link between the community and the Government Health System.50 He/she mainly provides health 
education and creates awareness of Maternal and Child Health and Family Welfare Services. He/she has 
to keep a track of communicable diseases and treat minor ailments and provide first aid to the patients.  
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Alma Ata Declaration and beyond 
1978 Alma Ata Declaration – Health For All by 200051 
The Declaration recommended that primary health care should include at least: education concerning 
prevailing health problems and methods of identifying, preventing and controlling them; promotion of 
food supply and proper nutrition, and adequate supply of safe water and basic sanitation; maternal and 
child health care, including family planning; immunization against major infectious diseases; prevention 
and control of local endemic diseases; appropriate treatment of common diseases and injuries; 
promotion of mental health and provision of essential drugs. It emphasized the need for strong first-
level care with strong secondary- and tertiary-level care linked to it. In one sense, primary health care 
reasserted the role and responsibilities of the State, and recognized that health is influenced by a 
multitude of factors and not just the health services. 
1980 ICSSR and ICMR – “Health for all- An Alternate Strategy”52 
The report also recommended the formulation of a comprehensive national health policy through an 
intersectoral approach that includes environment, nutrition, education, socio-economic, preventive and 
curative dimensions. 
1983   Mehta Committee on Medical Education Review53 
The Mehta committee mainly reviewed the medical education in all its aspects and specifically discussed 
about lack of availability of Health manpower data in India. It also recommended establishment of 
commission for universities of medical sciences and health education; method for updating manpower 
data and projections for doctors, nurses and pharmacists. 
1983 First National Health Policy54 
The major goal of this policy was to provide universal, comprehensive primary health services.  
1987 Bajaj Committee on health manpower planning, production and management55 
The major recommendations are: 
 Formulation of national medical and health education policy.  
 Formulation of national health manpower policy. 
 Establishment of an Educational Commission for Health Sciences (ECHS) on the lines of UGC.   
 Establishment of health science universities in various states and union territories.  
 Establishment of health manpower cells at center and in all states.  
 Vocationalization of education at 10+2 levels for health related fields with appropriate incentives, so 
that good quality paramedical personnel may be available in adequate numbers.  
 Carrying out a realistic health manpower survey. 
1996 Bajaj Committee on Public Health Systems56 
Key recommendations are policy initiatives with respect to review National Health Policy, 
Establishment of health impact assessment cell, surveillance of critically polluted areas, search for 
alternative strategy / strengthening of health services / system research, uniform adoption of public 
health Act by the local health authorities, establishing national notification system / national health 
regulations, joint council of health, family welfare and ISM and homeopathy, establishing an apex 
technical advisory body, constitution of Indian medical and health services, administrative 
restructuring of department of health and family welfare and Director General of Health Services 
(DGHS), strong health manpower planning division under DGHS, opening of regional schools of 
public health along with the emphasis on implementation of committee recommendations of 
manpower planning, production and management of 1987. 
 2000 National Population Policy (NPP)57 
The immediate objective of NPP was to address the unmet needs of contraception, health care 
infrastructure and health personnel and to provide integrated delivery for basic reproductive and 
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childcare services. It envisaged development of one-stop integrated and coordinated service 
delivery at the village level for basic reproductive and child health services through a partnership of 
the government with voluntary and non-governmental organizations. 
2002 Second National Health Policy58 
The major goals set by this policy are:  
 Eradication of Polio and Yaws by 2005 
 Elimination Leprosy by 2005 
 Elimination Kala Azar by 2010 
 Elimination Lymphatic Filariasis by 2015  
 Achievement of zero level growth of HIV/AIDS by 2007 
 Reduction of Mortality by 50% on account of TB Malaria, other vector and water borne diseases by 2010 
 Reduction of IMR to 30/100 and MMR to 100 per 100,000 by 2010 
 Increase the utilization of public health facilities from <20% to >75% by 2010 
 Increase health expenditure by Government as a %GDP from existing 0.9% to 2% by 2010 
 Establish an integrated system of surveillance, National Health Accounts and Health Statistics by 2005 
 Increase share of central grants to constitute at least 25% of total health spending by 2010 
 Increase state sector health spending from 5.5% to 7% of budget by 2005 and further increase to 8% by 2010 
2005 National Rural Health Mission (NRHM)59 
The National Rural Health Mission aims to restructure the health delivery systems towards providing 
universal access to equitable, affordable and quality health care responsive to the health needs of the 
community. Human resource requirement under NRHM has stepped up drastically, in view of renewed 
commitment to universal coverage. The challenges involved in training, recruitment, placement and 
motivation of health workers across the country cannot be neglected, if universal coverage is to be 
attained. 
2015 Pharmacy Practice Regulations, 201560 
Some of the salient features of the regulations are below.  
• It is mandatory to display owner’s name at or near the entrance of pharmacy  
• It is mandatory to display the name, registration number, qualification, and photograph of Registered 
pharmacist in dispensing area.  
• Registered pharmacist must dress formally and wear a clean white overall (coat/apron) with a badge 
displaying the name and registration number.  
• Registered pharmacist must attend minimum 2 refresher courses of minimum of 1 day duration each 
in a span of 5 years for renewal of the registration as pharmacist.  
• The regulations have in detail the duties of the registered pharmacists, as well as their duties to their 
patients, to each other, to the public and to the profession.  
• The regulations have listed a list of acts of commission or omission which if committed by a 
Registered Pharmacists amount to professional misconduct, thus rendering him/her liable for 
disciplinary action.  
 The regulations also list out the details of position title, job responsibilities, knowledge and skills of 
various cadres of pharmacists at hospital practice site, at a community pharmacy, and of drug 
information pharmacists. 
2015 National Health Policy (draft under progress) 
The main goal of the Policy is:  
The attainment of highest possible level of good health and well-being, through a preventive and 
promotive health care orientation in all developmental policies, and universal access to good quality 
health care services without anyone having to face financial hardship as a consequence.   
 
The objectives of the policy are:  
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Improve population health status through concerted policy action in all sectors and expand preventive, 
promotive, curative, palliative and rehabilitative services provided by the public health sector.    
 
Achieve a significant reduction in out of pocket expenditure due to health care costs and reduction in 
proportion of households experiencing catastrophic health expenditures and consequent 
impoverishment.    
 
Assure universal availability of free, comprehensive primary health care services, as an entitlement, for 
all aspects of reproductive, maternal, child and adolescent health and for the most prevalent 
communicable and non-communicable diseases in the population. 
 
Enable universal access to free essential drugs, diagnostics, emergency ambulance services, and 
emergency medical and surgical care services in public health facilities, so as to enhance the financial 
protection role of public facilities for all sections of the population.   
 
Ensure improved access and affordability of secondary and tertiary care services through a combination 
of public hospitals and strategic purchasing of services from the private health sector.    
 
Influence the growth of the private health care industry and medical technologies to ensure alignment 
with public health goals, and enable contribution to making health care systems more effective, 
efficient, rational, safe, affordable and ethical. 
 
2.4  Health Indicators in India 
Spending on health care in India was an estimated five percent of gross domestic product (GDP) in 2013. 
It is expected to remain at that level through 2016 and the total health care spending in local-currency 
terms is projected to rise at an annual rate of over 12%, from an estimated $96.3 billion in 2013 to 
$195.7 billion in 2018. 61 The government’s low spending on health care places much of the burden on 
patients and their families, as evidenced by the country’s out-of-pocket (OOP) spending rate, one of the 
world’s highest. According to the World Health Organization (WHO), just 33% of Indian health care 
expenditures in 2012 came from government sources. Of the remaining private spending, around 86% 
was OOP.62 India still spends only around 4.2% of its national GDP towards health care goods and 
services (compared to 18% by the US).63 Key Health Indicators in India are shown in Table 2 below.  
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Table 2. Key Health Indicators of India (Source: World Health Organization Country Office, India) 
Indicator  Statistics  Year  
Population  1,300,000,000 2015 
Population aged under 15 years (%) 29 2013 
Population aged over 60 years (%) 8 2013 
Median age (years) 26 2013 
Population living in urban areas (%) 32 2013 
Total infertility rate (per woman) 2.5 2013 
Number of live births per year (thousands) 25595.2 2013 
Number of deaths per year (thousands) 9944.9 2013 
Birth registration coverage (%)  84  2011 
Cause of death registration coverage (%) 8  2007 
Life expectancy at birth (years)  68.3 2016 
Gross national income per capita (PPP int $)  5350 2013 
Total expenditure on health per capita (Intl $) 215 2013 
Total expenditure on health as % of GDP  4 2013 
GDP = Gross Domestic Product 
2.5  India in Comparison to International Ranking 
World Health Organization recognizes health as a human right and a common denominator for ensuring 
social well-being.64  With the World Health Organization’s 2000 World Health Report ranking India’s 
health care system was at 112 out of 190 countries.65  
 
Comparison of health expenditure across various countries internationally is presented in Table 3. 
India’s per capita health expenditure was $146 PPP in 2011. Share of government expenditure in total 
health expenditure of India is just over 30%, which is the lowest among these 16 countries.  
  
 30 
 
Table 3. International comparison of health expenditure, 2011 (World Health Organization 2014) 
Country 
Per Capita 
Government 
expenditure (PPP$) 
Per capita 
Total Expenditure (PPP$) 
Share of Government 
Expenditure in Total (%) 
USA  4,047 8,467 47.8 
Germany 3,420 4,474 76.4 
France  3,169 4,128 76.8 
Canada  3,197 4,541 70.4 
U.K  2,728 3,364 81.1 
Brazil     474 1,035 45.8 
Mexico     505 1,004 50.3 
China     236    423 55.8 
Malaysia     341    619 55.1 
Indonesia       50    132 37.9 
Thailand     289    372 77.7 
Pakistan       26      83 31.3 
Sri Lanka       77    183 42.1 
Bangladesh       26      67 38.8 
Nepal       39      85 45.9  
India       44    146 30.1 
PPP= purchasing power parity 
 
2.6  Human Resources in Health Care  
Human Resources Management (HRM) is a vital management task in the field of health care and other 
services sectors. In these sectors, because of staff performance customer is facing challenges and 
experiences in quality of performance (Howard et al., 2006). Human resource management in these 
sectors plays pivotal role in the success of the reform of health sector.66  
 
There are strong linkages between population, health and development. India’s health challenges are 
not only huge in magnitude due to its large population but they are complex due to its diversity and the 
chronic poverty and inequality. There are extreme interstate variations, caused by not only the cultural 
diversity but because the states are at different stages of demographic transition, epidemiological 
transition and socioeconomic development.67 
 
Effectively functioning health systems depend on human resource, which range from medical, AYUSH 
and dental graduates and specialists, graduate, auxiliary nurses and pharmacists to other allied health 
professionals. Despite considerable improvement in health personnel in position (ANM 27%, nurses 
119%, doctors 16%, specialists 36%, pharmacists 38%), gap between staff in position and staff required 
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at the end of the plan was 52% for ANM and nurses, 76% for doctors, 88% for specialists and 58% for 
pharmacists.68 These shortages are attributed to delays in recruitment and to postings not being based 
on workload or sanctions. Public health cadre as envisioned in the Eleventh Plan to manage NRHM is not 
yet in place. Similarly, lack of sound human resource management policies result in irrational 
distribution of available human resource and suboptimal motivation.69 
 
The scarcity of skilled human resources has been one of the major bottlenecks in achieving the progress 
towards Millennium Development Goals (MDG’s). The proportion of skilled health providers stands very 
low at 100 per 100,000 populations as against the international minimum norm of 228 per 100,000 
populations to deliver basic maternal and child health services. Added to this, is the issue of skewed 
distribution of health workers towards the urban areas, which is evident from the fact that 60% of the 
health workforce in the urban areas, where only 28% percent of the country’s population reside (Census 
India 2001). As per World Health Statistics 2013, physicians 6.5, 10, 0.8, and 5.4 pharmacists per 10,000 
population in India 2005 – 2012 whereas, maximum 26.3 pharmacists per 10,000 population.70  
 
2.7  Health Workforce in India 71  
“India has a severe shortage of human resources for health. India’s health workforce is made up of a 
range of health workers who offer health-care services in different specialties of medicine. These 
personnel consists of allopathic doctors (31%), with bachelor degree or specialists; practitioners of 
ayurveda, yoga, naturopathy, unani, siddha, and homoeopathy (9%), with university degree or 
specializations; nurses and midwives (30%); pharmacists (11%) with diploma, bachelor, masters and 
PharmD (doctorate) degrees; and others (9%) which comprises of technicians and allied health workers; 
community health workers includes health educators and health assistants; accredited social health 
activists; registered medical practitioners with little or no formal training and traditional medicine 
practitioners and faith healers.72 A comprehensive national policy for human resources is needed to 
achieve universal health care in India.”73 Public health system has a shortage of medical and paramedical 
personnel. Government estimates (based on vacancies in sanctioned posts) indicate that 18% of primary 
health centers are without a doctor, about 38% are without a laboratory technician, and 16% are 
without a pharmacist,74,75 which shows existing shortages of laboratory technicians and pharmacists.76 
In cross-country comparisons, the total number of allopathic doctors, nurses, and midwifes (11.9 per 
10,000 people) is about half the WHO benchmark of 25.4 workers per 10,000 population.77 
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2.8  Pharma Vision 2020  
In December 2002, the Planning Commission of India setting the scene on health care, enshrined the 
India Vision 2020 for “…improving access to health services to meet the health care needs…”. 
The vision of the Pharmacy Council of India is enumerated below78: 
 In the year 2020, pharmacists and pharmaceutical scientists working within various disciplines of 
pharmacy will be established and recognized as the medicines experts and experts in health 
promotion and disease prevention. 
 The pharmacists will interact with other professionals as the preferred source of information 
and advice on prescribing and medicine management of disease. 
 The pharmacists will develop their pharmaceutical expertise and facilities in order to deliver 
high-tech and individually tailored medicines in the primary care setting. 
 The pharmacists will be actively involved in the National Health Programs like promotion of 
essential medicines, primary health care, HIV/AIDS, TB, malaria, tobacco use or family 
planning.  
 The pharmacists will become knowledgeable to participate in medication management and 
outcome monitoring, including the ability to alter doses and change medicines with agreed 
therapeutic protocols. 
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3 PHARMACISTS AND PUBLIC HEALTH IN INDIA  
 
In general, major health programs (communicable and non-communicable) are derived from 
the national health policy which need human resources for implementation. This chapter is 
focused on national health policy and existing programs in India, current status, opportunities 
and barriers for pharmacists in implementing or taking active part in these programs. Existing 
initiatives of pharmacy organizations in India in promoting role of pharmacists in NPHPs is 
presented. Furthermore, statements and policies of international organizations such as WHO 
and International Pharmaceutical Federation (FIP) and examples of worldwide organizations 
promoting role of pharmacists in public health are discussed.  
 
3.1 National Health Policy in India 
In the national health policy 2002, the word pharmacist is not mentioned79. Also historically, 
pharmacists have not been mentioned in Indian government's health and pharmaceutical 
policies, perhaps due to lack of clarity of their role and their potential beyond supply of 
pharmaceutical products. Policy makers should exploit potential of pharmacists in community, 
hospital and government settings for improving pharmaceutical services and health and thus 
relieve the doctors, dentists and nurses of unnecessary load of work. Policy makers usually see 
pharmacies as commercial enterprises and pharmacists as business people. Policy makers 
should view pharmacies as part of the health care sector and pharmacists as health care 
professionals providing health care services and focus on them as they do with other health 
care professionals. 
 
The new draft National Health Policy 2015;80 which is under final phase of preparation, 
addresses the urgent need to improve performance of health systems in India. Given the two-
way linkage between economic growth and health status, this National Health Policy is a 
declaration of the determination of the Government to leverage economic growth to achieve 
health outcomes and an explicit acknowledgement that better health contributes immensely to 
improved productivity as well as to equity.  
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The primary aim of the new National Health Policy 2015,81 is to inform, clarify, strengthen and 
prioritize the role of the government in shaping health systems in all its dimensions: investment 
in health, organization and financing of healthcare services, prevention of diseases and 
promotion of good health through cross sectoral action, access to technologies, developing 
human resources, encouraging medical pluralism, building the knowledge base required for 
better health, financial protection strategies, regulation and legislation for health.  
 
A policy is only as good as its implementation. Past policies, have faced innumerable constraints 
in implementation. The National Health Policy therefore envisages that an implementation 
framework be put in place to deliver these policy commitments. However, the implementation 
framework and policy are yet to be finalized.  
 
The most positive observation for the profession is that in the new draft national health policy 
2015, pharmacists are identified as human resources for health among doctors, nurses and 
dental health professionals.82 The draft policy also mentions the need of further expansion of 
the pharmacy education and the need to ensure the outputs of these institutions (including 
pharmacy) to meet the needs of the nation. The draft policy has also mentioned pharmacists as 
available complementary human resource options to develop expansion of primary care. This 
will not only improve availability of manpower with appropriate skills in public health system in 
remote areas but will also provide additional promotional avenues to many cadres and attract 
them to work in remote areas. As per the draft policy, the last ten years have seen a major 
expansion of medical, nursing and technical education, including pharmacy education. The 
policy mentions that there is greater opportunity to make use of these resources to provide 
local employment without compromising quality. The policy emphasizes enforcement of quality 
professional education or professional ethics and good practices to be implemented by 
professional councils; including Pharmacy Council of India. The policy calls for a major reform 
and strengthening of these bodies and their accountability.  
  
 35 
 
3.2  National Public Health Programs in India  
The government of India runs several national public health programs for the citizens of India. 
The major programs83 are to cover both communicable and non-communicable diseases, the 
main objectives of these programs are given in Table 4 below 
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Table 4. National Health Programs and Their Objectives84 
 
Program title Objective(s) 
Communicable diseases  
National HIV/AIDS Control 
Program 
The main objective of this program in India is that every person living with HIV has 
access to quality care and is treated with dignity. Effective prevention, care and 
support for HIV/AIDS is possible in an environment where human rights are 
respected and where those infected or affected by HIV/AIDS live a life without 
stigma and discrimination. 
Revised National Tuberculosis 
Control Program (RNTCP) 
 
TB control program is to achieve and maintain cure rate of at least 85% in new 
sputum positive pulmonary TB patients and detection of at least 70% of such cases. 
Directly Observed Treatment is highlight of this program. 
National Vector Borne 
Disease Control Program 
(NVBDCP) 
The objectives of the program is to prevent and control Malaria, Dengue, Lymphatic 
Filariasis, Kala-azar, Japanese Encephalitis and Chikungunya in India. 
National Leprosy Eradication 
Program (NLEP) 
Early detection & complete treatment of new leprosy cases. Carrying out house hold 
contact survey in detection. Early diagnosis and prompt multi drug therapy (MDT), 
through routine and special efforts. Information, Education & Communication (IEC) 
activities in the community to improve self reporting to Primary Health Centre 
(PHC) and reduction of stigma. Intensive monitoring and supervision at Primary 
Health Centre/ Community Health Centre. 
Non-communicable diseases  
National Mental Health 
Program (NMHP) 
1) To ensure the availability and accessibility of minimum mental healthcare for all in 
the foreseeable future, particularly to the most vulnerable and underprivileged 
sections of the population; 2) To encourage the application of mental health 
knowledge in general healthcare and in social development; and 3) To promote 
community participation in the mental health service development and to stimulate 
efforts towards self-help in the community.  
National Program for 
Prevention and Control of 
Deafness (NPPCD) 
1) To prevent the avoidable hearing loss on account of disease or injury; 2) Early 
identification, diagnosis and treatment of ear problems responsible for hearing loss 
and deafness; and 3) To strengthen the existing intersectoral linkages for continuity 
of the rehabilitation program, for persons with deafness. 
National Program for Control 
of Blindness (NPCB) 
1) To reduce the backlog of blindness through identification and treatment of blind 
at primary, secondary and tertiary levels; 2) Prevention of visual impairment; 
through provision of comprehensive eye care services and quality service delivery; 
3) To enhance community awareness on eye care and lay stress on preventive 
measures; and 4) To secure participation of Voluntary organizations/Private 
Practitioners in eye care.  
Pulse Polio program Children in the age group of 0-5 years administered Polio drops during the national 
and sub-nationals immunization rounds. About 172 million children are immunized 
during each National Immunization Day. 
Universal Immunization 
Program (UIP) 
Protection of children from life threatening conditions by providing vaccination. 
Vaccines provided under UIP are BCG (Bacillus Calmette Guerin), DPT (Diphtheria, 
Pertussis and Tetanus Toxoid), OPV (Oral Polio Vaccine), Measles, Hepatitis and TT 
(Tetanus Toxoid). 
National Tobacco Control 
Program (NTCP) 
1) To bring about greater awareness about the harmful effects of tobacco use and 
about the Tobacco control Laws; and 2) To facilitate effective implementation of the 
Tobacco Control Laws. 
National Program for Health 
Care of the Elderly (NPHCE) 
To provide separate, specialized and comprehensive health care to the senior citizen 
at various level of State health care delivery system including outreach services. 
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3.3  Current Stand and Opportunities for Indian Pharmacists in Public Health 
Though there is large number of pharmacists working both in public and private sector still 
remain largely an untapped resource in India.85,86,87 One of the glaring examples of this is 
reflected by the fact that the pharmacists do not find even a mention in National Health Policy 
200288 and National Pharmaceutical Policy. 89  Nine out of eleven National Public Health 
Programs (NPHPs) run by the government of India, namely leprosy and vector borne disease 
control, mental health, deafness and blindness control, pulse polio, universal immunization, 
health care of elderly and tobacco control programs.90 Pharmacists’ involvement in HIV/AIDS 
prevention and control; and tuberculosis control programs that have been recently rolled out.14  
 
However, for decades the health and pharmaceutical policies of India have overseen human 
resources readily available in pharmacy profession. The Indian public health standards 
formulated by the National Rural Health Mission (NRHM) do not place much emphasis on the 
role of pharmacists as compared to other categories of health care personnel, such as nurses 
and laboratory technicians.91  
 
These large numbers of pharmacists available are being used by health authorities to show 
improved and better statistics of health and medical personnel, but not being used in policies 
and patient care practice settings. In the worldwide scenario, pharmacists offer public health 
interventions more conveniently than other paramedics, since they are easily accessible and 
recognized as experts in matters of health92 and medicine, which should be adopted by Indian 
pharmacy profession. The huge workforce that is readily available is not officially a part of 
health care team. If this workforce is motivated and properly trained, they can become 
tremendous potential for improving public health in India. 
 
Internationally, there is an under use of pharmacists for patient care and public health efforts. 
A coordinated and multifaceted effort to advance workforce planning, training, and education 
is needed in order to prepare an adequate number of well-trained pharmacists for such roles.93 
In 2011, International Pharmaceutical Federation (FIP) in conjunction with WHO has come up 
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with a new version of Good Pharmacy Practice guidelines. 94 The expected roles of the 
pharmacists are: 95  
i) prepare, obtain, store, secure, distribute, dispense, administer and disposal medical 
products; 
ii) provide effective drug therapy management;  
iii) maintain and improve professional performance; and  
iv) contribute to improve effectiveness of the health-care system and public health. 
 
3.4  Pharmacists as Human Resources for Public Health Programs in India  
Manpower for health services has been described as ‘the heart of the health system in any 
country.96 , 97  World health workforce is facing significant challenges. With an estimated 
shortage of more than four million health workers worldwide, the global health workforce crisis 
is possibly the greatest health system constraint in countries seeking to meet their 2015 
Millennium Development goals (MDGs).98 As identified by the World Health report 2006, India 
is 1 of 57 countries facing shortage of Human Resources for Health.99,100 In India, the latest 
advances in medicine are  available to people who can pay, but the vast underclass of 800 
million people or more, have  little or no access to healthcare.101 The public health system in 
India has a shortage of medical and paramedical personnel. As of March 2013, the total number 
of registered doctors in the country was 885,233.102 Government estimates, based on vacancies 
in sanctioned posts, indicate that 18% of primary health centers are without a doctor, about 
38% are without a laboratory technician, and 16% are without a pharmacist.103,104  
 
Physicians are opinion leaders in health care policy making, and thus, in key position for 
building up strategies for pharmacists’ involvement in national public health programs. Creating 
evidence on physicians’ perceptions on the role of pharmacists in public health and patient care 
could guide pharmacists in preparing to take active part in national public health programs 
(NPHPs) and to appear on national health and pharmaceutical policies. Pharmacists’ 
involvement in NPHPs means active participation in one or more of 11 NPHPs run by the 
government of India.105  
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3.5  Public Health Programs – Pharmacists’ Involvement and Barriers 
Appropriate training and support is needed in order to increase pharmacists’ confidence in 
providing public health services.106 Apart from community pharmacy, the pharmacists do have 
an important role in public health.107 Pharmacists are well positioned to also serve the mission 
of public health, both in their individual pharmacist–patient relationships and in their 
population-based activities and collaborations with public health agencies. The areas and the 
role of pharmacists are as follows:108 
 Immunization programs: administration and promotion of immunization 
 Disaster preparedness and response, e.g., natural disaster: Education of public, planning of 
emergency response, surveillance of noticeable syndromic conditions, communication with 
public, provision of mass medications, etc. 
 Contraceptive services: Distribution of contraceptive measures and education about their use 
 Prevention and control of disease and injury: Promotion of healthy lifestyles, reduce 
hospitalizations. 
 
3.6 Existing Interventions of Pharmacists in Public Health in India 
There is no official accumulated database on existing interventions of Indian pharmacists in 
public health. However, various sources like journals databases and association reports, very 
few interventions of pharmacists’ initiatives in public health are collated below. 
 
“A systemic review109 concluded that most pharmacists viewed public health services as 
important and part of their role but secondary to medicine related roles. The majority of 
pharmacists in the review were positive about providing public health services and felt that this 
was an important role. This suggests that the changing role of community pharmacy from 
traditional dispensing activities to greater involvement in health improvement is largely 
accepted, and the importance of providing these services is understood. Pharmacists’ 
confidence in providing public health services was on the whole average to low. Time was 
consistently identified as a barrier to providing public health services. Lack of an adequate 
counseling space, lack of demand and expectation of a negative reaction from customers were 
also reported by some pharmacists as barriers. Appropriate training and support is needed in 
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order to increase pharmacists’ confidence in providing public health services. A need for further 
training was identified in relation to a number of public health services.”  
 
Raj Vaidya et al. (2012) described in an article “The role of the Pharmacist in the various 
national health programs (National Vector Borne Disease Program, Cancer Control Program, 
School Health program, Blindness Control Program, National AIDS Control Program, AYUSH, 
Prevention and control of Non Communicable Diseases, National Tobacco Control Program, 
etc.) has never been envisaged or documented, and pharmacists have never made attempts to 
do the same. However, this needs to be done on a priority basis. For the profession to develop, 
major initiatives should be established by setting practice standards, qualification and 
registration of pharmacists at all levels and quality assurance standards for practice of 
pharmacy in the National Health Programs.”110 
 
The pharmacy profession in India has been full of contrast. One side to the coin of pharmacy 
profession in India is the industry sector which is successful and at par with the world in all 
aspects; on the other side, pharmacy practice which remained much behind time. Pharmacists 
are still not regarded or performing as true health care professionals. The retail pharmacy has 
been dominated by the business attitude rather than a professional approach and therefore, 
community pharmacist has failed to provide patient oriented services.111 However, slowly as 
professional pharmacy advances in other parts of the world, and globalization sets in, it is 
realized by retail chemists association and other national pharmacists associations and 
regulatory authorities that there is immediate need to change. They are coming together on a 
common platform to work towards this distinct goal. This is best exemplified by collaboration of 
the Drugs Controller General of India office with the Indian Pharmaceutical Association (IPA) 
and the WHO to develop Good Pharmacy Practices for the Indian community pharmacies.112 As 
part of this process, pharmacy educationists realized that there is a need to bring in changes in 
pharmacy curriculum to produce future generation of competent pharmacists from public 
health perspectives. Due to emphasis given by visionary leaders and increasing expectations of 
educated consumers, the pharmacists themselves are realizing the need of patient focused 
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services. Thus the background work for the journey of the traders towards the transformation 
to health professionals has begun. The new generation pharmacists in India; with PharmD 
program started in 2008; are gearing up for a change and are willing to absorb new ideas. The 
following are example of such initiatives taken by the pharmacy profession: 
 
3.6.1  Pharmacists Fight against HIV/AIDS in India 
The Indian National Health Policy was reformulated on the basis of realistic considerations of 
capacity.113 As per UNAIDS Gap Report 2016, there are 2.1 million people living with HIV and 
86,000 new HIV infections in 2015 of which 43% of adults were on antiretroviral therapy. 114 In 
this context, proper role and involvement of pharmacists in medicine management and overall 
health care program becomes crucial.  
 
The WHO has signed a joint declaration in 1997 with FIP on the role of the pharmacists in the 
fight against HIV/AIDS pandemic.115 The IPA in its countrywide initiative undertook sensitization 
of pharmacists and their role during National Pharmacy Week campaign in 2000. FIP 
Community Pharmacy Section (CPS) appointed an observer from India for the term 2000-2004 
with a specific aim of developing Guiding Principle for pharmacists to deal with HIV/AIDS in 
India. The efforts were supported by the CPS and FIP Foundation for Education and Research. 
The guiding principles document was prepared with the help of working group and they were 
used for training the trainers and in-service pharmacists. More than 400 pharmacists from New 
Delhi, 250 from Mysore and 25 pharmacists from Kolkata were trained in 2004.116  
 
The training objectives were to: 
 motivate pharmacists to disseminate information to the society on protection against 
HIV/AIDS;  
 explain about the safe use of disposable needles and condoms;  
 inform the HIV/AIDS patients about proper usage of drugs, diet and lifestyle changes; 
 encourage and counsel the kith and kin of the AIDS patients;  
 offer moral support to lead a smooth life.  
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The training modules also dealt with role of pharmacists in prevention and information, 
pathophysiology, mode of transmission and therapeutics of AIDS, safe blood and blood 
products, diagnostic screening tests and perils of injectable drug use.  
 
Due to the vast demography and huge number of pharmacists, it is desirable to intensify the 
training process by joining the consortium of like-minded organizations for global funding and 
unleashing proper use of anti-retrovirals. However, since then the IPA has included training 
modules in their regular training programs.   
 
3.6.2  Pharmacists for Future Free of Tobacco  
India is the second largest consumer and third largest producer of tobacco in the world.117 A 
majority (86%) of tobacco sale in India consists of bidi, chewing tobacco and gutkha. There are 
240 million smokers in India, out of which 194 million are men and 45 million are women. India 
reports 5 million child smokers with 55,000 children starting regular tobacco use every year.  
 
The Indian Pharmaceutical Association has identified the need of pharmacists’ participation in 
smoking cessation by conducting a survey in 2003 on role of pharmacists in future free of 
tobacco.118 The survey included pharmacy students, community pharmacists and pharmacists 
working in other facets like industry, regulatory, academics and hospitals. The survey results 
showed that 95% participating pharmacists felt that they have a role to play in fight for the 
future free of tobacco.119 After this, several Associations both at national and local levels have 
started organizing campaigns during National Pharmacist Week celebrations and World 
Tobacco Day to promote the role of pharmacists in Tobacco free future. During these 
campaigns, pharmacists disseminated the information in local languages. Pharmacists gained 
confidence about their role in the society and politicians who were willing to work and support 
pharmacists have reached on one platform to work together. Though there was lot of 
momentum during 2003 and 2004, recently there are no specific activities registered. It is 
important that the associations and other professional bodies continue the good work for the 
benefit of the society.  
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3.6. 3 TB Fact Card Project 
The participation of pharmacists in TB fact card project (an initiative of Indian Pharmaceutical 
Association, Commonwealth Pharmaceutical Association and International Pharmaceutical 
Students Federation) indicates the beginning of a new era in the history of Indian pharmacy 
practice. The counseling offered treatment monitoring and creation of awareness about TB 
among the community by dissemination of information, and encompasses all the aspects of 
pharmaceutical care by the pharmacists. There is a healthy partnership which is getting 
established with physicians through such work. This has became a milestone project leading to 
put the pharmacists on national programs. In recent years, pharmacists and professional 
associations have actively promoted the pharmacist’s role in public health. There are examples 
of pharmacists taking initiatives to be a part of national health programs such as the Revised 
National Tuberculosis Control Program (RNTCP). For the first time 2014, the RNTCP guidelines 
mentioned the word “pharmacist” as specialists with expertise in managing Multi-Drug-
Resistant Tuberculosis (MDR-TB)120 which is a step forward.  
 
In 2012, a Memorandum of Understanding (MoU) between Central TB Division and IPA, PCI, 
AIOCD and FIP-WHO SEARO Forum of National Pharmaceutical Associations  with an objective 
to engage pharmacists in RNTCP for TB care and control in India.121 This MoU was valid for one 
year and is extended till 2017.122   
 
3.7 Barriers for Pharmacists’ Involvement in Public Health 
Community pharmacies have both the opportunity and potential to play an important role in 
public health. Earlier research has shown that despite their potential, community pharmacies 
have been underutilized in the provision of public healthcare services.123 A systematic review 
on community pharmacy and emerging public health initiatives in developing South East Asian 
countries recognized that attempts have been made by countries to expand scope of 
community pharmacy practice through piloting the introduction of new services in both 
pharmacy and public health practice.124 However, the pace of such expansion has been 
relatively slow and is not supported by a strong evidence base for pharmacist involvement in 
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public health. Several notable barriers internally and externally to the pharmacy environment 
such as lack of knowledge, lack of confidence, poor recognition from the general public and 
lack of supportive policies have constrained progress.125  
 
The following three are some of the most important barriers that cover major challenges for 
pharmacists in taking an active role in public health and national public health programs.  
 
? Education needed for healthcare services provision in community pharmacies 
The healthcare services in community pharmacies are currently insignificant and therefore, 
must undergo reforms to meet the changing needs of modern medicines users. The 
pharmacist's role in patient care is expected to grow, as professional and educational 
standards develop. Although pharmacists' contributions to health care are yet to be 
recognized, there is every reason to be optimistic toward making patient care in community 
pharmacy setting a success. For this, the educational system for pharmacists has to be 
adapted.126 Efforts should be expanded to increase coverage of public health topics within 
pharmacy curriculum and vice versa. Public health mainly focuses on preventative care and 
the population’s perspective. 127 
 
The issue is globally important for the pharmacy profession and the FIP has recognized it 
and created a global platform for discussions, leadership, shared challenges and success. 
Recognizing the need to support and strengthen pharmacy education worldwide, in 
November 2007, FIP, in collaboration with WHO and United Nations Educational, Scientific 
and Cultural Organization (UNESCO), formed the Pharmacy Education Taskforce. The 
purpose of the Taskforce is to oversee the implementation of the Pharmacy Education 
Taskforce Work Plan. The Action Plan aims to enable the sustainability of a pharmacy 
workforce that is relevant to local needs.  The Action Plan is dedicated to five domains of 
action: quality assurance, academic and institutional capacity, pharmacy support workforce, 
leaderhsip, and competency and vision for pharmacy education. In many countries 
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worldwide have already influenced the training as they have shifted towards PharmD 
programs with more clinical pharmacy preparing for patient care oriented practice.  
 
A study conducted among community pharmacists in Malaysia recommends that 
undergraduate pharmacy education be redesigned to include public health training to 
ensure graduating pharmacists are competent in performing a public health role.128 
 
? Under utilization of pharmacists in public health  
The potential for pharmacists to effect dramatic improvements in public health remains 
largely untapped.129 Today, public health services are in demand. An opportunity exists for 
the integration of pharmacy and public health shifting the pharmacy profession toward a 
promising future. Evidence suggests that utilizing pharmacists in public health settings helps 
to improve health outcomes, decrease costs, prevent diseases, minimize adverse drug 
events and maintain good patient health. 130  
 
? Lack of supporting policies and regulations  
Both at local and national level, pharmacists needs proper policy back up and strict 
regulations in supporting their role in active participation in national and public health 
programs.  
 
3.8  Statements and Recommendations of Various International Organizations on the Role 
of Pharmacists in Public Health 
Health promotion, disease prevention and lifestyle modification are activities at community 
level that have a public health focus. Worldwide, pharmacists can offer public health 
interventions more conveniently than other groups since they are easily accessible and 
recognized as experts in matters of health. Globally, pharmacists are a trusted source of 
information and advice on health and medicines. However, they cannot operate in isolation and 
must accept joint responsibility with all health professionals to serve community and public 
health goals. In this context, various international organizations have charted out several 
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recommendations, policies and statements on how the pharmacists can take important role in 
health care system and public health programs. Highlights of these recommendations, policies 
are described below.  
 
3.8.1  WHO Recommendations to Involve Pharmacists in Health Care System 
 
The recognition of the role of pharmacist in various facets and improvement of pharmacy 
quality of services began under the WHO’s revised drug strategy in WHA 1986. WHO convened 
two Consultative Group meetings in New Delhi, India in 1988 and Tokyo, Japan in 1993 on the 
role of pharmacists in health care system.131 The important recommendations in relation to the 
pharmacy education and on the role of pharmacists in health care system are:  
 Pharmacists should communicate and cooperate effectively with the other members 
of the health care team 
 The undergraduate pharmacy course should adequately cover the principles of 
national health and drug policies 
 Pharmacists should be members of health care teams and their roles in the team 
should be recognized 
 The curriculum should be properly balanced with contents of basic sciences, 
pharmaceutical sciences, biomedical and clinical sciences, socio-economic and 
behavioral sciences and practice experience  
 
The WHO WHA 47.12 resolution from 1994, emphasized pharmacists’ responsibility to provide 
advice on medicines and their use, to promote the concept of pharmaceutical care, and to 
actively participate in illness prevention and health promotion.  
 
Subsequently WHO organized two more meetings on the role of the pharmacist, in Vancouver, 
Canada in 1997 and in The Hague, The Netherlands in 1998. These meetings reinforced the 
need for pharmacy curricular reform.132  
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3.8.2  FIP Policies and Statements on Pharmacy Education and Pharmacist Role in Healthcare 
The following are few of International Pharmaceutical Federation’s guidelines, statements, 
policies related to GPP and pharmacy education to promote pharmacists’ role in public 
health. 
 In response to the WHO’s recommendations, FIP in 1992 has developed standards for 
pharmacy services under the heading “Good pharmacy practice in community and hospital 
pharmacy settings”. Following the recommendations of the WHO Expert Committee and the 
endorsement of the FIP Council in 1997, the FIP/WHO joint document on good pharmacy 
practice (GPP) was published in 1999 in the thirty-fifth report of the WHO Expert 
Committee on Specifications for Pharmaceutical Preparations.133 
 In 2000, FIP Council has adopted a statement of policy on Good Pharmacy Education 
Practice providing a conceptual framework for the design, implementation and assessment 
of contemporary education programs for pharmacists throughout the world.134  
 In 2002, FIP adopted a Statement of professional standards continuing professional 
development.  
 FIP Statement of policy on quality assurance of pharmacy education, 2009. This statement is 
intended as a companion piece to FIP’s Statement of Policy on Good Pharmacy Education 
Practice. 
 The 2011 FIP’s GPP document underlines the requirements of Good Pharmacy Practice and 
how to set standards required for GPP, (which also imply a quality management framework 
and a strategic plan for developing services). GPP is organized around 4 major roles for 
pharmacists. “Contribute to improve effectiveness of the health-care system and public 
health” is one among them.  
 FIP has also issued statements on professional standards for continuing professional 
development, good pharmacy education practice135 and pharmaceutical care.136 
A joint document, “Developing pharmacy practice: a focus on patient care” by International 
Pharmaceutical Federation (FIP) and WHO emphasize that pharmacists should engage in 
preventive care activities that promote public health and prevent diseases.137 
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3.8.3  Examples of Other Organizations Promoting Role of Pharmacists in Public Health 
Internationally, there is an increased focus on the promotion of pharmacists’ role in public 
health area. There are several examples where international organizations are working hard to 
make progress in this focused area. The following few highlighted examples shown in Table 5.  
Table 5. International examples where pharmacists’ role in public health area is in focus  
Country  Organization  Promotion of pharmacists’ role in public health  
USA American Public 
Health 
Association 
(APHA)  
In 2006, American Public Health Association (APHA) has rolled out a policy 
statement on the Role of pharmacists in Public Health. In order to facilitate the 
development in this area, APHA recommended the following desired actions138: 
a. Supports greater inclusion of public health concepts in the curricula of schools 
of pharmacy, as well as the development of more joint PharmD/MPH programs; 
b. Reiterates the need for increased awareness of the role of pharmacists in public 
health through the dissemination of information among schools of public 
health, professional societies, policy-makers and other health care employers;  
c. Encourages the transdisciplinary collaborations of health planning agencies, 
schools of public health, schools of pharmacy, public health agencies, policy-
makers and pharmacy and public health professionals to develop legislation and 
advocate for plans that address health care needs spanning from local to 
worldwide; 
d. Supports the influx of more pharmacists trained in public health, in response to 
the pharmacist and public health worker shortages;  
e. Urges Congress to charge CMS to recognize pharmacists as health care providers 
within its programs (e.g., under Medicare) to function in public health capacities 
and to be eligible for proper reimbursement in such capacities. As is the case 
with all licensed providers, this should be restricted to services provided within 
the terms of the state pharmacy licensure regulations; and 
f. Encourages participation of pharmacists and other public health professionals in 
transdisciplinary research. 
American Society 
of Health-System 
Pharmacists 
(ASHP) 
In 2008, American Society of Health-System Pharmacists (ASHP) rolled out a 
statement on the role of Health-System Pharmacists in Public Health139. The 
statement identified following examples of activities that health-system 
pharmacists can engage in to promote public health: 
a. Providing population-based care;  
b. Developing disease prevention and control programs (including medication 
safety programs) in their institutions and communities;  
c. Developing health-education policies and programs within their institutions that 
address the needs of patients, other health care professionals, community 
leaders, and the public; 
d. Collaborating with state and local authorities, including health departments and 
boards of health, to address local and regional health care needs (including 
environmental hazard and emergency preparedness programs); 
e. Advocating for sound legislation, regulations, and public policy regarding 
disease prevention and management; and  
f. Engaging in population-based research and initiating campaigns to disseminate 
new knowledge. 
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Example from 
AACPs study  
More examples of recent milestones, events and important documents finding in 
USA (in AACPs study)140 are given below: 
a. CAPE included public health as a focus of pharmacy education; continued in 
CAPE 2013 and ACPE 2016 Standards141 
b. APhA Statement: Role of the Pharmacist in Public Health Awareness (2005)142 
c. U.S. Public Health Service: Improving Patient and Health System Outcomes 
through Advanced Pharmacy Practice (2011)143 
d. Centers for Disease Control and Prevention: A Program Guide for Public Health: 
Partnering with Pharmacists in the Prevention and Control of Chronic Diseases 
(2012)144 
e. National Association of County and City Health Officials: Building and Sustaining 
Strong Partnerships between Pharmacies and Health Departments at State and 
Local Levels (2013)145 
f. CDC Public Health Grand Rounds: How Pharmacists Can Improve our Nation’s 
Health (2014)146 
g. APHA approved Pharmacy Special Primary Interest Group (SPIG) (2014)147  
h. Academic Pharmacy Now article highlighting the Public Health SIG (2015)148 
Australia Pharmaceutical 
Society of 
Australia  
A report from Australia “Building upon pharmacists’ practice in Australia - a vision 
for the profession pharmacists” stated that Australia’s pharmacists realize the 
vision by undertaking several functions and one of them is “providing preventive 
and public health services” by:  
a. facilitating public health campaigns in local communities including health 
promotion, pandemic response, immunization and monitoring;  
b. providing access to screening and health checks to detect risk factors; providing 
healthy lifestyle advice and monitoring; and providing community education on 
medicines and health.149 
UK Royal 
Pharmaceutical 
Society of Great 
Britain 
RPSGB) went a step ahead and prepared Professional Standards for Public Health 
Practice for Pharmacy, for pharmacists and pharmacy teams working in England 
and Wales. These standards provide a framework to support pharmacists and their 
teams to improve public health services, and shape future services and pharmacy 
roles to deliver quality patient care and improve health outcomes.150 
Denmark National efforts  Health promotion in community pharmacy Denmark’s country report151 from 2000 
described five initiatives where pharmacies took initiative in improving public 
health. These initiative are: pharmacy-based smoking cessation, weight reduction, 
pharmacy services for the elderly, quality improvement of drug therapy for asthma 
patients, diabetes year-2000. These programs are still in practice in Denmark. 
EU  European 
Pharmacists 
Forum (EPF) 
In March 2015, the European Pharmacists Forum (EPF) prepared a white paper and 
call to action on the role of pharmacy in supporting public health.152 The EPF called 
upon national governments, payers and insurers, manufacturers to work 
collaboratively with pharmacy and pharmacists’ associations to develop 
pharmacy’s role in improving public health and patient outcomes. 
 
The above mentioned are few examples where pharmacists are taking active part in various 
public health programs in their respective countries. Different parts of the world are taking 
different initiatives based on their population needs and opportunities to improve citizens’ 
health. This study is focusing on mainly on how the Indian pharmacists can be best utilized to 
make them part of health care system and to involve in public health programs.   
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4 PHARMACY PRACTICE IN INDIA  
This chapter will brief on history of pharmacy practice and pharmacy practice regulations, 
pharmacy ownership, types of community pharmacies, pharmacist work areas, how community 
pharmacy works including supply chain and distribution system in India. Furthermore, a brief on 
current status and future of pharmacy practice in India and vision are discussed.  
 
4.1  History of Pharmacy Practice in India  
Early Indian (Hindu) medicine is divided into two periods. The first continuing from the earliest 
beginning until about 800 B.C. (Vedic period) and the second roughly from 800 B.C. to 1000 A.D. 
(Brahmanic period). After 1000 A.D. largest parts of India came under Islamic rule and Arab 
doctors took over the medical practice in the country. In ancient India, students leant the art of 
preparing flower juices, extracting liquors, concocting different herbal combinations, making 
new compounds of minerals and extracting alkalies out of minerals. Students were also trained 
in planting, grafting, general care of plants, as also identifying different herbs and when and 
how to cultivate and preserve them.153  
 
4.2  Pharmacy Regulations in India 
4.2.1  History and Development of Pharmacy Regulations in India154,155 
The history of pharmacy profession or regulations in India started with Opium act in 1878. The 
profession went thought several changes under evolution process from compounders to 
chemists to pharmacists with bachelor and masters and PharmD. Today, pharmacy profession is 
striving hard to realize its vision and mission to achieve best practices and to provide better 
pharmaceutical care services to the patients. In this process, the regulatory authorizes are 
doing their best to implement Pharmacy Practice Regulations (2015) to harmonize the practice 
of pharmacy throughout the country. Table 6 below gives an overview of the Acts or 
Regulations that came into force in India concerning drugs and pharmaceuticals since 1878 till 
2015.   
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Table 6. An overview of Acts or Regulations of India concerning drugs and pharmaceuticals  
Year Act or Regulation Description 
1878 Opium Act Dealt with cultivation of poppy and the manufacture, transport, export, import and sale of opium. 
1889 Indian Merchandise Act Misbranding of goods in general. 
1894 Indian Tariff Act Levy of customs duty on goods including foods, drinks, drugs, chemicals and medicines imported or exported. 
1898 Sea Customs Act Goods with ‘false trade description’ were prevented from importing under this act. 
1919 Poisons Act Regulated the import, possession and sale of poisons. 
1937 Import of Drugs Bill Later it was withdrawn. 
1940 Drugs Bill To regulate the import, manufacture, sale and distribution of drugs in British India. This Bill was finally adopted as ‘Drugs Act of 1940’. 
1941 Drugs Act of 1940 The first Drugs Technical Advisory Board (D.T.A.B.) under Drugs Act of 1940 was constituted. 
1941 Central Drugs Laboratory National statutory laboratory of the Government of India for quality control of Drug and Cosmetics 
1945 Drugs Rule 
The Drugs Act has been modified from time to time and at present 
the provisions of the Act cover Cosmetics and Ayurvedic, Unani and 
Homeopathic medicines in some respects. 
1945 Pharmacy Bill Pharmacy Bill to standardize the Pharmacy Education in India. 
1946 Indian Pharmacopoeial List It contains lists of drugs in use in India at that time which were not included in British Pharmacopoeia. 
1948 Pharmacy Act 1948 An Act to regulate the profession of pharmacy. 
1948 Indian Pharmacopoeial Committee Constituted for publication of Indian Pharmacopeia. 
1949 Pharmacy Council of India Established under Pharmacy Act 1948. 
1954 Education Regulation Education Regulation have come in force in some states but other states lagged behind. 
1954 Drugs and Magic Remedies Act To stop misleading advertisements. 
1954 Prevention of Food Adulteration Act 
To maintain standards in usage of additives, preservatives, 
antioxidants, flavoring agents, chelating agents as permitted in the 
Indian Pharmacopoeia 
1955 Medicinal and Toilet Preparations Act 
Introduced to enforce uniform duty for all states for alcohol 
products. 
1955 Indian Pharmacopoeial Commission  First Edition of Indian Pharmacopoeia was published. 
1985 Narcotic and Psychotropic Substances Act To protect society from the dangers of addictive drugs. 
1995 Drugs (Price Control) Order Controls the price of drugs in India and this Order changed from time to time. 
2002 Patents (Amendment) Act  To bring India’s patent regime into compliance with the WTO TRIPs Agreement. 
2008 PharmD regulations Regulations for PharmD education in India. 
2014 
Minimum Qualification for 
Teachers in Pharmacy Institutions 
Regulations 
To maintain the minimum standards of teaching in various 
departments of a pharmacy college or institution imparting 
diploma, graduate and post-graduate education shall be as 
prescribed there under. 
2015 Pharmacy Practice Regulations 
To ensure best practices to implement Code of pharmacy ethics, 
duties, responsibilities of pharmacist, inspection of pharmacies, 
maintain GPP, CEP and implementing other laws related to D&C Act 
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Pharmacists working in the community practice setting are either diploma pharmacists or 
graduate pharmacists with BPharm degrees. Their presence is legally required during the 
dispensing of prescription medicines and selling of OTC medicines according to Rule 65(15) of 
the Drugs and Cosmetics Rules 1945. 
 
Pharmacists represent the third largest health care professional group in the world after nurses 
and doctors/physicians.156 Public health deals with improving health or preventing illness in a 
population, and public health programs are usually coordinated by the government or a 
group/body accountable to a community.157 Improving public health in any country requires 
intersectoral action and combined efforts of people from various professions and disciplinary 
backgrounds.158  
 
4.2.2  Regulation of Pharmacies in India  
Pharmacy practice in India is governed by the Drugs & Cosmetics Act 1940 and the Drugs & 
Cosmetics Rules 1945 formed under the Act, which stipulated manufacturing, distribution and 
sale of drugs, where the regulations to acquire a license to run a pharmacy are prescribed 
under “Part VI - sale of drugs other than homoeopathic medicines”. The State Governments 
appoint the licensing authorities, i.e., State Drug Control Offices for this purpose. Though the 
practice of homoeopathic medicine is common in India, a separate license is required to sell 
such medicines. The regulatory officers with titles drug inspectors or drug controllers appointed 
under the Act regulate the licensing and running of pharmacies (also called medical stores, 
chemists and druggists).159 
 
4.2.3  Regulation of Pharmacist Registration in India 
In 1948, the Pharmacy Act was enacted as the India’s first minimum standard of educational 
qualification for pharmacy practice to regulate the practice, education, and profession of 
pharmacy. 160 Minimum qualification for registration and practice of pharmacy in India is a pass 
in one or more of the following:161  
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i) DPharm, a 2 year program from an institution approved under Section 12 of the Pharmacy 
Act, followed by 500 hours of practical training in one or more of the following institutions 
namely, (a) Hospitals/dispensaries run by Central/State Government; (b) a pharmacy, chemist 
and druggist licensed under the Drugs and Cosmetics Rules, 1945 made under the Drugs and 
Cosmetics Act, 1940; (c) Drugs manufacturing unit licensed under the Drugs and Cosmetics Act, 
1940 and Rules made there under.  
ii) BPharm a 4 year degree program from an institution approved by the PCI under section 12 of 
the Pharmacy Act. BPharm is a 4 years degree program.  
iii) PharmD a 6 year full time doctorate program as per the PharmD Regulations 2008, framed 
under section 10 of the Pharmacy Act 1948. 
 
4.2.4  The New Pharmacy Practice Regulations (2015)  
In exercise of the powers conferred by Section 10 and 18 of the Pharmacy Act, 1948 (8 of 1948), 
the Pharmacy Council of India, with the approval of the Central Government made Pharmacy 
Practice regulations, 2015. These regulations are made to ensure the best practices to 
implement Code of Pharmacy Ethics, rolled out the duties and responsibilities of registered 
pharmacist in general, inspection of pharmacies by the inspectors to inspect pharmacies, 
maintaining Good Pharmacy Practices and Continuing Education Programs and making sure of 
implementing other laws related to Drugs and Cosmetics Act. Practice regulations, 2015 rolled 
out duties of registered pharmacists to their patients and also described pharmacist 
responsibilities in connection to dispensing and/or supply of drugs, promotion of rational use of 
drugs and patient counseling. Duties of registered pharmacist to the public and to the 
profession, misconduct and punishments and disciplinary action were also described in these 
regulations. These regulations will help to change the face of pharmacy practice in India. 
Provisions of patient counseling and the provision of those acts or services necessary to provide 
pharmaceutical care in all areas of patient care including primary care. The professional 
regulations (Pharmacy Practice regulations, 2015) ensure the minimum practice standards in 
the society. These regulations are new hope to the profession.162 Various duties of pharmacists 
as described the new regulations are reproduced below:  
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Duties of registered pharmacists to their patients163  
Obligations to the Sick:  
(a) Though a registered pharmacist is not bound to attend each and every person asking his 
services, he shall not only be ever ready to respond to the calls of the sick and the injured, but 
shall be mindful of the high character of his mission and the responsibility he discharges in the 
course of his professional duties.  Pharmacists shall never forget that the health and the lives of 
those entrusted to his care depend on his skill and attention.  
(b) Registered pharmacist having any incapacity detrimental to the patient or which can affect 
his performance vis-àvis the patient, shall not be permitted to practice his profession.  
(c)   Pharmaceutical care (in addition to the provisions of Drugs and Cosmetics Rules 1945 and 
Schedule N of the said Rules) the following provisions shall be included. No person other than a 
Registered Pharmacist shall compound, prepare, mix, dispense or supply of any medicine on 
the prescription of a Registered Medical Practitioner (Schedule H & X drugs). A Registered 
Pharmacist shall review the patient record and each prescription presented for supply for the 
purpose of promoting therapeutic appropriateness by indentifying:  
i) Over utilization or under utilization  
ii) Therapeutic duplication  
iii) Drug-disease interactions  
iv) Drug-drug interactions  
v) Incorrect drug dosage or duration of drug treatment  
vi) Drug-allergy interactions  
vii) Correlation of availability of drugs (to avoid artificial shortage of drugs)  
viii) Clinical abuse/misuse.  
 
Patience, Delicacy and Secrecy 
Patience and delicacy shall characterize the registered pharmacist. Confidences concerning 
individual or domestic life entrusted by patients to a registered pharmacist and defects in the 
disposition or character of patients observed during medical attendance shall never be revealed 
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unless their revelation is required by the laws of the State. Sometimes, however, a registered 
pharmacist shall determine whether his duty to society requires him to employ knowledge, 
obtained through confidence as a registered pharmacist, to protect a healthy person against a 
communicable disease to which he is about to be exposed. In such instance, the registered 
pharmacist shall act as he would wish another to act toward one of his own family in like 
circumstances.  
 
Duties of registered pharmacist  
Dispensing/supply of Drugs:   
a. The various activities of dispensing (prescription assembly) like removal of drugs from the 
packing, filling the prescription etc. may be performed under the super-vision of a registered 
pharmacist by any person who has been trained to perform these activities.  However, the 
actual dispensing of drugs to patients shall only be performed by the Registered pharmacist 
after due verification of the prescription filled by others.  
b. A Registered pharmacist shall undertake a pharmaceutical assessment of every   prescription 
presented for dispensing.  For the purpose of the act, pharmaceutical  assessment is defined as 
the point at which Registered pharmacist applies his knowledge to establish the safety, quality, 
efficacy and rational use of drugs treatments specified by a prescriber.  
c. Patient confidentiality shall be maintained at all times.  
d. Appropriate information shall be provided to the patient or the care giver and, where possible, 
understanding of this information should be checked.  
e. For all prescriptions handled by the pharmacy:  
 (i) Patient details shall be checked and confirmed;  
 (ii) Pharmaceutical assessment shall be made;  
 (iii) Proper documentation shall be maintained.  
f. Assessment of the prescription should include but not be limited to assessment of 
whether :  
(i) The prescription is legally valid.  
(ii) The prescription includes an appropriate dosage form and appropriate route of 
administration. 
(iii) Prescription is appropriate to the patient’s condition.  
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(iv) Duration of treatment is correct.  
(v) Prescription is appropriate according to patient’s para-meters (age, weight etc.) 
and previous medication. 
(vi) Prescription is compatible with other medications.  
(vii) Prescription is consistent with formulary and guidelines, if any.  
(viii) Possibility of side effects and ad-verse drug reactions exist.  
(ix) Contra-indicated.  
(x) Potential for misuse and inappropriate use of the medicines in prescription by 
patient exists.  
(xi) Prescription is complying with labeling requirements.  
g. Compounding, dispensing and labeling of required drug products should ensure that : 
(i) The drug product matches the prescription.  
(ii) The drug product has not expired.  
(iii) The    drug    product   is appropriately compounded (if necessary), packed and 
labeled appropriately.  
(iv) The accuracy of dispensing is checked by Registered Pharmacist.  
(v) Proper documentation is made.  
h. Delivery of the drug product to the patient/carer is done in such a way as to ensure that:  
(i) The Registered pharmacist hands over the drug to the patient/carer. 
(ii) Appropriate information on drugs is provided to the patient/carer.  
 
Pharmacist for promotion of rational drug use  
To promote rational use of drugs, the pharmacist shall involve himself in activities such as:  
(i) Preparation of formularies both at the hospital level and at state/ national levels. 
(ii) Critical assessment of promotional materials prepared by the drug companies.  
(iii) Dissemination of evaluated information through authorized sources.  
(iv) Updating the knowledge of drugs through continuing education programs and 
also to organize educational programs for health professionals.  
(v) Preparation and dissemination of patient information leaflets.  
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Patient counseling  
Upon receipt of a prescription (prescription drug order) and following a review of the patient’s 
record, a Registered Pharmacist shall personally initiate discussion of matters that will enhance 
or optimize drug therapy with each patient or care given of such patient. Such discussion shall 
be in person, whenever practicable or by telephone and shall include appropriate elements of 
patient counseling. Such elements may include the following:  
(i) Name and description of the drugs;  
(ii) The dosage form, dose, route of administration, and duration of drug therapy;  
(iii) Intended use of the drug and expected action;  
(iv) Special directions and precautions for the drug;  
(v) Common severe side effects or adverse effects or interactions and therapeutic contra 
indications that may be encountered, including their avoidance, and the action 
required if they occur;  
(vi) Techniques for self monitoring drug therapy;  
(vii) Proper storage of the drugs;  
(viii) Prescription refill information;  
(ix) Action to be taken in the event of a missed dose;  
(x) To ensure rational use of drugs.  
Pharmacies providing patient counseling shall have regard to the following:  
 Only Registered pharmacists are involved in counseling.   
 Facilities are provided for confidential conversation and patient confidentiality is 
maintained.  
 Patient information leaflets are provided.  
 Proper documentation is made.  
 Unnecessary counseling should be avoided.   
 Counseling for Patient’s Benefit: In every consultation, the benefit to the patient is of 
foremost importance. All registered pharmacists engaged in the case should be frank 
with the patient and his attendants.  
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 Punctuality in counseling: Utmost punctuality should be observed by a registered 
pharmacist in making themselves available for counseling. 
 
The pharmacist shall maintain the records pertaining to drugs administered to the patients 
(drug card) that may be utilized for the evaluation of the drug therapy.  
 
The pharmacist is authorized (as a Health care professional) to undertake process and outcome 
research, health promotion and education and provide health information.  Also to undertake 
the pharmacoepidemiological studies. 
 
Duties of registered pharmacist to the public and to the profession  
Registered pharmacists as Citizens: Registered pharmacists, as good citizens, possessed of 
special training shall disseminate advice on public health issues. They should play their part in 
enforcing the laws of the community and in sustaining the institutions that advance the 
interests of humanity. They shall particularly co-operate with the authorities in the 
administration of sanitary/public health laws and regulations.  
 
Physician/Nurses: Registered pharmacists shall seek cooperation from physicians, dentists and 
nurses wherever required. 
 
Public and Community Health: Registered pharmacists, especially those engaged in public 
health work, shall enlighten the public concerning quarantine regulations and measures for the 
prevention of epidemic and communicable diseases. At all times the registered pharmacist shall 
notify the constituted public health authorities of every case of communicable disease under 
his care, in accordance with the laws, rules and regulations of the health authorities. When an 
epidemic occurs a registered pharmacist shall not abandon his duty for fear of contacting the 
disease for himself.  
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4.3 Ownership of Community Pharmacies in India 
It is mandatory to get a license to run a pharmacy in India.164 The community/retail pharmacy 
sector is the prime source of medicines for both ambulatory and hospitalized patients 
(minimum stock in many hospitals). The medicines manufactured by pharmaceutical companies 
are made available to the community pharmacy level through their distributor or clearing and 
forwarding agent.165 Pharmacy licensing is controlled by the Food and Drug Administration of 
India which awards a license only to a qualified pharmacist to operate.166  
 
In India, ownership of a pharmacy is not an exclusive domain of the pharmacist alone, as in 
many European nations. This has resulted in anyone without proper education or qualification 
or background or experience to start a pharmacy. Pharmacists own few pharmacies, but a large 
majority are owned by non-pharmacists. 167  Individuals pharmacists and partnerships or 
corporate owned must have a supervising pharmacist.168 As per the Indian Brand Equity 
Foundation (IBEF), pharmacy is one of the top five key players in Indian retail industry.  
 
Figure 2. Flow diagram showing the process of setting up a new pharmacy in India 
 
 
 
 
 
 
 
 
 
 
Pharmacy licenses are approval by 
State Drugs Control offices under 
D&C Act. 
Registered Pharmacist   
Pharmacist is responsible for 
implementing the Regulations of 
Pharmacy Practice 
Pharmacist is responsible for 
implementing the D&C Act. 
Investor 
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4.4  Types of Community Pharmacies in India 
Pharmacy chains are expanding operations using different store formats. Primarily, community 
pharmacies are to serve the people of India in the following different formats169 as shown in 
Table 7.  
 
Table 7. Types of community pharmacies in India  
Type of pharmacy Description  
Hospital pharmacies  are usually set-up in hospitals and dispense a limited number 
of medicines.  
 cater mainly to the requirements of patients admitted in 
hospitals. 
Independent / standalone  
pharmacies  
 located in or near residential areas  
 some offer home delivery  
 target customers from middle and upper class households 
Malls/ shop-in-shops   located in supermarkets, malls or departmental stores 
 Spenser has tie-up with LifeKen Medicines for its daily stores 
in south India  
Townships   located in supermarkets, malls or departmental stores 
 
Apart from the above pharmacy types, the Government of India under the Aegis of Department 
of Pharmaceutical, Jan Aushadhi initiative was taken in 2008 to make quality drugs available at 
affordable prices through dedicated stores selling generic medicines which are available at 
lesser prices but are equivalent in quality and efficacy as expensive branded drugs. These 
pharmacies stock only generic medicine approved and listed by the Bureau of Pharma Public 
sector undertakings of India (BPPI). These are called Jan Aushadhi stores and are currently 137 
such pharmacies in India.  
 
4.5  Types of Pharmacist Work Areas in India 
Apart from Industry, regulatory agencies, marketing, academics, research, pharmacists practice 
in the various settings. “Pharmacy Practitioner” means an individual with valid license/ 
registration or otherwise authorized under the Act to counsel or otherwise and administer 
drugs in the course of professional practice, these individuals may be practicing as 
Community/Hospital/Clinical/Drug information-pharmacist. 
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Community pharmacist is an individual currently registered and who works according to legal 
and ethical guidelines to ensure the correct and safe supply of medical products to the general 
public. They are involved in maintaining and improving people's health by providing advice and 
information as well as supplying prescription medicines. 
 
The area of government practice for pharmacists covers Rural Medical Dispensary (RMD); 
Primary Health Centre (PHC); Community Health Centre (CHC); Urban Health Centre (UHC); 
district, Sub-divisional and Rural hospitals; large tertiary care and teaching hospitals and other 
public hospitals including Railways, ESIS, Coal India, CGHS, MPT, Airlines, Armed Forces, Jail 
hospitals, etc. 
 
Hospital pharmacists is an individual currently registered and working in a hospital pharmacy 
service, primarily within the public / private sector. They are responsible for ensuring the safe, 
appropriate and cost-effective use of medicines. Hospital pharmacists use their specialist 
knowledge to dispense drugs and advice patients about the medicines which have been 
prescribed. They work collaboratively with other health care professionals to devise the most 
appropriate drug treatment for patients. Some pharmacists are also involved in manufacturing 
required drug treatments. 
 
Drug Information Pharmacist is an individual currently registered who works in a community 
pharmacy/hospital Pharmacy/teaching hospital/ other health care settings and provides 
information and advice regarding drug interactions, side effects, dosage and proper medication 
storage to patients/physicians/dentists/other health care professionals. 
 
Clinical Pharmacist is an individual currently registered and who provides patient care that 
optimizes the use of medication and promotes health, wellness and disease prevention. Clinical 
pharmacists care for patients in all health care settings. Clinical pharmacists often collaborate 
with physicians and other healthcare professionals. 
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4.6  Workflow of a Typical Community Pharmacy in India  
The workflow of a community pharmacy is simple like in any other country doing direct 
dispensing. In India, generally there is no prescription drop off system. Usually the patient 
comes directly from the physicians, clinics or hospitals with prescriptions expecting the 
pharmacy to dispense or fill or refill the prescription. Depending on the size of the pharmacy, 
there are one or more pharmacists and shop assistants, who receive the patients and find 
medicine. The pharmacist checks medicine, counsel the patients after which the patient will go 
to cash counter and pay. This is only a common concept, however, in small pharmacies there is 
only one pharmacist managing all the functions. In some pharmacies pharmacist and assistant 
divide the functions. Figure 3 below illustrates common workflow of a community pharmacy in 
India.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Illustration of a common workflow of a community pharmacy in India 
 
Pharmacies attached to the GP’s office usually know the products that the physicians would 
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is no co-pay settlement from the private insurance companies or from the government 
insurance system. Community pharmacies are not tied up with private insurance companies if a 
patient has insurance which reimburses his/her medicine, reimbursement will be processed 
directly between the patient and insurance company. Therefore, pharmacy has lesser 
administration work and pharmacies do not need to wait for settlement of reimbursements, 
which means, the patients pay for their medicine from the pocket. Usually, sales medical 
representatives from pharma industry visit both physicians and the pharmacies, where they 
brief the products and also offer promotions to push the products. Pharmacies order the 
medicine via sales representatives or through the wholesalers, depending on the size of 
manufacturing company and there are different policies that the companies follow.  
 
4.7  Medicines Information Resources for Community Pharmacists in India  
Indian pharmacists have available several medicines information sources to serve their 
customers. Official sources of drug information are Central Drug Research Institute (CDRI) and 
National Formulary of India (NFI) and the several drug information centers run in collaboration 
with state pharmacy councils, WHO country office, Universities, hospitals and other 
autonomous bodies. Chauhan et al.170 has presented an overview of drug information source 
centers available in India which is given below: 
 
National Information Centre on Drug and Pharmaceuticals (NICDAP) 
National Information Centre on Drug and Pharmaceuticals (NICDAP) which uses the library 
resources of Central Drug Research Institute; Government of India a constituent laboratory of 
Council of Scientific and Industrial Research. R&D activities in CDRI are supported by a modern 
knowledge Resource Center which comprises a fully computerized library with a rich collection 
of relevant books and periodicals, on-line subscription of a large number of databases and 
periodicals and an Information Center which provides many services as well as on-line response 
to queries.  
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National Formulary of India (NFI)  
NFI is a guidance document for healthcare professionals and contains clinically oriented 
summaries about drugs. NFI is an official tool for pharmacists in India which is prepared by the 
Indian Pharmacopoeia Commission, under the Ministry of Health, Government of India. The 
drugs contained in NFI have been chosen for rational and economic prescribing. It helps in 
selection of drugs from a wide range of available drugs in the market. NFI is the drug formal 
information resource in India.  
 
Apart from these, there are also several drug information centers established in collaboration 
with state pharmacy councils, WHO Country Office, universities, hospitals and other 
autonomous bodies. These centers are funded independently by State Pharmacy Councils or in 
collaboration with any other governmental, private or non-profitable organizations. It is free for 
pharmacists and/or patients to contact the DCIs to obtain any information related to medicines. 
These drug information centers receive queries/questions both from health professionals and 
patients over telephone, direct access and during the ward rounds; if DCI is located in a 
hospital. The following are some of the DCIs. 
 
List of Drug Information Centers Run at State Pharmacy Councils in India (Regional) 
 Drug Information Center, Maharashtra State Pharmacy Council, Maharashtra 
 Andhra Pradesh state pharmacy council, Andhra Pradesh 
 Drug information center, Jaipur, Rajasthan 
 Drug information center, Raipur, Chhattisgarh 
 Karnataka state pharmacy council (KSPC), Bangalore, Karnataka 
 
DIC's Set Up By Karnataka State Pharmacy Council, CDSCO, and Who India Country Office 
 Drug information center, Jaipur, Rajasthan 
 Drug information center, Raipur, Chhattisgarh 
 Drug information center, Panaji, Goa 
 Drug information center, Dibrugarh, Assam 
 
Other Drug, Poison or Alcohol Information Centers in India 
 Alcohol and drug information center (ADIC), Trivandrum, Kerala 
 Bowring and Lady Curzon hospital, Bangalore, Karnataka 
 Bulletin on drug and health information (BIDI), Kolkata, West Bengal 
 CDMU documentation center, Calcutta, West Bengal 
 Christian medical college hospital Vellore, Tamil Nadu 
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 Department of Pharmacy Practice, Chidambaram, Tamil Nadu 
 Department of Pharmacy Practice, National Institute of Pharmaceutical Education and 
Research (NIPER), Chandigarh 
 Drug Information Center, Division of Pharmacy Practice Department of Pharmacy, 
Annamalai University, Tamil Nadu 
 Drug information center, (KSPC), Bowring and Lady Curzon hospital, Bangalore, 
Karnataka 
 Drug information center, (KSPC), Victoria Hospital, Bangalore, Karnataka 
 Jawaharlal Nehru Medical College Hospital (JNMC), Belgaum, Karnataka 
 JIPMER Drug Information Center, Department of Pharmacology JIPMER hospital 
Gorimedu, Pondicherry 
 JSS, Mysore, Karnataka 
 JSS, Ooty, Karnataka 
 Kasturba Medical College (KMC), Manipal, Karnataka 
 Kempagowda Institute of Medical Sciences (KIMS), Bangalore, Karnataka 
 N.R.S. Medical College and Hospital, Calcutta, West Bengal 
 National Poisons Information Center, All India Institute of Medical Sciences, New Delhi 
 Pharma information center, Chennai, Tamil Nadu 
 Poison control center and department of analytical toxicology, Amrita Institute of 
Medical Sciences and Research, Cochin, Kerala 
 Poison control, training and research center, government general hospital Chennai 
 Poison information center, national institute of occupational health, Ahmadabad 
 RIPER poison and drug information center, RDT Hospital, Bathalapalli, Andhra Pradesh 
 Sri Ramachandra Hospital, Porur, Chennai, Tamil Nadu 
 Sri Ramakrishna mission hospital, Coimbatore, Tamil Nadu 
 Toxicology and IMCU unit, government general hospital, Chennai, Tamil Nadu 
 Trivandrum medical college, Trivandrum, Kerala 
 
4.8  Complex Supply Chain or Distribution System in India  
The distribution of medicines and cosmetics is governed by various drug laws like the Drugs and 
Cosmetics Act and Rules,171 Narcotic Drugs and Psychotropic Substances Act.  
 
Drug distribution in India has witnessed a paradigm shift. Before 1990, pharmaceutical 
companies used a different distribution system, in which they established their own depots and 
warehouses that now have been replaced by clearing and forwarding agents (CFAs). These 
organizations are primarily responsible for maintaining storage (stock) of the company’s 
products and forwarding SKUs to the stockist on request. Most companies keep 1–3 CFAs in 
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each Indian state. On an average, a company may work with a total of 25–35 CFAs. Unlike a CFA 
that can handle the stock of one company, a stockist (distributor) can simultaneously handle 
more than one company (usually, 5–15 depending on the city area), and may go up to even 30–
50 different manufacturers. The stockist, in turn, after 30–45 days (a typical credit or time limit) 
pays for the products directly in the name of the pharmaceutical company. The CFAs are paid 
by the company yearly, once or twice, on a basis of the percentage of total turnover of 
products.172,173   
 CFAs: These organizations are primarily responsible for maintaining storage (stock) of 
the company’s products and forwarding SKUs to the stockist on request. Most 
companies keep 1–3 CFAs in each Indian state. On an average, a company may work 
with a total of 25–35 CFAs. The CFAs are paid by the company yearly, once or twice, on a 
basis of the percentage of total turnover of products. 
 Stockist: is the distributor, who can simultaneously handle more than one company 
(usually, 5–15 depending on the city area), and may go up to even 30–50 different 
manufacturers. They pay for the products directly in the name of the pharmaceutical 
company after 30 to 45 days. 
 The retail pharmacy obtains products from the stockist or substockist through whom it 
finally reaches the consumers (patients). 
 
Unlike in the West, where a manufacturer can directly supply goods at the retail level, products 
in India move through a chain of intermediaries. The manufacturer supplies goods to the first 
layer comprising a clearing and forwarding agent, a super stockist or a company-owned depot. 
These, in turn, supply to stockist from whose premises goods are routed to wholesalers, 
medical institutions, hospitals and retailers. The retailer dispenses the drugs to final consumers. 
Manufacturers can directly supply to institutions and hospitals, but never to a retailer.174 Drug 
distribution in India is layered and regulated, which is showed in the flow diagram in Figure 4 
below.  
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Retailer /pharmacies  
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C&F, Depot/superstockist  
Institution Stockist/wholesaler  Hospital 
 
Figure 4. Flow diagram of drug distribution system in India (Source: Pharmacy in India, 2009: In 
the service of proper use of medicines) 
 
4.9 Duties of Pharmacist  
Like in another country, the pharmacists in India have several roles. They have several 
responsibilities like dispensing prescription medicine, provide required medicine information 
and counsel the patients to obtain optimal therapeutic outcomes, maintain medication records, 
health promotion and prevention of diseases, advice on self-care, pharmacovigilance, 
professional guidance to patients and other health care workers, and disposal of unused 
medicines. The pharmacists are also responsible for procurement, inventory and storage 
management. In 2011, The Pharmacy Council of India adopted WHO Good Pharmacy Practice 
(GPP) guidelines in community and hospital pharmacy settings175 and in 2015 the Pharmacy 
Practice regulations came into force. The GPP guidelines will help improving pharmacists 
professional contribution among other health professional and also in the society.  
 68 
 
4.10 Pharmacy Profession - Future of Pharmacy Practice in India 
In 2003, the Pharma Vision 2020 Charter was released by the then President of India, Dr. A.P.J. 
Abdul Kalam, at the 55th Indian Pharmaceutical Congress at Chennai. The Vision 2020 is 
focused on promoting the highest professional ethical standards of pharmacy, focusing the 
image of pharmacists and competent healthcare professionals, sensitizing the community, 
government and others on vital professional issues and supporting pharmaceutical education 
and sciences in all aspects. Indian Pharmaceutical Association once again, with the support of 
the leaders of the pharmacy profession presented the road map to Pharma Vision 2020 at the 
58th Indian Pharmaceutical Congress held in December 2006 at Mumbai. The themes of the 
subsequent Congresses have been centered on Pharma Vision 2020.176,177 In the year 2020, 
pharmacist and pharmaceutical scientist working within various disciplines of pharmacy will be 
well established and recognized as medicine expert and will be an expert in health promotion 
and disease prevention. The Vision 2020 theme is being carry forwarded through the National 
Pharmacy Week every year and also Indian Pharmaceutical Congress. This year the theme of 
the Indian Pharmaceutical Congress is "Pharma Vision 2020-Pharmacists for a Healthy India" 
with a tag line, 'Quality Pharmaceuticals and Patient Welfare'. 
 
4.11  The Vision 2020 of Indian Pharmacy Profession 
According to Pharma Vision 2020 Charter, in the year 2020, pharmacists and pharmaceutical 
scientists working within various disciplines of pharmacy will be established and recognized as 
the medicines experts and experts in health promotion and disease prevention.  
 The pharmacists will interact with other professionals as the preferred source of 
information and advice on prescribing and medicine management of disease. 
 Pharmacists will develop their pharmaceutical expertise and facilities in order to deliver 
high-tech and individually-tailored medicines in the primary care setting.  
 Pharmacists will actively involve in national health program like promotion of essential 
medicines, primary health care, HIV/AIDS, TB, Malaria, tobacco use or family planning.  
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 Pharmacists will become knowledgeable to participate in medication management and 
outcome monitoring, including the ability to alter doses and change medicines with 
agreed therapeutic protocols. 
 
Indian pharmacist will be actively involved in national health program and perform 
individualized therapy. Finally a pharmacist should be patient oriented rather than product-
oriented, so that he can be a total healthcare provider. 
 
4.12  Future of Pharmacy Profession and Challenges 178 
The number of individuals in India having lifestyle diseases, such as diabetes, hypertension, 
coronary heart diseases and cancer are steadily rising.179 Pharmacists thus have the potential to 
help the nation in facing these challenges. Pharmacists with their knowledge and expertise can 
help in production, distribution, storage and dispensing of quality medicines, promoting 
rational medicine use, health promotion, medicines management, providing patient counseling 
to improve adherence of therapy, assisting patients in making effective self-medication choices 
and decisions for their health and much more.  
 
India has a vast and growing pharmaceutical industry. With the implementation of the WTO 
(World Trade Organization) proposals on intellectual property rights, the Indian pharmaceutical 
industry will quickly have to increase its focus and invest more in terms of money, 
infrastructure and manpower on research and development of new medicines, both for tropical 
diseases as well as lifestyle/chronic diseases.  
 
All these factors indicate that Indian healthcare industry has a long way to go and pharmacists 
have to play a vital role in it. In rural areas, where often availability of doctors is a serious 
problem, pharmacists can take up active roles in providing basic health care and advice on 
medicine use, health promotion, and self medication. Pharmacists can also look upon new 
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avenues in immunizations, tobacco cessation, home visits for medication review and care, 
counseling services, etc. 
 
In the coming years, there will be an increasing demand for qualified pharmacists in all sectors, 
namely research, regulatory affairs, manufacturing, marketing, clinical, community, academics, 
etc. both in our country as well as across the world. 
 
Pharmacy is a rewarding career, in terms of personal satisfaction and financial compensation, 
as well as service to the people. So start planning from today. As the old Chinese saying goes “A 
journey of a thousand miles begins with one small step”.   
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5  PHARMACY EDUCATION IN INDIA  
 
This chapter covers history of pharmacy profession in India and how pharmacy education 
evolved, pharmacy education programs including admission requirements, production overview 
and education regulations and quality of pharmacy education. There is also brief description on 
pharmacy education in previously selected other countries, namely USA, Denmark and Finland.  
 
5.1  History of Pharmacy Education in India  
India is made up of 29 States and 6 Union Territories with a population of over 1.3 billion 
residents.180 India has the second largest education system in the world.181 Its higher education 
system is also one of the largest in the world, and has been witnessing healthy growth in its 
number of institutions and enrollment in last few decades. While professional courses account 
for a third of enrolment, the fee for such courses is significantly higher than general courses 
(upwards of 10 times), resulting in majority spending towards such courses. 182,183 Such 
professional courses are medical and dental doctor, law, engineering and pharmacy. 
 
The colonial period (1750–1947) brought the new western system of medicine and paved the 
way to emerge pharmacy houses in India. Though pharmacy was practiced since ages in India, it 
is recognized as a profession only from 18th century.184,185 Pharmacy education in India, at the 
certificate level, was started in 1842 in Goa by the Portuguese186 and as a university level 
program at the Banaras Hindu University as BPharm course in 1937.187 The courses were 
provided for studies in pharmaceutical chemistry, pharmacy, pharmacognosy, and 
pharmaceutical economics which prepared graduates to work as specialists in quality control 
and standardization of drugs for pharmaceutical companies, 188, 189 but not for patient care in 
pharmacy practice.10 As per the report of the health survey and planning committee of 
Government of India, 1961, the course for the graduate pharmacists (BPharm) was designed to 
train the smaller number who will be engaged in manufacturing concerns, analytical 
laboratories, and educational medical institutions,190 which continued to have the same 
contents.  
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The pharmacy practice scenario and especially community pharmacy practice during pre-
independence era was highly unregulated and there were no restrictions on the practice of 
pharmacy in India.191 After the Indian independence in 1947, the Pharmacy Act 1948 was 
enacted for the regulation of the profession and practice of pharmacy in India.  
 
The Pharmacy Council of India (PCI), a statutory body governed, was constituted under section 
3 of the Pharmacy Act, 1948 to regulate the pharmacy education and profession in India. 
Important functions and duties of the PCI are:  
i) to prescribe minimum standard of education required for qualifying as a pharmacist,  
ii) to ensure uniform implementation of the educational standards throughout the country,  
iii) framing of Education Regulations prescribing the conditions to be fulfilled by the 
institutions seeking approval of the PCI for imparting education in pharmacy,  
iv) inspection of pharmacy institutions seeking approval under the Pharmacy Act to verify 
availability of the prescribed norms,  
v) to approve the course of study and examination for pharmacists,  
vi) to maintain Central Register of Pharmacists and  
vii) to approve qualifications granted outside the territories to which the Pharmacy Act 
extends i.e. the approval of foreign qualification.192 
 
During past decade, the pharmacy profession has expanded significantly in implementation of 
need-based educational programs and professional practice.193 However, future of pharmacy 
profession rests on (1) developing well-qualified, knowledgeable, skilled, and competent human 
resources; (2) providing high-quality pharmaceutical care services in health care system; and (3) 
fulfilling other professional obligations/responsibilities on the basis of societal need. These are 
achievable only through changes in the legislative framework that improve and maintain high 
standards of the pharmacy profession in both educational and practice settings. 
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5.2  Pharmacy Education Programs and Admission Requirements in India 
To meet varying needs of the profession in India at different levels,194 several pharmacy 
programs offered, which are diploma in pharmacy (DPharm) a 2 year full time program; 
bachelor of pharmacy (BPharm), a 4 year full-time program; master of pharmacy (MPharm), a 2 
year program – with specialization in biotechnology, pharmaceutical chemistry, quality 
assurance, pharmaceutics, pharmacognosy, pharmacology, pharmacy practice; master of 
science in pharmacy [MS (Pharm)], master of technology in pharmacy [MTech (Pharm)], doctor 
of pharmacy (PharmD), a 6 year program and doctor of philosophy  (PhD) in pharmacy. 
However, DPharm, BPharm and PharmD are the only recognized programs to become 
registered pharmacist in India. There are over 1,700 institutions that offer different pharmacy 
programs in India with an intake of over 100,000 students per academic year.195 Pharmacy 
education system in India with entry level requirements to various programs is illustrated in 
Figure 5. Upon successful completion of one or more programs shown within the dots can 
practice pharmacy as registered pharmacists in India.  
 
5.2.1  Admission Requirements for the Enrolment of Pharmacy Programs  
Available pharmacy programs, duration and eligibility requirements to enter different programs 
are also explained below.  
 
5.2.2  Diploma in Pharmacy (DPharm) 196  
Admission to DPharm program as per Education Regulations 1991, pass in any of the following 
examinations with Physics, Chemistry and Biology or Mathematics:  
i) intermediate examination in Science; (higher secondary examination);  
ii) first year of the three year degree course in science;  
iii) 10 year of secondary education (high school) + 2 years higher secondary examination 
(academic stream) in science;  
iv) pre-degree examination;  
v) any other qualification approved by PCI as equivalent to any of the above examination. 
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5.2.3  Bachelor of Pharmacy (BPharm) 
Admission to the first-year BPharm program is made directly from higher secondary school 
(10+2 with physics, chemistry, biology or mathematics) plus on the basis of marks obtained in 
the higher secondary examination and/or on the basis of a merit list rank prepared based on 
scores on an entrance examination administered by a state or individual institution.12 
 
5.2.4  Master of Pharmacy (MPharm) 
The criterion for entry to an MPharm program is academic performance in the BPharm or an 
entrance test or both. Currently, there is more demand for the MPharm programs than the 
availability of places in the country.12 An important criterion, a high Graduate Pharmacy 
Aptitude Test (GPAT) score, qualifies a student to receive government scholarship during the 
period of their MPharm study. This criterion is optional for admission to the first-year MPharm 
program. However, all the public institutions require both past academic performance and 
GPAT score for application to the MPharm program.12, 197 
 
5.2.5  Doctor of Pharmacy (PharmD) 
A six academic years (five years of study and one year of internship/residency) full time 
program. Minimum qualification for admission to PharmD is a pass in:  
i) 10+2 examination with physics and chemistry as compulsory subjects along with 
mathematics or biology or  
ii) DPharm course from an institution approved by PCI or  
iii) any other qualification approved by PCI as equivalent to any of the above 
examinations.198 
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Figure 5. Pharmacy education system in India. Up on successful completion of one or more 
programs shown within the dots can practice pharmacy as registered pharmacists in India. 
* To pursue PharmD (Post Baccalaureate) which is three years full-time program (2 years of 
study and 1 year residency), pass in BPharm from an institution approved by the PCI is 
minimum criteria for admission. 
 
5.3  Production Overview 
An overview on types of pharmacy programs and number of colleges offering pharmacy 
programs and approved student intake per year is described in Table 8.21 India has provision for 
over 100,000 pharmacy admissions each year, which includes DPharm, BPharm and PharmD.21  
 
There are about one million registered pharmacists in India working in various positions, 
applying their unique knowledge and skills, contributing to the health of the nation.199  
 
  
Higher Secondary Examination 
(12 years in school): Entry level 
PharmD PharmD (Post 
Baccalaureate)* 
BPharm 
DPharm 
MPharm 
PhD 
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Table 8. Pharmacy programs, regulatory bodies and number of colleges and admissions in India 
Academic program   Duration of 
program 
Duration of 
internship*  
Regulation 
authority  
 Number of 
colleges 
Number of 
admissions  
DPharm  2 years  3 months  PCI + AICTE 708 42,062 
BPharm 4 years  3 months  PCI + AICTE 919 59,844 
PharmD  5 years  12 months   PCI  142   4,270 
PharmD  
(Post Baccalaureate) 
3 years  12 months  PCI   57      570 
*Internship program = practical training in hospitals/dispensaries and/or in a pharmacy and/or 
drugs manufacturing unit  
 
PCI = Pharmacy Council of India 
AICTE = All India Council for Technical Education  
 
5.4  Regulation of Pharmacy Education in India 
Pharmacy education in India is regulated by 2 statutory bodies: PCI and AICTE. AICTE was 
established under the AICTE Act 1987. The AICTE is primarily responsible for planning, 
formulating, maintaining norms and standards in technical education, 200  which includes 
pharmacy. Pharmacy education at all levels excluding PharmD is regulated by AICTE. All 
institutions running DPharm, BPharm and MPharm must have an approval from AICTE to run 
the courses.201  
 
5.5  Quality of Pharmacy Education India 
National Board of Accreditation (NBA) is established under the All India Council for Technical 
Education Act, 1987, to access and accredit the colleges and/or institutions of technical and 
professional education. NBA is to promote and recognize excellence in technical education in 
colleges and universities - at both the undergraduate and post-graduate levels. NBA accredits 
pharmacy programs at diploma (DPharm), degree (BPharm) and Postgraduate (MPharm) levels. 
NBA accredits programs and not colleges/ institutions/ departments.202 
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PCI is in process to establish National Taskforce for Quality Assurance in Pharmacy Education 
(NTF QAPE) to oversee the implementation of PCI’s initiative for quality assurance in pharmacy 
education.203,204 The initiative aims to enable the sustainability of a pharmacy workforce that is 
relevant to local needs and also align with global expectations. The PCI envisages that by the 
year 2020, NTF QAPE will help overcome weaknesses in the education system and help produce 
appropriately trained pharmacists with the competencies to not only meet the demands of the 
country, but also be a part of a global competent health care workforce.29  
 
Some premium institutions from India are also applying for the USA’s Accreditation Council for 
Pharmacy Education’s (ACPE) accreditation program under ACPE’s International Services 
Program,205 which provides the confidence in the quality of education that the institutions are 
providing. 
 
5.5.1  Quality of Pharmacy Teaching in India  
The Pharmacy Council of India, through an Extraordinary Gazette approved by the central 
government of India on 12, November 2014,206 made new regulations to maintain the minimum 
standards of teaching in various departments of a pharmacy college or institution imparting 
diploma, graduate and post-graduate education shall be as prescribed there under.  
 
5.5.2  Bachelor of Pharmacy (Practice) Regulations, 2014 207  
Bachelor of Pharmacy (Practice) consists of a degree certificate of having completed the course 
of study and passed examination as prescribed in these regulations for the purpose of 
additional qualification to be entered in the register of pharmacists. These new regulations will 
help upgrading the qualification of practicing pharmacists with Diploma in Pharmacy.  
 
In global pharmacy and pharmaceutical education initiatives, the call for circular reform has 
been raised by International Pharmaceutical Federation (FIP).208  In developed countries, 
patient-centered curricula and public health pharmacy are focused on tackling ever-changing 
health environments.209 If the full potential of pharmacists is to realize in India, their expertise 
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in medicine management should be utilized to make them part of national health and 
pharmaceutical policies, the curriculum of different Indian pharmacy education programs needs 
to ensure that pharmacists are able to take their role in patient-centered activities and national 
public health programs. For this purpose, it is important to assess curriculum for public health 
and patient care aspects and compare with other countries where there is more emphasis and 
exposure on these aspects.  
 
5.6  Pharmacy Education in Other Countries 
5.6.1  Pharmacy Education Programs in USA  
USA has PharmD as the only program to practice the pharmacy in the country as a pharmacist 
(Table 1). PharmD programs at all US universities must be accredited by the Accreditation 
Council for Pharmacy Education (ACPE), the national agency for accreditation of professional 
degree programs in pharmacy and providers of continuing pharmacy education.210 Schools of 
Pharmacy offering the traditional Master of Science in Pharmacy (MSc Pharm) and PhD 
programs prepare students for teaching and research careers. In USA, after successful 
completion of PharmD, one cannot directly register as pharmacist and start practicing 
pharmacy. The graduates with PharmD, willing to practice pharmacy must also:  
i) complete internship, whose length vary for each state,  
ii) pass North American Pharmacist Licensure Examination (NAPLEX), and  
iii) Multistate Pharmacy Jurisprudence Examination (MPJE) state law examination which is 
conducted by State Pharmacy Boards.  
Moreover, proof of completing continuing education programs, approved by Accreditation 
Council for Pharmacy Education (ACPE), is required for the renewal of pharmacist license.211 
 
5.6.2  Pharmacy Education Programs in Denmark 
To become registered pharmacist and/or to own a pharmacy in Denmark, minimum 
qualification required is MSc degree in pharmacy212 (Table 1).  MSc degree from Danish 
University of Pharmaceutical Sciences is the oldest program in Denmark. University of Southern 
Denmark is also offering both BSc and MSc in pharmacy programs duly recognized to register as 
a pharmacist which is accredited by ACE Denmark, the Danish Accreditation Institute.213 In 
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Denmark, upon successful completion of MSc(Pharm) degree with 6 months internship 
(altogether 5 years), there are no additional exams required to be completed for becoming 
registered pharmacist and to practice pharmacy.  
 
5.6.3  Pharmacy Education Programs in Finland 
Finland has adopted a 2-tier university undergraduate training program for pharmacists 
consisting of BSc and MSc degrees, which is in line with the Bologna Declaration harmonizing 
structures of the European university degrees.214,215 The BSc degree consists of 180 ECTS credits 
and it takes 3 years to complete. The MSc degree takes an additional 2 years to complete (total 
300 ECTS credits).216 MSc level pharmacists mostly work in managerial and leadership positions 
and in positions requiring advanced pharmaceutical expertise. A majority of BSc pharmacists 
work in community pharmacies being responsible for dispensing, patient counselling and 
customer service. A pharmacy can be owned only by a MSc pharmacist.217 
 
In addition to the minimum requirements specified in Directive 2005/36/EC of the European 
Union and of the Council for Pharmaceutical Education, students pursuing the BSc(Pharm)  and 
MSc(Pharm) degree must obtain professional and practical competencies in areas determined 
nationally important for pharmacists to acquire during their basic education. An essential part 
of BSc(Pharm) curriculum in Finland is an obligatory internship of 6 months (30 ECTS credits), 
which is integrated with professional study at the university.218 The internship can be taken in a 
community pharmacy which is open to the public (minimum 3 months/15 ECTS credits), or in a 
hospital under supervision of that hospital’s pharmaceutical department (maximum 3 
months/15 credits).219,220,221 
 
Finnish BSc and MSc degrees are designed to prepare students for professional practice. The 
curriculum has elective courses both in the bachelor's and master’s degree. The master's 
degree aims at developing further the students’ scientific skills and includes an obligatory 6-
month research project (Master’s thesis, 40 ECTS credits).222 In Finland, both BSc (3 years) and 
MSc (5 years) of pharmacy can register and practice as pharmacist, however, only pharmacists 
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with a MSc degree may own a community pharmacy.223 Both the bachelors and masters 
programs have personal study plan which is approved by the professor or other nominated 
senior instructor. The personal study plan gives flexibility to the students to choose their area of 
interest. Students interested in community pharmacy practice, and social and clinical pharmacy 
can plan their studies and become experts. In Finland, graduates with bachelor’s (BSc) and 
master’s (MSc) degree in pharmacy do not need additional exams to become registered 
pharmacist and practice pharmacy. 
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6  CONCLUSION OF THE LITERATURE REVIEW  
 
India has shortage of medical and paramedical workforce and the pharmacists’ role in public 
health is not recognized by the policy makers and is not enrolled. There is evidence on 
expansion of the role of pharmacists in public health programs through pilot projects, but at a 
relatively slow pace. The barriers for pharmacists could be internal and external to the 
pharmacy environment such as knowledge, confidence levels, and recognition in general public 
and supportive policies. The pharmacists in India are not actively involved in public health 
programs while there is a great potential and opportunity to play an important role. To make 
this happen, it is important to examine and understand pharmacy curriculum, pharmacists’, 
physicians’ and public perceptions on pharmacist knowledge in public health programs and 
perceptions on pharmacist role in public health.  
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7 OBJECTIVES OF THE STUDY 
This study consists of 4 parts that were conducted during 2012 – 2014. The objective of this 
study was to assess public health and patient care aspects in pharmacy education and the role 
of pharmacists in national health care programs in India. The research goal was to find out 
possibilities and ways of extending pharmacists involvement in national public health programs 
and how pharmacist education could partly facilitate this shift. 
 
The following are detailed objectives by sub-studies:  
 to review pharmacy education system in India (I, II) 
 to compare the Indian pharmacy curricula of Diploma in Pharmacy (DPharm), Bachelor 
of Pharmacy (BPharm), and Doctor of Pharmacy (PharmD) to see the overall differences 
with a focus on the amount of time devoted for pharmaceutical policies and public 
health, patient care, and pharmacy practice aspects in the programs. (I).  
 to compare Indian pharmacy curriculum of Diploma in Pharmacy (DPharm), Bachelor of 
Pharmacy (BPharm) and Doctor of Pharmacy (PharmD) with Pharmacy curriculum of 
USA, Finland and Denmark to see overall differences with a focus on the amount of time 
devoted in the programs for pharmaceutical policies and public health, patient care and 
pharmacy practice aspects. (II) 
 to explore final year DPharm, BPharm and PharmD students’ awareness, perceived 
knowledge and attitude, and acquaintance with 11 major National Public Health 
Programs (NPHPs) and their attitude towards pharmacists’ involvement in public health 
and patient care. (III)  
 to characterize physician perceptions on the role of pharmacists in public health and 
patient care. (IV)   
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8 METHODS 
A triangulation process was used in this study by combining quantitative and qualitative 
methods (Figure 6, Table 9). The chosen methods were a comparative programmatic research 
(I, II) and cross-sectional surveys (III, IV). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. The outline of the study  
 
  
Design  Programmatic research 
Methods  
Study I: Curricula 
Comparison of 
Indian programs  
Sample   
Goal   
Analysis of contents of different pharmacy programs in India and assessment of 
pharmacy students and physicians’ perceptions on pharmacists’ involvement in 
patient care and national public health programs. 
Study III:  
Students’ survey 
Study IV: 
Physicians’ survey 
Study II: 
Comparison of 
curricula of India 
with 3 selected 
countries 
Cross sectional survey 
Study III:  
Final year 
pharmacy students  
Study IV:  
Practicing 
physicians 
DPharm, BPharm, 
PharmaD curricula 
Curricula from 
India: DPharm, 
BPharm, PharmD. 
International: USA, 
Finland and 
Denmark  
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Table 9. Overview of research plan by substudies I-IV 
Study Aim of the study Study design and method Analysis 
    
I To compare Indian pharmacy curriculum of 
DPharm, BPharm, and PharmD programs to 
see overall differences with a focus on the 
amount of time devoted for public health, 
patient care, and pharmacy practice 
aspects. 
Programmatic research  The curriculum contents were 
divided into four core areas. The 
duration of time spent on each 
core subject area was given in 
number of hours, which were used 
for comparison. 
    
II To compare Indian pharmacy curricula with 
Pharmacy curriculum of USA, Finland and 
Denmark to assess differences with a focus 
on pharmaceutical policies and public 
health, patient care and pharmacy practice 
aspects. 
Programmatic research  The curriculum contents were 
divided into four core areas and 
number of hours were collated and 
analyzed. 
    
III To explore awareness, perceived 
knowledge and attitude of Indian pharmacy 
students on National Public Health 
Programs (NPHPs). 
A cross-sectional classroom 
survey to a convenient sample 
of final year pharmacy students 
in five pharmacy schools 
(n=326, response rate 100%) 
Descriptive statistics (means, 
standard deviations,  Chi-square 
tests) 
    
IV To characterizing physicians’ perceptions 
on the role of pharmacists in public health 
and patient care in India. 
A cross-sectional survey to a 
convenience sample of physicians 
in Southern region in India 
(n=800, response rate 16%) 
Descriptive statistics (means, 
standard deviations,  Chi-square 
tests) 
 
The current research was divided into the following four studies, each of them being published 
as a separate original publication (I-IV). Two studies were programmatic studies (I, II), while the 
remaining two were cross-sectional surveys (III, IV). 
 
8.1  Pharmacy Curricula Comparison 
A comparison of pharmacy curriculum to see the overall differences with a focus on the amount 
of time devoted for pharmaceutical policies and public health, patient care and pharmacy 
practice aspects was conducted. To do so, the curricula were analyzed and the work was 
divided into two parts.  
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8.1.1  Public Health and Patient Care Aspects in Indian Pharmacy Curricula: A Comparison 
between DPharm, BPharm and PharmD Programs (I) 
The first part of the research compared the Indian pharmacy curriculum of Diploma in 
Pharmacy (DPharm), Bachelor of Pharmacy (BPharm), and Doctor of Pharmacy (PharmD) to see 
the overall differences with a focus on the amount of time devoted for pharmaceutical policies 
and public health, patient care and pharmacy practice aspects in the programs. 
 
This was a programmatic research conducted between March 2012 and January 2013. The 
curricula were collected from the statutory bodies, not from the individual universities as the 
universities follow the standard curriculum provided by these statutory bodies, namely 
Pharmacy Council of India (PCI) and All India Council for Technical Education (AICTE).  
 
Syllabus of Indian Pharmacy courses leading to become a registered pharmacist, DPharm, 
BPharm and PharmD were collected. The syllabus for DPharm224 and PharmD225 programs are 
uniform throughout the nation with same subjects, chapters and number of teaching hours per 
year as prescribed under the PCI Education Regulations 1991 and PharmD Regulations 2008, 
respectively, which were used for the comparison. It is mandatory for all the colleges 
conducting DPharm and PharmD to follow the syllabus prescribed by PCI under the relevant 
Acts. As per the Clause 10(i) of the AICTE Act 1987, it is mandatory for all the AICTE approved 
BPharm programs to maintain the uniformity in accordance with model curriculum. In 
fulfillment of this Clause, a Model curriculum for BPharm is prescribed by the AICTE in 2011,226 
which was used for the comparison in this study.  
 
Syllabus of Indian Pharmacy courses leading to become a registered pharmacist, DPharm, 
BPharm and PharmD was collected. The curriculum content from each program were divided 
into four core areas named as: Area 1: Basic Biomedical Sciences; Area 2: Pharmaceutical 
Sciences; Area 3: Social/Behavioral/Administrative Sciences; and Area 4: Clinical Sciences; as 
outlined in Appendix-B of Accreditation Council of Pharmacy Education’s (ACPE) accreditation 
standards and guidelines for the professional program in pharmacy leading to the doctor of 
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pharmacy degree, 2011 version.227 The core curriculum comparison results were analyzed from 
each pharmacy program and compared with special focus on Social/Behavioral/Administrative 
Sciences and Clinical Sciences areas.  
 
From each test curriculum that was collated, the number of hours of each core area was 
separated as described in ACPE’s accreditation standards and guidelines and the National 
Association of Boards of Pharmacies’s (NABP) Pharmacy Curriculum Outcomes Assessment 
(PCOA) guidelines.228 Subjects from each program are divided into theory lectures and practical 
hours in the laboratory. Theory hours are defined as the class-room teaching on chapters from 
curriculum by the lecturers/professors. The practical hours are defined as hours spent in 
laboratory or in a practical setting. The duration of time spent on each subject is given in 
number of hours, which is used for comparison. 
 
8.1.2  Public Health and Patient Care Aspects in Indian Pharmacy Curricula: A Comparison 
with USA, Finland and Denmark (II) 
The aim of this study was to compare Indian pharmacy curriculum of Diploma in Pharmacy 
(DPharm), Bachelor of Pharmacy (BPharm) and Doctor of Pharmacy (PharmD) with Pharmacy 
curriculum of USA, Finland and Denmark to see overall differences with a focus on the amount 
of time devoted to pharmaceutical policies and public health, patient care and pharmacy 
practice aspects in the programs.  
 
8.1.2.1  Methodology 
To achieve the objective of the study, this programmatic research was designed to compare 
curriculum of Indian pharmacy education programs (DPharm, BPharm and PharmD) with the 
pharmacy curriculum of Denmark, Finland and USA, where pharmacy is being practiced with 
patient care in focus. The study was conducted between March 2013 and August 2014. 
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8.1.2.1.1  Selection of Countries 
WHO has grouped its Member States into six regions: African Region, Region of the Americas, 
Eastern Mediterranean Region, European Region, South East Asia Region (SEAR) and Western 
Pacific Region (WPR).229 India covers the largest part in SEAR, USA is an important member of 
Region of America, and Finland and Denmark are from Europe Region. Though countries like 
Australia from WPR also demonstrate patient focused pharmacy practice, but the comparison 
was limited to the USA, Denmark and Finland. This is because most remarkable professional 
philosophies guiding patient focused and clinical based pharmacy practice originate from the 
USA.230 Pharmacists in Northern Europe seem to be best positioned in health care chain to 
detect, prevent, and solve drug-related problems.231 
 
8.1.2.1.2  Selection of Curricula 
Syllabus of Indian Pharmacy courses leading to registered pharmacist title, DPharm, BPharm 
and PharmD were collected. The syllabus for DPharm232 and PharmD programs are uniform 
throughout the nation with the same subjects, chapters and number of teaching hours per year 
as prescribed under the PCI Education Regulations 1991 and PharmD Regulations 2008 
(India),233  respectively, which were used for the comparison. It is mandatory for all the colleges 
conducting DPharm and PharmD programs to follow the syllabus prescribed by PCI under the 
relevant Acts. As per the Clause 10(i) of the AICTE Act 1987, it is mandatory for all the AICTE 
approved BPharm programs to maintain the uniformity in accordance with the Model 
Curriculum. In fulfillment of this Clause, a Model Curriculum for BPharm is prescribed by the 
AICTE in 2011,234 which was used for comparison in this study. This curriculum is a guideline for 
the universities, and hence, BPharm curriculum from randomly selected two different 
universities is tested to see if they are in-line with the Model Curriculum of AICTE. Both these 
universities have approximately the same amounts of core subject areas (2-5 percent 
variation).235  
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USA PharmD curriculum was randomly selected from the University of Florida. Master of 
Science in Pharmacy program from both the University of Helsinki, Finland, and the University 
of Copenhagen, Denmark were used for comparison (curriculum valid in 2012 – 2013 academic 
year). 
 
8.1.2.1.3  Conversion of Credits into Hours 
Selected Indian curricula were available in number of hours. However, other selected 
curriculums were available in number of credits. The University of Florida curriculum is defined 
in credits, where each credit is equivalent to 17 hours.236 One ECTS credit (European Credit 
Transfer System) of Finnish and Danish curriculum is equivalent to 27 hours of student 
work.237,238 Using these conversion references, all curriculums included in this study were 
converted into number of hours-format to make them comparable.  
 
8.1.2.1.4  Division of Core Curriculum Content and Comparison 
This study applied the same method as was used in a previous study which defined the 
curriculum content and compared existing pharmacy curricula in India in terms of public health 
and patient care aspects.239 
 
The curriculum content from each study curriculum was divided into the following four core 
areas: area 1: Basic Biomedical Sciences; area 2: Pharmaceutical Sciences; area 3: 
Social/Behavioral/Administrative Sciences; and area 4: Clinical Sciences; as outlined in 
Appendix-B of ACPE “Accreditation standards and guidelines for the professional program in 
pharmacy leading to the doctor of pharmacy degree, 2011 version”.240 The core curriculum 
areas from each program were tabulated and the results were analyzed and compared with a 
focus on area 3 and area 4.  
 
In Core area 3: health and pharmaceutical policies, practice management, pharmaco econom-
ics, pharmaco-epidemiology, pharmacy law, regulatory affairs, ethics, professional 
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communication, social and behavioral aspects of practice both in community and hospital 
pharmacy practice were collated.  
 
In Core area 4: pharmacotherapy, drug information, medication safety and literature evaluation 
and research design aspects were collated. Special focus was made to see if there was emphasis 
on patient care (for example efforts to improve therapeutic outcomes by counseling, disease 
and medicine management, maintaining patient profiles), health and pharmaceutical policies 
and public health programs (for example, knowledge and preparation to take part in national 
health programs, such as HIV/AIDS Control, Tuberculosis Control, Vector Borne Disease Control, 
Leprosy Eradication, Pulse Polio, Universal Vaccination and Tobacco Control programs241) in the 
curriculum. From each curriculum collated number of hours from each core area was separated 
as described in ACPE’s accreditation standards and guidelines and the National Association of 
Boards of Pharmacies’s (NABP) Pharmacy Curriculum Outcomes Assessment (PCOA) 
guidelines.242 Subjects from each program were divided into theory lectures and practical hours 
in the laboratory. Theory hours are defined as the class-room teaching on chapters from 
curriculum by the lecturers/professors. The practical hours are defined as hours spent in labora-
tory or in a practical setting. 
 
8.2  Role of Pharmacists in National Public Health Programs in India: A Survey on Pharmacy 
Students’ Perceived Knowledge and Attitude (III) 
 
The objective of this study was to explore final year DPharm, BPharm and PharmD students’ 
awareness, perceived knowledge, attitude, and acquaintance with 11 major National Public 
Health Programs (NPHPs) in India, and their attitude towards pharmacists’ involvement in 
public health and patient care. 
 
8.2.1  Study Design 
The study was conducted as a cross-sectional classroom survey in 2014. A survey instrument 
with 27 items was formulated by taking “A Survey Exploring Knowledge and Perceptions of 
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General Practitioners Towards the Use of Generic Medicines in the Northern State of 
Malaysia”243 and “Pharmacy Students’ Perspectives on a PharmD/MPH Dual Degree Program at 
a Large Metropolitan School of Pharmacy”,244 as main references.  
 
8.2.2  Survey Instrument 
The survey instrument (Annexure 1) assessed pharmacy students in:  
i) perceived knowledge and attitude on National Public Health Programs in general; and  
ii) perceived knowledge on individual National Public Health Programs.  
iii) The students were asked to give their top two preferences of work area (job discipline) 
after completion of their pharmacy education.  
 
The following 11 major programs as prioritized by the Ministry of Health and Family Welfare, 
Government of India, were included in the survey instrument245: (1) HIV/ AIDS Control; (2) 
Revised National Tuberculosis Control (RNTCP); (3) Vector Borne Disease Control (NVBDCP); (4) 
Leprosy Eradication (NLEP); (5) National Mental Health (NMPH); (6) Prevention and Control of 
Deafness (NPPCD); (7) Control of Blindness (NPCB); (8) Pulse Polio; (9) Universal Immunization 
(UIP); (10) Tobacco Control (NTCP); and (11) Health Care of the Elderly (NPHCE).  
 
8.2.3  Method 
The questionnaire was initially validated by two professors, two pharmacists and 6 students for 
contents before data collection. The survey instrument was distributed to students from 5 
randomly selected pharmacy colleges from Southern part of India. A brief introduction on 
NPHPs and objectives of the study were provided to students. The survey was conducted 
among DPharm (2nd year), BPharm (4th year) and PharmD (6th year) students. This was a 
classroom survey, students independently responded to the questionnaire in classrooms. The 
data were collated and analyzed by using SAS (version 9.3). Chi-square tests were used to 
determine any statistical differences in responses between various student groups with p value 
of <0.5 deemed as significant. The study did not need Ethical Committee approval as per the 
University of Helsinki Ethical guidelines. However, all the students in-principle agreed to 
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complete the survey tool. The anonymity of the responding students was assured in all phases 
of the study. 
 
8.3  Pharmacists in National Public Health Programs in India: A Pilot Study Highlighting 
Physicians’ Perceptions (IV) 
 
8.3.1  Study Design 
This was a cross-sectional survey to a convenience sample of physicians in Southern region in 
India. 
 
8.3.2  Survey Instrument  
The method of this cross-sectional small-scale pilot study was designed using the following 
three studies as baseline references: “Physician perceptions of pharmacist roles in a primary 
care setting in Qatar”,246  “Professional training and roles of community pharmacists in 
Malaysia: views from general medical practitioners”247 and “Extending the roles of community 
pharmacists: views from general medical practitioners”.248   
 
A survey tool was developed with 28 structured questions divided into three sections: (i) 
physicians’ experiences of interaction and cooperation with pharmacists; (ii) physicians’ general 
opinion on pharmacists’ involvement in NPHPs; (iii) Physicians’ opinion on pharmacists’ role in 
11 major individual NPHPs. The questionnaire was initially validated by two professors, two 
pharmacists and two physicians for content before data collection. Their views and comments 
were considered and incorporated, as perceived appropriate, into the final questionnaire 
(Annexure 2). 
 
8.3.3  Method 
Six volunteers personally visited 800 physicians working in private hospitals and as independent 
practitioners in Southern region in India and collected data during the period of March to 
November 2014. Well in advance, the volunteers were briefed about the importance of the 
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study and process of collecting data. The volunteers made two visits: the first visit was to 
explain and deliver the print version of the survey tool, then the second visit to collect the data. 
To document the consent of physicians and to maintain authenticity of the study, participating 
physicians were requested to fill the questionnaire personally and sign and stamp it at the end 
of the survey form.  
 
To maintain anonymity of the respondents, data forms were numbered and the numbers were 
used as IDs during the data entry in University of Helsinki’s E-lomake online survey portal. The 
data were collated, extracted and descriptive statistical analysis was conducted by SAS (version 
9.3). Results are presented as frequencies and percentages. The physicians’ perceptions of 
pharmacists’ role in NPHPs were reflected according to length of their medical practice. Chi-
square tests were used to determine if there were any statistical differences in the responses in 
this respect.  For this purpose, the survey respondents were segregated into the following 4 
groups based on the number of years of professional practice:  Group A with less than 5 years 
of professional practice (43%, n=55); Group B with 5-10 years of practice (26%, n=33), Group C 
with 11-15 years of practice (12%, n=15) and Group D with more than 15 years of practice (20%, 
n=26). 
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9  RESULTS 
This chapter focuses on describing key findings of the original studies I-IV, summarized below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 7. Summary of key findings (I-IV).  
POCA = Pharmacy Curriculum Outcomes Assessment Guidelines of National Association of 
Boards of Pharmacy, USA. NPHPs = National Public Health Programs 
   
Key findings from curriculum comparison studies  
 
Comparison among Indian pharmacy programs (I): 
 Less emphasis on social/ behavioral/administrative 
and clinical sciences from DPharm and BPharm 
programs to support pharmacists’ role in patient care 
and public health. 
 DPharm and BPharm curriculum focused more on 
industry and less on patient care. 
 PharmD is focused on clinical pharmacy and patient-
oriented services.  
 DPharm and BPharm curriculums are not preparing 
pharmacists to take part in public health, patient and 
pharmaceutical care services.  
 There is a gap in curriculum, particularly at DPharm 
level. 
 Indian pharmacy programs do not have the same 
length and knowledge levels, but the graduates obtain 
the same title (pharmacist). 
Curriculum comparison between India, USA, Finland and 
Denmark’s pharmacy programs (II): 
 The proportions of 4 core areas remarkably varied 
between the curricula assessed.  
 Unlike in USA, graduates from India, Denmark and 
Finland does not need to take any additional assess-
ment examinations to practice pharmacy. 
 Need for introduction of community service in DPharm 
and BPharm programs were identified. 
 Indian programs were covering more basic and 
biomedical sciences when compared to programs in 
USA, Finland and Denmark.  
 PCOA recommends 22% of social/ 
behavioral/administrative sciences in curricula, but 
none of the programs were fulfilling it. 
 Finnish and Danish curricula have more electives than 
Indian or US curricula. 
 Pharmaceutical policy and public health topics were 
least allocated in all the programs studied. 
Pharmacy Students’ 
 perceived knowledge and attitude on role of 
pharmacists in NPHPs (III):  
 83% of participating students (n=326) opined that it 
was very important/important to include NPHPs in 
normal pharmacists’ training programs 
 DPharm and PharmD students indicated higher interest 
in NPHPs than BPharm students. 
 Only 21% of students believed that their current 
knowledge was very much sufficient/sufficient to 
become active part of NPHPs. Need for knowledge 
improvement is identified.  
 81% students felt that they have very 
important/important role to play in NPHPs 
  96% were willing to take up a professional role and 
want to learn more about NPHPs. 
 Pulse polio, HIV/AIDS, Tuberculosis-, Tobacco-, 
Blindness -control and universal vaccination programs 
Physicians’ perceptions on pharmacists in NPHPs in 
India: a pilot study highlighting (IV):  
 98% of participating physicians (n=129) were 
comfortable with current pharmacists’ roles in general  
 96% were comfortable or somewhat comfortable to 
collaborate with pharmacists 
 82% regarded pharmacists as part of health care team 
 Young physicians with shorter professional practice 
were more positive on pharmacists’ involvement in 
NPHPs than senior physicians with an experience of 
over 10 years. 
 Overall response of accepting pharmacists’ role and 
involvement in NPHPs was positive. 
 Pulse Polio, HIV/AIDS, Tuberculosis, Tobacco control 
and Leprosy eradication programs being top NPHPs 
where physicians perceived pharmacists had an 
important role to play. 
Key findings from student and physician surveys   
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9.1  Pharmacy Curricula Comparison 
 
9.1.1  Public Health and Patient Care Aspects in Indian Pharmacy Curricula: A Comparison 
between DPharm, BPharm, and PharmD Programs (I) 
The curriculum blueprint for each program is shown in Table 10 (DPharm), Table 11 (BPharm), 
and Table 12 (PharmD), which is divided into theory and practical hours in four core areas.  
 
Table 10 shows that DPharm program has only 1500 hours, of which 850 hours (57%) are of 
theory and 650 hours (43%) are of practical work. Under area 3, social/ behavioral/ 
administrative pharmacy sciences, DPharm has 175 hours (12%), and under area 4, clinical 
sciences has a total 125 hours of which 75 hours are of theory and 50 hours of practice.  
 
Table 10. DPharm curriculum blueprint which is divided into core areas according to teaching hours (1500 
teaching hours in total) 
Core area and subject  T hrs* P hrs* Total  
Area 1 Basic and Biomedical sciences  
Human Anatomy and Physiology 75 50 
Biochemistry and Clinical Pathology 50 75 
Total 125 125 250 
% 8 8 17 
Area 2  Pharmaceutical Sciences 
Pharmaceutical Chemistry-I 75 75 
Pharmaceutical Chemistry-II 100 75 
Pharmaceutics-I 75 100 
Pharmaceutics-II 75 100 
Pharmacology  and Toxicology 75 50 
Pharmacognosy 75 75 
Total 475 475 950 
% 32 32 63 
Area 3 
Social/Behavioral/Administrative Pharmacy Sciences 
Health Education and Community Pharmacy 50  
Drug Store and Business Management 75 - 
Pharmaceutical Jurisprudence 50 - 
Total 175 0 175 
% 12 0 12 
Area 4 Clinical Sciences 
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Hospital and Clinical Pharmacy 75 50 
Total 75 50 125 
% 5 3 8 
Total hours  850 650 
Total % 57 43 
Grand total (both theory and practical) 1500 100 
* T hrs = Theory classes in hours 
* P hrs = Practical classes in hours  
 
From Table 11, it is observed that “Model curriculum for BPharm” is covering 1155 hours (31%) 
of basic and biomedical sciences and 2190 hours (58%) of pharmaceutical sciences, totaling 
3750 hours of the curriculum, which means 89% of total time is being spent learning basic, 
biomedical, and pharmaceutical sciences. Of the total time, 1740 hours (46%) are dedicated to 
traditional practical lab work. The focus areas related to practice and public health is not as 
significantly emphasized. The core area 3, social/behavioral/administrative pharmacy sciences, 
covers 315 hours (8%) and core area 4, clinical sciences, covers only 90 hours (2%).  
 
Table 11. BPharm curriculum blueprint which is divided into core areas (3750 teaching hours in total)  
Core area and subject T hrs* P hrs* Total % 
Area 1 Basic and Biomedical sciences  
Remedial Mathematics (Biology at 10 +2 level) 45 0 
Remedial Biology (Mathematics at 10 +2 level) 30 90 
Computer & statistics 60 90 
Anatomy, Physiology and Health Education 60 90 
Pathophysiology 60 0 
Microbiology 60 90 
Biotechnology  60 90 
Biochemistry 60 60 
Organic Chemistry I 60 90 
Environmental Sciences 60 0 
Total 555 600 1155 
% 15 16 31 
Area 2 Pharmaceutical Sciences 
Organic Chemistry II 60 90 
Physical Pharmacy 60 90 
Physical Chemistry 60 90 
Pharmaceutical Chemistry I 60 0 
Pharmaceutical Chemistry II 60 0 
Pharmaceutical Chemistry III 60 0 
Pharmaceutical Chemistry IV 60 90 
Pharmaceutial Analysis I 60 90 
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Pharmaceutical Analysis II 60 90 
Pharmaceutics I 60 90 
Pharmaceutics II 60 90 
Pharmaceutics III 60 90 
Pharmaceutical Engineering 60 0 
Biopharmaceutics & Pharmacokinetics 60 0 
Pharmacology I 60 0 
Pharmacology II 60 90 
Pharmacognosy I 60 0 
Pharmacognosy II 60 90 
Pharmacognosy III 60 60 
Total 1140 1050 2190 
% 30 28 58 
Area 3 Social/Behavioral/Administrative Pharmacy Sciences 
Functional English and communication skills 45 0 
Hospital & Dispensing pharmacy  60 90 
Pharmaceutical Jurisprudence 60 0 
Pharmaceutical Management 60 0 
Total 225 90 315 
% 11 2 8 
Area 4 Clinical Sciences 
Clinical Pharmacy & Therapeutics 60 0 
Electives/Seminar /Literature review 30 0 
Total 90 0 90 
% 2 0 2 
Total of all 4 core areas  2010 1740 
Total percent of all 4 core areas  54 46 
Grand total hrs (both theory & practical) 3750 100 
* T hrs = Theory classes in hours and P hrs = Practical classes in hours  
 
Table 12 shows that PharmD curriculum comprises 1056 hours (18%) of basic and biomedical 
sciences and 2112 hours (37%) of pharmaceutical sciences. However, PharmD covers 561hours 
(10%) of social/behavioral/administrative sciences and 1980 hours (36%) of clinical sciences. 
Apart from this, it is also mandatory for the graduates to undergo one year of internship during 
the sixth year involving specialty units in hospitals. The duration of the internship is divided as 
six months in general medicine department in a hospital and six months in specialty 
departments (two months each in three specialty departments). It is a phase of training where 
if a student is exposed to actual pharmacy practice or clinical pharmacy services and acquires 
skills under supervision so that he or she may become capable of functioning independently.249 
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Table 12. PharmD curriculum blueprint which is divided into core areas (5709 teaching hours in total)  
Core area and subject T hrs* P hrs* Tutorial hrs* Total 
Area 1 Basic and Biomedical sciences 
Remedial Mathematics/ Biology  99 99 33 
Human Anatomy and Physiology  99 99 33 
Pathophysiology  99 0 33 
Pharmaceutical Microbiology  99 99 33 
Medicinal Biochemistry 99 99 33 
Total 495 396 165 1056 
% 9 7 3 18 
Area 2 Pharmaceutical Sciences 
Pharmaceutical Organic Chemistry  99 99 33 
Pharmaceutical Inorganic Chemistry  66 99 33 
Pharmaceutical Analysis  99 99 33 
Medicinal Chemistry  99 99 33 
Pharmaceutics 66 99 33 
Pharmaceutical Formulations  66 99 33 
Biopharmaceutics and Pharmacokinetics  99 99 33 
Pharmacology-I  99 0 33 
Pharmacology-II  99 99 33 
Pharmacognosy and 
phytopharmaceuticals  99 99 33 
Total hours 891 891 330 2112 
% 16 16 6 37 
Area 3 Social/Behavioral/Administrative Pharmacy Sciences 
Community Pharmacy  66 0 33 
Hospital Pharmacy  66 99 33 
Pharmacoepidemiology and 
Pharmacoeconomics 99 0 33 
Biostatistics and Research Methodology 66 0 33 
Pharmaceutical Jurisprudence  66 0 0 
Total hours  330 99 132 561 
% 6 2 2 10 
Area 4 Clinical Sciences 
Clinical Toxicology  66 0 33 
Clinical Research 99 0 33 
Clinical Pharmacy  99 99 33 
Pharmacotherapeutics-I  99 99 33 
Pharmacotherapeutics-II 99 99 33 
Pharmacotherapeutics-III 99 99 33 
Clinical Pharmacokinetics and 
Pharmacotherapeutic Drug Monitoring 66 0 33 
Clerkship (Ward rounds on daily basis) 0 0 33 
Project work (Six Months) 0 660 0 
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Total hours  660 1056 264 1980 
% 12 18 5 35 
Grand total hours  2376 2442 891 5709 
% 42 43 16 
* T hrs = Theory classes in hours, P hrs = Practical classes in hours and Tutorial hours: After 2-3 hours 
theory class, students are divided into small groups, where they discuss and debate for an hour on what 
was learnt in Theory classes under the guidance and supervision of lecturer or professor.  
 
A comparison of number of hours from each core subject area of all three different programs is 
illustrated in Figure 8. This shows much less emphasis on social/ behavioral/ administrative and 
clinical sciences from DPharm and BPharm programs to support pharmacists’ role in patient 
care and public health. Figure 8 is a2D-bar graph with two vertical x-axis values. X-axis on the 
left shows the percentage, and x-axis on the right shows duration of the program in years. 
 
 
Figure 8. Comparison of hours of core areas in curriculums of different programs. 
 
Out of two years of education in DPharm program, 63% of the time is being spent on 
pharmaceutical sciences, and 43% of the curriculum is filled with compounding practical 
exposure in the labs without focus on health policies, public health, pharmacy practice areas 
like medication management and review of patient profiles, etc. It is also lacking course work in 
health care policy, patient care, patient counseling, and communication aspects.  
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9.1.2  Public Health and Patient Care Aspects in Indian Pharmacy Curricula: A Comparison 
with USA, Finland and Denmark (II) 
Table 13 shows an overview of pharmacy programs available in four selected countries, length 
of each pharmacy program, regulatory body responsible for pharmacist registration and 
additional assessment examinations required to pass to obtain pharmacist registration. 
 
Tablet 13. An overview of pharmacy programs leading to registered pharmacist in India, USA, Denmark and Finland  
Country Academic qualification 
Duration of 
program 
Duration of 
internship Regulatory authority 
Additional 
requirements to 
practice pharmacy 
India  
DPharm 2 years  3 months  PCI + AICTE 
None  
BPharm 4 years 3 months  PCI + AICTE 
MPharm 2 years (1 year dissertation) None  
AICTE  
PharmD 5 years 12 months PCI  
USA  
PharmD  
4 + (2-3 years pre-
pharmacy studies) 
Varies from 
state to state 
(1200-1500 
hours)  
NABP/ State Boards 
of Pharmacy  
NAPLEX + MPJE  
Finland 
BSc (Pharm) 2.5 years 6 months  National Supervisory 
Authority for Welfare 
and Health (Valvira) 
None 
MSc (Pharm)  4.5 years  6 months1  
Denmark  MSc (Pharm)  4.5 years  6 months
1  Danish Health and 
Medicines Agency  None  
*Internship program = practical training in hospitals/dispensaries and/or in a community 
pharmacy and/or drugs manufacturing unit.  
1According to European Union regulations, minimum 3 months of the 6-months internship must 
be done in a community pharmacy. The remaining 3 months can be done in a hospital or 
community pharmacy20 
PCI = Pharmacy Council of India; AICTE = All India Council for Technical Education; NAPLEX = 
North American Pharmacist Licensure Examination; MPJE = Multistate Pharmacy Jurisprudence 
Examination. 
 
9.1.2.1  Pharmacy Education in India 
Minimum qualification for registration and practice of pharmacy in India is a pass in either of 
DPharm or BPharm or PharmD programs from PCI approved institution with 3 months 
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internship for DPharm and BPharm and 12 months internship for PharmD (Table 13). Pharmacy 
education in India is regulated by 2 statutory bodies: Pharmacy Council of India and All India 
Council for Technical Education. Indian pharmacy graduate does not need to take any 
additional assessment examinations to practice pharmacy. 
 
9.1.2.2  Pharmacy Education in USA  
USA has PharmD as the only program to practice the pharmacy in the country as a pharmacist 
(Table 13). PharmD programs at all US universities must be accredited by the Accreditation 
Council for Pharmacy Education (ACPE), the national agency for accreditation of professional 
degree programs in pharmacy and providers of continuing pharmacy education.250 Schools of 
Pharmacy offering the traditional Master of Science in Pharmacy (MSc Pharm) and PhD 
programs prepare students for teaching and research careers. In USA, after successful 
completion of PharmD, one cannot directly register as pharmacist and start practicing 
pharmacy. The graduates with PharmD, willing to practice pharmacy must also: i) complete 
internship, whose length vary for each state, ii) pass North American Pharmacist Licensure 
Examination (NAPLEX), and iii) Multistate Pharmacy Jurisprudence Examination (MPJE) state 
law examination which is conducted by State Pharmacy Boards. Moreover, proof of completing 
continuing education in programs approved by the Accreditation Council for Pharmacy 
Education (ACPE) is required for renewal of pharmacist license. 
 
9.1.2.3  Pharmacy Education in Denmark  
To become registered pharmacist and/or to own a pharmacy in Denmark, minimum 
qualification required is MSc degree in pharmacy251 (Table 13). MSc degree from Danish 
University of Pharmaceutical Sciences is the oldest program in Denmark. University of Southern 
Denmark is also offering both BSc and MSc in pharmacy programs duly recognized to register as 
a pharmacist which is accredited by the Danish Accreditation Institute (ACE Denmark).252 In 
Denmark, upon successful completions of MSc (Pharm) degree with 6 months internship 
(altogether 5 years), there are no additional exams required to be completed for becoming 
registered pharmacist and to practice pharmacy. 
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9.1.2.4  Pharmacy Education in Finland  
Finland has adopted a 2-tier university training program for pharmacists consisting of BSc and 
MSc degrees, which is in line with the Bologna Declaration harmonizing structures of the 
European university degrees253,254 (Table 13).The BSc degree consists of 180 ECTS credits and it 
takes 3 years to complete. The MSc degree takes an additional 2 years to complete (total 300 
ECTS credits).255 MSc level pharmacists mostly work in managerial and leadership positions and 
in positions requiring advanced pharmaceutical expertise. A majority of BSc pharmacists work 
in community pharmacies being responsible for dispensing, patient counseling and customer 
service. Only MSc pharmacists can own a pharmacy.256 
 
In addition to the minimum requirements specified in Directive 2005/36/EC of the European 
Union and of the Council for Pharmaceutical Education, students pursuing the BSc(Pharm)  and 
MSc(Pharm) degree must obtain professional and practical competencies in areas determined 
nationally important for pharmacists to acquire during their basic education. An essential part 
of BSc(Pharm) curriculum in Finland is an obligatory internship of 6 months (30 ECTS credits), 
which is integrated with professional study at the university.257 The internship can be taken in a 
community pharmacy which is open to the public (minimum 3 months/15 ECTS credits), or in a 
hospital under supervision of that hospital’s pharmaceutical department (maximum 3 
months/15 credits).258,259,260 
 
Finnish BSc and MSc degrees are designed to prepare students for professional practice. The 
curriculum has elective courses both in the bachelor's and master’s degree. The master's 
degree aims at developing further the students’ scientific skills and includes an obligatory6-
month research project (Master’s thesis, 40 ECTS credits).261 In Finland, both BSc (3 years) and 
MSc (5 years) of pharmacy can register and practice as pharmacist, however, only pharmacists 
with a MSc degree may own a community pharmacy.262 Both the bachelors and masters 
programs have personal study plan which is approved by the professor or other nominated 
senior instructor. The personal study plan gives flexibility to the students to choose their area of 
interest. Students interested in community pharmacy practice, and social and clinical pharmacy 
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can plan their studies and become experts. In Finland, graduates with bachelor’s (BSc) and 
master’s (MSc) degree in pharmacy do not need additional exams to become registered 
pharmacist and practice pharmacy. 
 
9.1.2.5  Comparison of Total Time Spent in Each Core Content Area 
The curricula from all four countries were divided into theory and practical hours in four core 
areas. The results of Comparison of total time spent in each core content area, in number of 
hours, from India, USA, Denmark and Finland is described below.  
 
Table 14. Comparison of total time spent in each core content area, in number of hours, in each study program in 
India, USA, Denmark and Finland.  
Core Area 
DPharm India: 
Total hours 
1500 
BPharm India: 
Total hours 
3750 
PharmD India: 
Total hours 
5709 
MSc Pharm 
Finland:  Total 
hours 8100* 
MSc Pharm 
Denmark: Total 
hours 8400** 
PharmD USA: 
Total hours 
2482 
PCOA*
** 
% Hours % Hours % Hours % Hours % Hours % Hours % 
Basic and 
Biomedical 
sciences  
17 250 31 1155 18 1056 10 783 12 980 12 306 16 
Pharmaceutical 
Sciences 63 950 58 2190 37 2112 28 2241 40 3374 13 323 30 
Social/ 
behavioral/ 
administrative 
Sciences 
12 175 8 315 8 462 15 1188 7 560 8 204 22 
Clinical Sciences  8 125 2 90 36 2079 14 1107 16 1386 66 1649 32 
* Finnish MSc (Pharm) curriculum has electives 2781 hours (34%) of the curriculum   
** Danish MSc (Pharm) curriculum has electives 2100 hours (25%) of the curriculum 
*** Pharmacy Curriculum Outcomes Assessment Guidelines of National Association of Boards of Pharmacy, USA 
 
Core area 1: basic and biomedical sciences 
Indian pharmacy programs are covering more basic and biomedical sciences compared to 
Denmark, Finland and USA (Table 14). This applies particularly to Indian BPharm program, of 
which 31% of the total hours are related to basic and biomedical sciences.  The corresponding 
proportions in Indian DPharm and PharmD programs are 17% and 18%, respectively.  In other 
countries of the study, the proportion is 10-12%.  
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Core Area 2: pharmaceutical sciences  
The proportion of pharmaceutical sciences in pharmacy programs varies a lot between 
countries and degrees (Table 14). Both DPharm and BPharm programs in India are allocating 
about 60% of total time to pharmaceutical sciences. Indian PharmD curriculum is covering 2112 
hours of pharmaceutical sciences, which is higher than suggested PCOA percent (37% vs. 30%, 
respectively). 
 
Core Area 3: Social/behavioral/administrative sciences  
Social/behavioral/administrative sciences can be considered as the backbone subjects to public 
health oriented pharmacy practice. PCOA is recommending 22% of the curriculum to be 
devoted to social/behavioral/administrative sciences, but none of the test programs are 
covering recommended amount of time. DPharm curriculum in India is covering 12% (175 
hours), BPharm and PharmD are covering 8% (315 hours and 462 hours, respectively). Finnish 
MSc (Pharm) has 15% (1188hours) which is highest among all. Indian programs are lacking 
course work in behavioral and social sciences, health care policy, patient counseling and 
communication aspects.263 
 
Core Area 4: clinical sciences 
This core area gives proper knowledge to practicing pharmacists to provide patient care that 
optimizes the use of medication and promotes health, wellness, and disease prevention.264By 
spending more number of hours in clinical sciences, pharmacists can acquire knowledge to offer 
better patient care to enhance therapeutic outcomes. PCOA recommends devoting 32% of the 
time for clinical sciences. However, Indian DPharm and BPharm are covering 8% (125 hours) 
and 2% (90 hours) of clinical sciences, respectively. PharmD curriculum is covering 36% of 
clinical sciences which is at par with the PCOA recommendation (32%).The US-PharmD program 
has 66% (1649 hours) of clinical sciences which is more than 2-fold compared to the PCOA 
recommendation.  
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9.2  Role of Pharmacists in National Public Health Programs in India: A Survey on Pharmacy 
Students’ Perceived Knowledge and Attitude (III) 
Among a total of 326 responding students, 159 (49%) were male and 167 (51%) female 
students from final year D Pharm (n=101), BPharm (n=109); and Pharm D (n=116) program in 
India (Table 15). 
  
Table 15. Demographic characteristics of student respondents (n=326) according to pharmacy 
program  
 
Variable DPharm 
(n=101) 
BPharm 
(n=109) 
PharmD 
(n=116) 
Total 
(n=326) 
p-value* 
Gender, n(%) 
Male 
Female 
 
57 (56) 
44 (44) 
 
56 (51) 
53 (49) 
 
46 (39) 
70 (61) 
 
159 (49) 
167 (51) 
0.032 
Age 
Mean (SD) 
Median 
Min;max 
 
20.9 (1.9) 
21 
18;27 
 
21.1 (1.2) 
21 
20;29 
 
22.8 (1.5) 
23 
20;29 
 
21.6 (1.8) 
21 
18;29 
 
 
Chi-square test was used. 
*p = < 0.05 was considered significant 
 
Their top 3 ‘first preferences of work area’ after completion of education were: hospital (23% of 
the respondents prioritizing this as the first preference of work area), drug manufacturing 
industry (22%) and community pharmacy (20%) (Table 16). 
 
Table 16. Student preferences of work area after completing education according to pharmacy program (% of the 
respondents, n=326) 
Question 
Response, n (%) 
Total  
(n=326) 
DPharm  
(n=101) 
BPharm  
(n=109) 
PharmD  
(n=116) 
Where do you plan to work after graduation? 
 Community Pharmacy 
 Hospital Pharmacy 
 Drug Manufacturing Industry 
 Research and Development  
 Clinical Research 
 Regulatory affairs in industry 
 Regulatory officer in government 
 Higher studies 
 Marketing 
 Teaching 
 Any other, please specify 
1st  2nd  1st  2nd  1st  2nd  1st  2nd  
64 (20) 
76 (23) 
71 (22) 
20 (6) 
33 (10) 
10 (3) 
8 (2) 
26 (8) 
10 (3) 
3 (1) 
5 (2) 
40 (12)  
50 (15) 
34 (10) 
19 (6) 
40 (12) 
19 (6) 
21 (6) 
38 (12) 
24 (7) 
34 (10) 
7 (12) 
8 (8) 
31 (31) 
28 (28) 
8 (8) 
2 (2) 
2 (2) 
1 (1) 
15 (15) 
0 (0) 
2 (2) 
4 (4) 
14 (14)  
8 (8) 
10 (10) 
4 (4) 
4 (4) 
9 (9) 
6 (6) 
14 (14) 
15 (15) 
10 (10) 
7 (7) 
27 (25) 
18 (17) 
25 (23) 
12 (11) 
4 (4) 
5 (5) 
0 (0) 
8 (7) 
9 (8) 
1 (1) 
0 (0) 
15 (14)  
21 (19) 
13 (12) 
9 (8) 
9 (8) 
4 (4) 
7 (6) 
18 (17) 
7 (6) 
6 (6) 
0 (0) 
29 (25) 
27 (23) 
18 (16) 
0 (0) 
27 (23) 
3 (3) 
7 (6) 
3 (3) 
1 (1) 
0 (0) 
1 (1) 
11 (9)  
21 (18) 
11 (9) 
6 (5) 
27 (23) 
6 (5) 
8 (7) 
6 (5) 
2 (2) 
18 (16) 
0 (0) 
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9.2.1  Pharmacy Students’ Attitude and Perceived Knowledge in National Public Health 
Programs 
Table 17 shows students’ perceptions on their knowledge in national public health programs 
(NPHPs). There was 100% agreement on the necessity for the pharmacists to know about 
NPHPs. Most (69%) of the students reported having studied about disease prevention and 
dissemination of information, but only 28% felt that the amount of time devoted to learn public 
health aspects in basic pharmacy studies was sufficient. Sixty-seven percent of the students had 
not studied National Health Policy and 60% had not studied pharmaceutical policy in pharmacy 
curriculum. Most typically, training was through some lectures during the basic studies (36% of 
the respondents) or self-study (21%). A small proportion of the students (4%) had received at 
least one course on NPHPs in continuing education. Out of total of 326 respondents, 58% 
reported that they had adequate knowledge to take part in NPHPs. The proportion of students 
reporting adequate knowledge to take part in NPHPs was highest among Pharm D (66%) and D 
Pharm (62%) students and lowest among BPharm students (45%, p < 0.001). The same trend 
was found in assessing students knowing about NPHPs in India: 41% of Pharm D students 
reported knowing NPHPs well, but only 17% and 10% of D Pharm and BPharm students, 
respectively (p < 0.001). 
 
Table 17. Pharmacy students’ (n=326) perceived knowledge in NPHPs stratified by pharmacy 
program 
Question 
Response, n (%) 
Total  
(n= 326) 
DPharm  
(n = 101) 
BPharm  
(n=109) 
PharmD  
(n=116) 
p-
value*  
Have you studied about National Health Policy in your 
pharmacy curriculum? 
Yes 
No 
Do not know 
Do not remember 
 
 
96 (30) 
220 (67) 
7 (2) 
3 (1) 
 
 
25 (25) 
72 (71) 
2 (2) 
2 (2) 
 
 
13 (12) 
94 (86) 
1 (1) 
1 (1) 
 
 
58 (50) 
54 (47) 
4 (4) 
0 (0) 
 
<0.001  
Have you studied pharmaceutical policy in your 
pharmacy curriculum? 
Yes 
No 
Do not know 
Do not remember 
 
 
111 (34) 
197 (60) 
10 (3) 
8 (3) 
 
 
31 (31) 
67 (66) 
0 (0) 
3 (3) 
 
 
19 (17) 
84 (77) 
3 (3) 
3 (3) 
 
 
61 (52) 
46 (40) 
7 (6) 
2(2) 
 
<0.001 
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Do you know the national public health programs in 
India? 
Yes, I know well 
Yes, I know to some extent 
Yes, I have heard, but do not know contents 
No, I have never heard about them 
 
76 (23) 
100 (31) 
114 (35) 
36 (11) 
 
17 (17) 
38 (38) 
29 (29) 
17 (17) 
 
11 (10) 
31 (29) 
57 (52) 
10 (9) 
 
48 (41) 
31 (27) 
28 (24) 
9 (8) 
 
<0.001 
Have you received lectures or completed any courses 
that provided information on national public health 
programs? 
   Yes, I have received lectures during my basic studies
  
    Yes, I have received at least 1 course in continuing 
education 
    Yes, I have studied about NHPs as self-study 
    I have not received any training on national health 
programs 
 
 
117 (36) 
13 (4) 
69 (21) 
127 (39) 
 
 
25 (25) 
2 (2) 
16 (16) 
58 (57) 
 
 
21 (19) 
5 (5) 
39 (36) 
44 (40) 
 
 
71 (61) 
6 (5) 
14 (12) 
25 (22) 
 
<0.001 
Is the amount of time devoted to learn public health 
aspects sufficient? (Basic pharmacy studies) 
Yes, it is sufficient 
No, not sufficient 
No opinion 
 
 
90 (28) 
166 (51) 
70 (21) 
 
 
27 (27) 
45 (44) 
29 (29) 
 
 
36 (33) 
48 (44) 
25 (23) 
 
 
27 (23) 
73 (63) 
16 (14) 
 
0.012 
Based on your pharmacy education, do you have 
adequate knowledge to take part in national public 
health programs? 
Yes  
No  
No opinion  
Not necessary for pharmacists 
 
 
188 (58) 
73 (22) 
59 (18) 
6 (2) 
 
 
63 (62) 
23 (23) 
14 (14) 
1 (1) 
 
 
49 (45) 
21 (19) 
34 (31) 
5 (5) 
 
 
76 (66) 
29 (25) 
11 (9) 
0 (0) 
 
<0.001 
 
Have you studied about disease prevention and 
dissemination of information in National Public Health 
Programs? 
Yes  
No  
Do not know  
 
 
225 (69) 
91 (28) 
10 (3) 
 
 
69 (68) 
28 (28) 
4 (4) 
 
 
70 (64) 
36 (33) 
3 (3) 
 
 
86 (74) 
27 (23) 
3 (3) 
 
0.539 
Is it necessary for the pharmacists to know about 
national public health programs? 
Yes  
No  
 
 
326 (100) 
0 (0) 
 
 
101 (100) 
0 (0) 
 
 
109 
(100) 
0 (0) 
 
 
116 
(100) 
0 (0) 
 
- 
Chi-square test was used. 
*p = < 0.05 was considered significant. 
 
Of all respondents, 83% (91% of Pharm D, 90% of D Pharm and 69% of BPharm students; p= < 
0.001) had the opinion that it was very important or important to include NPHPs in normal 
training programs for pharmacists (Table 18). Only 21% (p=0.001) of the students believed that 
their current knowledge about NPHPs was very much sufficient or sufficient to become active 
part of NPHPs. However, 81% students felt that they have very important or important role to 
play in NPHPs. Almost all, 96% were willing to take up professional role in NPHPs and 81% 
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wanted to learn more on NPHPs. The proportion of students having been ever involved in any 
NPHPs during their pharmacy education program was highest for Pharm D students (73%) and 
lowest for BPharm students (28%). The trend was the same concerning internships (51% vs. 
23%, respectively). 
 
Table 18. Pharmacy students' (n=326) attitude on NPHPs - stratified by pharmacy program 
Question 
Response, n (%) 
Total  
(n= 326) 
DPharm 
(n = 101) 
BPharm  
(n=109) 
PharmD  
(n=116) 
p-value*  
Do you think that it is important to include National Public 
Health Programs in normal training program for pharmacists? 
Very important  
Important 
Moderately 
Of little importance 
Unimportant  
 
 
186 (57) 
86 (26) 
45 (14) 
7 (2) 
2 (1) 
 
 
70 (69) 
21 (21) 
6 (6) 
4 (4) 
0 (0) 
 
 
50 (46) 
25 (23) 
32 (29) 
2 (2) 
0 (0) 
 
 
66 (57) 
40 (34) 
7 (6) 
1 (1) 
2 (2) 
 
<0.001 
Do you feel that your current knowledge about public health 
programs in the country is sufficient? 
Very much sufficient 
Sufficient  
Neutral  
Not sufficient 
Totally insufficient 
 
 
14 (4) 
56 (17) 
64 (20) 
175 (54) 
17 (5) 
 
 
3 (3) 
22 (22) 
31 (31) 
39 (39) 
6 (6) 
 
 
4 (4) 
13 (12) 
12 (11) 
72 (66) 
8 (7) 
 
 
7 (6) 
21 (18) 
21 (18) 
64 (55) 
3 (3) 
 
0.001 
Do you feel you have an important role to play in public health 
programs? 
Very important  
Important 
Moderately 
Of little importance 
Unimportant 
 
176 (54) 
89 (27) 
24 (8) 
34 (11) 
0 (0) 
 
60 (59) 
28 (28) 
10 (10) 
3 (3) 
0 (0) 
 
42 (38) 
29 (27) 
8 (7) 
30 (28) 
0 (0) 
 
77 (66) 
32 (28) 
6 (5) 
1 (1) 
0 (0) 
<0.001  
During your pharmacy education program, have you ever been 
involved in any public health program(s)? 
Yes  
No 
 
 
156 (48) 
170 (52) 
 
 
41 (41) 
60 (59) 
 
 
30 (28) 
79 (72) 
 
 
85 (73) 
31 (27) 
 
<0.001 
Have you ever involved in any public health program(s) during 
your internship? 
Yes  
No 
 
 
134 (41) 
192 (59) 
 
 
50 (49) 
51 (51) 
 
 
25 (23) 
84 (77) 
 
 
59 (51) 
57 (49) 
 
<0.001 
Are you willing to take up a professional role in public health 
program? 
Yes  
No 
Do not know 
 
252 (77) 
60 (19) 
14 (4) 
 
86 (85) 
11 (11) 
4 (4) 
 
71 (65) 
34 (31) 
4 (4) 
 
95 (82) 
15 (13) 
6 (5) 
0.001 
Do you want to learn or learn more about Public Health programs 
in your curriculum? 
Yes  
No 
Do not know 
 
 
263 (81) 
49 (15) 
14 (4) 
 
 
91 (90) 
6 (6) 
4 (4) 
 
 
68 (62) 
35 (32) 
6 (6) 
 
 
104 (90) 
8 (7) 
4 (3) 
 
<0.001 
Chi-square test was used. 
*p = < 0.05 was considered significant. 
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9.2.2  Perceived Knowledge in Major National Public Health Programs in Communicable 
Diseases 
Of communicable diseases, most willingly students would take part in HIV/AIDS control (83% of 
all respondents), Tuberculosis control (75%), leprosy eradication programs and National Vector 
Borne Disease Control program (NVBDCP) (64% of each) (Table 19).  
 
Table 19. Perceived knowledge in major NPHPs in communicable diseases - stratified by 
pharmacy program (n=326)  
Question 
Response, n (%) 
Total  
(n= 326) 
DPharm 
(n = 101) 
BPharm  
(n=109) 
PharmD  
(n=116) 
p-
value* 
HIV/AIDS control program 
NACO envisions an India where every person living with HIV has access to quality care and is treated with dignity. Effective 
prevention, care and support for HIV/AIDS is possible in an environment where human rights are respected and where those 
infected or affected by HIV/AIDS live a life without stigma and discrimination. 
Do you know about the program? 
Yes  
No 
 
293 (90) 
33 (10) 
 
86 (85) 
15 (15) 
 
101 (93) 
8 (7) 
 
106 (91) 
10 (9) 
0.157 
Do you have a role to play? 
Yes 
No 
 
245 (75) 
81 (25) 
 
62 (61) 
39 (39) 
 
81 (74) 
28 (26) 
 
102 (88) 
14 (12) 
<0.001 
Are you willing to take part? 
Yes 
No 
 
269 (83) 
57 (17) 
 
73 (72) 
28 (28) 
 
100 (92) 
9 (8) 
 
96 (83) 
20 (17) 
0.001 
Revised National Tuberculosis Control Program (RNTCP) 
The objective of TB control Program is to achieve and maintain cure rate of at least 85% in new sputum positive pulmonary TB 
patients, and to achieve and maintain detection of at least 70% of such cases. Directly Observed Treatment is highlight of this 
program. 
Do you know about the program? 
Yes  
No 
 
255 (78) 
71 (22) 
 
71 (70) 
30 (30) 
 
82 (75) 
27 (25) 
 
102 (88) 
14 (12) 
0.005 
Do you have a role to play? 
Yes 
No 
 
221 (68) 
105 (32) 
 
59 (58) 
42 (42) 
 
64 (59) 
45 (41) 
 
98 (88) 
18 (16) 
<0.001 
Are you willing to take part? 
Yes 
No 
 
244 (75) 
82 (25) 
 
72 (71) 
29 (29) 
 
77 (71) 
32 (29) 
 
95 (82) 
21 (18) 
0.092 
National Vector Borne Disease Control program (NVBDCP) 
The objective of the program is to prevent and control Malaria, Dengue, Lymphatic Filariasis, Kala-azar, Japanese Encephalitis 
and Chikungunya in India. 
Do you know about the program? 
Yes  
No 
 
211 (65) 
115 (35) 
 
66 (65) 
35 (35) 
 
63 (58) 
46 (42) 
 
82 (71) 
34 (29) 
0.128 
Do you have a role to play? 
Yes 
No 
 
186 (57) 
140 (43) 
 
52 (51) 
49 (49) 
 
53 (49) 
56 (51) 
 
81 (70) 
35 (30) 
0.002 
Are you willing to take part? 
Yes 
No 
 
210 (64) 
116 (36) 
 
68 (67) 
33 (33) 
 
62 (57) 
47 (43) 
 
80 (69) 
36 (31) 
0.128 
National Leprosy Eradication Program (NLEP) 
Highlights of the program: Early detection & complete treatment of new leprosy cases. Carrying out house hold contact survey in 
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detection. Early diagnosis & prompt MDT, through routine and special efforts. Information, Education & Communication 
(IEC) activities in the community to improve self reporting to Primary Health Centre (PHC) and reduction of stigma. 
Intensive monitoring and supervision at Primary Health Centre/Community Health Centre. 
Do you know about the program? 
Yes  
No 
 
226 (69) 
100 (31) 
 
70 (69) 
31 (31) 
 
66 (61) 
43 (39) 
 
90 (78) 
26 (22) 
0.022 
Do you have a role to play? 
Yes 
No 
 
203 (62) 
123 (38) 
 
54 (53) 
47 (47) 
 
57 (52) 
52 (48) 
 
92 (79) 
24 (21) 
<0.001 
Are you willing to take part? 
Yes 
No 
 
209 (64) 
117 (36) 
 
64 (63) 
37 (37) 
 
59 (54) 
50 (46) 
 
86 (74) 
30 (26) 
0.007 
Chi-square test was used. 
*p = < 0.05 was considered significant. 
 
Of non-communicable diseases, 72% of the students were willing to take part in Blindness 
control, 76% pulse polio programs and 67% in Universal Vaccination Program (Table 20). Under 
other programs prioritized as NPHPs (Table 6) 90% of the respondents were willing to take part 
in National Tobacco Control program and 60% Program for Health Care of the Elderly. 
 
Table 20. Perceived knowledge in major NPHPs in non-communicable diseases and other areas - 
stratified by pharmacy program (n=326) 
Question 
Response, n (%) 
Total  
(n= 326) 
DPharm 
(n = 
101) 
BPharm  
(n= 109) 
PharmD  
(n= 116) 
p-
value* 
National Mental Health Program (NMHP)  
Objectives: 1. To ensure the availability and accessibility of minimum mental healthcare for all in the foreseeable future, 
particularly to the most vulnerable and underprivileged sections of the population; 2. To encourage the application of mental 
health knowledge in general healthcare and in social development; and 3. To promote community participation in the mental 
health service development and to stimulate efforts towards self-help in the community. 
Do you know about the program? 
Yes  
No 
 
213 (65) 
113 (35) 
 
66 (65) 
35 (35) 
 
61 (56) 
48 (44) 
 
86 (74) 
30 (26) 
0.017 
Do you have a role to play? 
Yes 
No 
 
178 (55) 
148 (45) 
 
55 (54) 
46 (46) 
 
49 (45) 
60 (55) 
 
74 (64) 
42 (36) 
0.018 
Are you willing to take part? 
Yes 
No 
 
217 (67) 
109 (33) 
 
68 (67) 
33 (33) 
 
61 (56) 
48 (44) 
 
88 (76) 
28 (24) 
0.007 
National Program for Prevention and Control of Deafness (NPPCD) 
Highlights: 1. To prevent the avoidable hearing loss on account of disease or injury, 2. Early identification, diagnosis and treatment 
of ear problems responsible for hearing loss and deafness, 3. To strengthen the existing inter-sectoral linkages for continuity of the 
rehabilitation programme, for persons with deafness. 
Do you know about the program? 
Yes  
No 
 
181 (56) 
145 (44) 
 
53 (52) 
48 (48) 
 
55 (50) 
54 (50) 
 
73 (63) 
43 (37) 
0.129 
Do you have a role to play? 
Yes 
 
169 (52) 
 
53 (52) 
 
39 (36) 
 
77 (66) 
<0.001 
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No 157 (48) 48 (48) 70 (64) 39 (34) 
Are you willing to take part? 
Yes 
No 
 
189 (58) 
137 (42) 
 
43 (43) 
58 (57) 
 
51 (47) 
58 (53) 
 
80 (69) 
36 (31) 
0.001 
National Program for Control of Blindness (NPCB) 
Highlights: 1. To reduce the backlog of blindness through identification and treatment of blind at primary, secondary and tertiary 
levels. 2. Prevention of visual impairment; through provision of comprehensive eye care services and quality service delivery. 3. 
To enhance community awareness on eye care and lay stress on preventive measures; 4. To secure participation of Voluntary 
Organizations/Private Practitioners in eye Care 
Do you know about the program? 
Yes  
No 
 
238 (73) 
88 (27) 
 
75 (74) 
26 (26) 
 
86 (80) 
23 (21) 
 
77 (66) 
39 (34) 
0.101 
Do you have a role to play? 
Yes 
No 
 
213 (65) 
113 (35) 
 
65 (64) 
36 (36) 
 
71 (65) 
38 (35) 
 
77 (66) 
39 (34) 
0.951 
Are you willing to take part? 
Yes 
No 
 
234 (72) 
92 (28) 
 
69 (68) 
32 (32) 
 
87 (80) 
22 (20) 
 
78 (67) 
38 (33) 
0.072 
Pulse Polio program 
Objectives: Children in the age group of 0-5 years administered Polio drops during the national and sub-nationals immunization 
rounds. About 172 million children are immunized during each National Immunization Day. 
Do you know about the program? 
Yes  
No 
 
260 (80) 
66 (20) 
 
70 (69) 
31 (31) 
 
92 (84) 
17 (16) 
 
98 (84) 
18 (16) 
0.007 
Do you have a role to play? 
Yes 
No 
 
229 (70) 
97 (30) 
 
56 (55) 
45 (45) 
 
76 (70) 
33 (30) 
 
97 (84) 
19 (16) 
<0.001 
Are you willing to take part? 
Yes 
No 
 
248 (76) 
78 (24) 
 
65 (64) 
36 (36) 
 
87 (80) 
22 (20) 
 
96 (83) 
20 (17) 
0.004 
Universal Immunization Program (UIP)  
Objective: Protection of children from life threatening conditions by providing vaccination. Under UIP, following vaccines are 
provided: 1. BCG, 2. DPT, 3. OPV (Oral Polio Vaccine), 4. Measles, 5. Hepatitis B, 6. TT (Tetanus Toxoid), etc. 
Do you know about the program? 
Yes  
No 
 
220 (67) 
106 (33) 
 
75 (74) 
26 (26) 
 
58 (53) 
51 (47) 
 
87 (75) 
29 (25) 
0.001 
Do you have a role to play? 
Yes 
No 
 
197 (60) 
129 (40) 
 
59 (58) 
42 (42) 
 
46 (42) 
63 (58) 
 
92 (79) 
24 (21) 
<0.001 
Are you willing to take part? 
Yes 
No 
 
220 (67) 
106 (33) 
 
69 (68) 
32 (32) 
 
59 (54) 
50 (46) 
 
92 (79) 
24 (21) 
0.003 
National Tobacco Control Program (NTCP) 
Types of benefits of NTCP: 1.To bring about greater awareness about the harmful effects of tobacco use and about the Tobacco 
Control Laws and 2.To facilitate effective implementation of the Tobacco Control Laws. 
Do you know about the program? 
Yes  
No 
 
294 (90) 
32 (10) 
 
88 (87) 
13 (13) 
 
101 (93) 
8 (7) 
 
105 (91) 
11 (10) 
0.399 
Do you have a role to play? 
Yes 
No 
 
265 (81) 
61 (19) 
 
73 (72) 
28 (28) 
 
88 (81) 
21 (19) 
 
104 (90) 
12 (10) 
0.005 
Are you willing to take part? 
Yes 
No 
 
292 (90) 
34 (10) 
 
85 (84) 
16 (16) 
 
104 (95) 
5 (5) 
 
103 (89) 
13 (11) 
0.027 
National Program for Health Care of the Elderly (NPHCE) 
Objective is to provide separate, specialized and comprehensive health care to the senior citizens at various level of State health 
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care delivery system including outreach services. 
Do you know about the program? 
Yes  
No 
 
171 (52) 
155 (48) 
 
47 (47) 
54 (53) 
 
42 (39) 
67 (61) 
 
82 (71) 
34 (29) 
<0.001 
Do you have a role to play? 
Yes 
No 
 
176 (54) 
150 (46) 
 
56 (55) 
45 (45) 
 
34 (31) 
75 (69) 
 
86 (74) 
30 (26) 
<0.001 
Are you willing to take part? 
Yes 
No 
 
197 (60) 
129 (40) 
 
63 (62) 
38 (35) 
 
46 (42) 
63 (58) 
 
88 (76) 
28 (24) 
<0.001 
Chi-square test was used. 
*p = < 0.05 was considered significant. 
 
9.3  Pharmacists in National Public Health Programs in India: A Pilot Study Highlighting 
Physicians’ Perceptions (IV) 
Of total 800 physicians, 129 responded, leading to a response rate of 16% (Table 21). Of the 
respondents, 83% were men and 17% women with a median age of 34 years. Forty-one percent 
of the respondents had Bachelor of Medicine and Bachelor of Surgery (MBBS) degree and 53% 
Post Graduate in Medicine (MD) and Master of Surgery (MS) as their highest academic degree. 
The respondents were working in various sectors, the highest proportion (43% of the 
respondents) being working in corporate hospitals at the time of the survey. Almost half (43%) 
of the respondents had less than 5 years’ experience in professional practice, 26% with 5-10 
years, 15% with 11-15 years and 20% with over 15 years of experience.  
  
  
 112 
 
Table 21. Characteristics of the responding physicians (% of the respondents, n=129) 
 
Variable n (%) 
Gender 
 Male 
 Female 
 
107 (83) 
22 (17) 
Age, years 
 ≤ 30 
 31-40 
 41- 50 
 > 50 
 
36 (28) 
47 (36) 
20 (16) 
26 (20) 
Education qualification 
 MBBS 
 MS/MD 
 Other  
 
53 (41) 
69 (53) 
7 (05) 
Number of year in practice  
 < 5 
 5-10 
 11-15 
 > 15 
 
55 (43) 
33 (26) 
15 (12) 
26 (20) 
Current designation 
 Family doctor 
 Medical officer 
 CMO 
 Surgeon            
 Other 
 
45 (35) 
8 (06) 
3 (02) 
18 (14) 
55 (43) 
Current practice setting 
 Private  
 Corporate 
 Government 
 Other  
 
16 (12) 
56 (43) 
2 (02) 
55 (43) 
 
 
Table 22 shows the results of the survey questions related to physicians’ and pharmacists’ 
interaction and collaboration in general. A majority (90%) of the physicians had a pharmacy 
close to their practice and 88% of them reported referring patients to buy medicine from those 
close by pharmacies. Of all responding physicians, 81% indicated contacting their pharmacy 
frequently for professional matters, 68% of them on daily or at least weekly basis. Physicians 
with less than 5 years and 5-10 years of practice experience reported contacting pharmacists 
more frequently (96% and 88%, respectively) than physicians with 11-15 years and over 15 
years of professional experience (60% and 54%, respectively). A majority of the physicians also 
perceived that pharmacists were knowledgeable (84%), service oriented (83%) and were 
providing very sufficient or sufficient patient counseling on medicines to supplement 
physician’s counseling, e.g., on administration, dosage and  side effects.  Again, this perception 
 113 
 
was more common in younger physicians with <5 years of practice experience (89%) and 5-10 
years of experience (75%), than in senior physicians with 11-15 years’ experience (53%) and >15 
years’ experience (69%). Almost all physicians (98%) were comfortable with pharmacists’ roles 
in general, 96% were comfortable or somewhat comfortable to collaborate with pharmacists 
and 82% regarded pharmacists as part of health care team.  
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Table 22. Physicians’ experiences of cooperation and interaction with pharmacists according to their years of 
professional practice (% of the respondents. n=129)  
 
Question 
Responses according to years of professional practice, n (%) 
Total  
(n=129)  
< 5 yrs 
(n=55)  
5-10 yrs 
(n=33)  
11-15 
yrs 
(n=15)  
>15 yrs 
(n=26) 
p-
value*  
Is there a pharmacy attached or close to your practice?         
              Yes 
              No 
116 (90) 
13 (10) 
55 (100) 
0 (0) 
32 (97) 
01 (03) 
12 (80) 
03 (20) 
17 (65) 
9 (35) <0.001 
Do you refer your patients with prescription to a pharmacy in your practice area to buy their medicine? 
              Yes 
              No 
114 (88) 
15 (12) 
51 (93) 
4 (07) 
31 (94) 
2 (06) 
14 (93) 
1 (07) 
18 (69) 
8 (31) <0.001 
Do you contact your pharmacy frequently for professional matters? 
              Yes 
              No 
105 (81) 
24 (19) 
53 (96) 
2 (04) 
29 (88) 
4 (12) 
9 (60) 
6 (40) 
14 (54) 
12 (46) <0.001 
On an average, please estimate the frequency of your interactions with a pharmacist 
              Every day 
              Once or more than once a week 
              Once or more than once a month 
              Less than once a month 
40 (31) 
48 (37) 
22 (17) 
19 (15) 
17 (31) 
20 (36) 
15 (27) 
3 (5) 
15 (45) 
13 (39) 
4 (12) 
1 (03) 
4 (27) 
5 (33) 
1 (07) 
5 (33) 
4 (15) 
10 (38) 
2 (08) 
10 (38) 
<0.001 
Do you think that your pharmacist is knowledgeable? 
              Yes 
              No  
109 (84) 
20 (16) 
54 (98) 
1 (02) 
27 (82) 
6 (18) 
6 (40) 
9 (60) 
22 (85) 
4 (15) <0.001 
Do you think that your pharmacist is service oriented? 
              Yes  
              No  
107 (83) 
22 (17) 
53 (96) 
2 (04) 
26 (79) 
7 (21) 
12 (80) 
3 (20) 
16 (62) 
10 (38) 0.001 
Do you think the pharmacy / your pharmacist is providing patient counseling on medicine, administration, dosage, 
side effects etc., to supplement your counseling, is at a satisfactory level? 
 Very much sufficient   
 Sufficient  
 Neutral  
 Not sufficient  
 Totally insufficient 
31 (24) 
69 (53) 
15 (12) 
10 (08) 
4 (03) 
10 (18) 
39 (71) 
3 (05) 
3 (05) 
0 (0) 
14 (42) 
11 (33) 
4 (12) 
3 (09) 
1 (03) 
2 (13) 
6 (40) 
4 (27) 
1 (07) 
2 (13) 
5 (19) 
13 (50) 
4 (15) 
3 (12) 
1 (04) 
0.013 
Please rate your comfort with pharmacist roles described 
 Very comfortable  
 Somewhat comfortable  
 Uncomfortable  
81 (63) 
45 (35) 
03 (02) 
40 (73) 
14 (25) 
01 (02) 
24 (73) 
08 (24) 
01 (03) 
03 (20) 
11 (73) 
01 (07) 
14 (54) 
12 (46) 
0 (0) 
0.006 
Do you have any barriers to collaborate with pharmacists as a part of health care team? 
 Very comfortable  
 Somewhat comfortable  
 Uncomfortable 
77 (60) 
47 (36) 
05 (04) 
36 (65) 
18 (33) 
01 (02) 
27 (82) 
05 (15) 
01 (03) 
05 (33) 
09 (60) 
01 (07) 
09 (35) 
15 (58) 
02 (08) 
0.003 
Do you see pharmacists as a part of health care team? 
 Yes 
 No 
 No opinion  
106 (82) 
10 (08) 
13 (10) 
53 (96) 
02 (04) 
0 (0) 
29 (88) 
01 (03) 
03 (09) 
10 (67) 
01 (07) 
04 (27) 
14 (54) 
06 (23) 
06 (23) 
<0.001 
 
          Chi-square test was used. 
          * < 0.05 is considered significant. 
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Table 23 shows the results of physicians’ general opinion on pharmacists’ involvement in 
NPHPs. Around 50% of all physicians regarded pharmacists as a mere vendor/dispenser of 
prescription drugs. The physicians with shorter professional practice (Group A and Group B) 
were more positive (84% and 76%, respectively) on pharmacists’ involvement in NPHPs than 
physicians having at least 11 years’ experience (Group C: 40% and Group D: 27%, respectively). 
In the same manner, more physicians from Group A and B (83% and 94%, respectively), 
perceived that the pharmacists have very important to moderately important role in public 
health programs, compared to physicians from Group C and D (67% and 62%, respectively). 
However, 93%, 83%, 73% and 62% of physicians from Group A, B, C and D, respectively, 
perceived that it is important or moderately important to involve pharmacists in NPHPs. The 
respective proportions of physicians estimating pharmacists’ knowledge sufficient for the 
involvement were 80%, 60%, 26% and 35%,  p<0.001. The results show a trend in acceptance of 
pharmacists’ involvement in NPHPs based on the length of physicians’ professional experience:  
the longer the physicians’ practice experience was, the less favorable they were for 
pharmacists’ involvement in NPHPs.  
 
Table 23. Physicians general opinions on pharmacists’ involvement in National Public Health Programs 
(NPHPs) according to their years of professional practice (% of the respondents, n=129). 
 
Question 
Response according to years of professional practice, n (%) 
Total  
(n=129)  
< 5 yrs 
(n=55)  
5-10 yrs 
(n=33)  
11-15 
yrs  
(n=15)  
>15 yrs 
(n=26) 
p-
value*  
Do you see the pharmacist as a mere vendor/dispenser of prescription drugs? 
  Yes 
  No 
  Do not know   
57 (44) 
64 (50) 
08 (06) 
14 (25) 
39 (71) 
02 (04) 
23 (70) 
7 (21) 
3 (09) 
7 (47) 
8 (53) 
0 (0) 
13 (50) 
10 (38) 
3 (12) 
<0.006 
Your perception on pharmacists’ role in National Public Health Programs: 
  Positive  
  Neutral  
  Negative  
  No opinion  
84 (65) 
24 (19) 
06 (05) 
15 (12) 
46 (84) 
04 (07) 
01 (02) 
04 (07) 
25 (76) 
5 (15) 
0 (0) 
3 (09) 
6 (40) 
7 (47) 
0 (0)2 
(13) 
7 (27) 
8 (31) 
5 (19) 
6 (23) 
<0.001 
Do you feel pharmacists have an important role to play in public health programs? 
  Yes, very important  
  Yes, moderately important  
  No, not important  
  No opinion   
85 (66) 
22 (17) 
05 (04) 
15 (12) 
48 (87) 
04 (07) 
01 (02) 
02 (04) 
23 (70) 
06 (18) 
0 (0) 
04 (12) 
07 (47) 
03 (20) 
01 (07) 
04 (27) 
07 (27) 
09 (35) 
03 (12) 
07 (27) 
<0.001 
Do you think it is important to include pharmacists in National public health programs? 
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  Yes, very important  
  Yes, moderately important  
  No, not important  
  No opinion  
85 (66) 
22 (17) 
10 (08) 
12 (09) 
45 (82) 
06 (11) 
02 (04) 
02 (04) 
24 (73) 
05 (15) 
0 (0) 
04 (12) 
08 (53) 
03 (20) 
01 (07) 
03 (20) 
08 (31) 
08 (31) 
07 (27) 
03 (12) 
<0.001 
Do you feel that pharmacists’ current knowledge on various public health programs is sufficient? 
  Very much sufficient   
  Sufficient  
  Neutral  
  Not sufficient  
  Totally insufficient   
29 (22) 
48 (37) 
14 (11) 
25 (19) 
13 (10) 
11 (20) 
33 (60) 
04 (07) 
06 (11) 
01 (02) 
14 (42) 
06 (18) 
03 (09) 
07 (21) 
03 (09) 
02 (13) 
02 (13) 
04 (27) 
04 (27) 
03 (20) 
02 (08) 
07 (27) 
03 (12) 
08 (31) 
06 (23) 
<0.001 
Chi-square test was used. 
* < 0.05 is considered significant. 
 
Table 24 shows the results of physicians’ opinions on pharmacists’ involvement in 11 selected 
NPHPs in India. Overall response of accepting pharmacists’ role and involvement in NPHPs was 
very positive, ranging from 67 – 83% for different programs. Similar trend as in the previous 
section was found again, where more the physicians’ practice experience, the less the 
acceptance for pharmacists’ role in particular NPHPs. The trends in their opinions were quite 
similar in all selected NPHPs. As per the results, Pulse Polio, HIV/AIDS, Tuberculosis and 
Tobacco control and Leprosy eradication programs were the top five NPHPs where physicians 
perceived that the pharmacists has a role to play.  
 
Table 24. Physicians’ opinions on pharmacists’ involvement in the major national public health programs 
established by Indian Government (% of the respondents according to their years of professional practice, n=129)  
Title of the National Public Health 
Program and its   objectives 
Response according to years of professional practice, n (%) 
Total  
(n=129)  
< 5 yrs 
(n=55)  
5-10 
yrs 
(n=33)  
11-15 
yrs  
(n=15)  
>15 yrs 
(n=26) 
p-
value*  
HIV/AIDS Control Program 
Objectives: NACO envisions in India where every person living with HIV has access to quality care and is treated with dignity. Effective 
prevention, care and support for HIV/AIDS is possible in an environment where human rights are respected and where those infected or 
affected by HIV/AIDS live a life without stigma and discrimination. 
Can the pharmacist play a role in HIV/AIDS Control Program? 
  Yes  
  No 
  Do not know 
107 (83) 
17 (13) 
05 (04) 
54 (98) 
01 (02) 
0 (0) 
28 (85) 
03 (09) 
02 (06) 
12 (80) 
01 (07) 
02 (13) 
13 (50) 
12 (46) 
01 (04) 
<0.001 
Revised National Tuberculosis Control Program (RNTCP) 
The objective of TB control Program is to achieve and maintain cure rate of at least 85% in new sputum positive pulmonary TB patients, 
and to achieve and maintain detection of at least 70% of such cases. Directly Observed Treatment is highlight of this program. 
Can the pharmacist play a role in Revised National Tuberculosis Control Program (RNTCP)? 
   Yes  
   No 
   Do not know 
106 (82)  
18 (14) 
05 (04) 
55 (100) 
0 (0) 
0 (0) 
28 (85) 
05 (15) 
0 (0) 
10 (67) 
01 (06) 
04 (27) 
13 (50) 
12 (46) 
01 (04) 
<0.001 
National Vector Borne Disease Control Program (NVBDCP) 
The objective of the program is to prevent and control Malaria. Dengue, Lymphatic Filariasis, Kala-azar, Japanese Encephalitis and 
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Chikungunya in India  
Can the pharmacist play a role in National Vector Borne Disease Control program (NVBDCP) ? 
   Yes  
   No 
   Do not know 
94 (73) 
27 (21) 
08 (06) 
52 (95) 
03 (05) 
0 (0) 
25 (76) 
06 (18) 
02 (06) 
08 (53) 
03 (20) 
04 (27) 
09 (35) 
15 (58) 
02 (08) 
<0.001 
National Leprosy Eradication Program (NLEP) 
Objectives of the program: Early detection & complete treatment of new leprosy cases. Carrying out house hold contact survey in 
detection. Early diagnosis & prompt MDT, through routine and special efforts. Information, Education & Communication (IEC) 
activities in the community to improve self reporting to Primary Health Centre (PHC) and reduction of stigma. Intensive 
monitoring and supervision at Primary Health Centre/ Community Health Centre. 
Can the pharmacist play a role in National Leprosy Eradication Program (NLEP)? 
   Yes  
   No 
   Do not know 
99 (77) 
19 (15) 
11 (09) 
54 (98) 
01 (02) 
0 (0) 
25 (76) 
05 (15) 
03 (09) 
10 (67) 
01 (07) 
04 (27) 
10 (38) 
12 (46) 
04 (15) 
<0.001 
National Mental Health Program (NMHP) 
Objectives: 1) To ensure the availability and accessibility of minimum mental healthcare for all in the foreseeable future, particularly to 
the most vulnerable and underprivileged sections of the population; 2) To encourage the application of mental health knowledge in 
general healthcare and in social development; and 3) To promote community participation in the mental health service development and 
to stimulate efforts towards self-help in the community.  
Can the pharmacist play a role in National Mental Health Program (NMHP)? 
   Yes  
   No 
   Do not know  
94 (73) 
23 (18) 
12 (09) 
51 (93) 
04 (07) 
0 (0) 
22 (67) 
06 (18) 
05 (15) 
08 (53) 
03 (20) 
04 (27) 
13 (50) 
10 (38) 
03 (12) 
<0.001 
National Program for Prevention and Control of Deafness (NPPCD) 
Objectives: 1) To prevent the avoidable hearing loss on account of disease or injury; 2) Early identification, diagnosis and treatment of 
ear problems responsible for hearing loss and deafness; and 3) To strengthen the existing intersectoral linkages for continuity of the 
rehabilitation program, for persons with deafness. 
Can the pharmacist play a role in National Program for Prevention and Control of Deafness (NPPCD)? 
   Yes  
   No 
   Do not know 
88 (68) 
35 (27) 
06 (05) 
49 (89) 
06 (11) 
0 (0) 
25 (76) 
7 (21) 
1 (03) 
06 (40) 
05 (33) 
04 (27) 
08 (31) 
17 (65) 
01 (04) 
<0.001 
National Program for Control of Blindness (NPCB) 
Objectives: 1) To reduce the backlog of blindness through identification and treatment of blind at primary, secondary and tertiary levels; 
2) Prevention of visual impairment; through provision of comprehensive eye care services and quality service delivery; 3) To enhance 
community awareness on eye care and lay stress on preventive measures; and 4) To secure participation of Voluntary 
organizations/Private Practitioners in eye care.  
Can the pharmacist play a role in National Program for Control of Blindness (NPCB)? 
   Yes 
   No  
   Do not know  
87 (67) 
30 (23) 
12 (09) 
50 (91) 
05 (9) 
0 (0) 
24 (73) 
06 (18) 
03 (09) 
07 (47) 
05 (33) 
03 (20) 
06 (23) 
14 (54) 
06 (23) 
<0.001 
Pulse Polio program 
Objectives: Children in the age group of 0-5 years administered Polio drops during the national and sub-nationals immunization rounds. 
About 172 million children are immunized during each National Immunization Day. 
Can the pharmacist play a role in Pulse Polio program? 
   Yes  
   No 
   Do not know  
108 (84) 
17 (13) 
04 (03) 
53 (96) 
02 (04) 
0 (0) 
30 (91) 
01 (03) 
02 (06) 
11 (73) 
03 (20) 
01 (07) 
14 (54) 
11 (42) 
01 (04) 
<0.001 
Universal Immunization Program (UIP) 
Objective: Protection of children from life threatening conditions by providing vaccination. Under UIP, following vaccines are provided: 
1) BCG; 2) DPT; 3) OPV (oral polio vaccine); 4) Measles; 5) Hepatitis; 6) TT (Tetanus Toxoid) etc. 
Can the pharmacist play a role in Universal Immunization Program (UIP)? 
   Yes  
   No 
   Do not know  
96 (74) 
21 (16) 
12 (09) 
53 (96) 
02 (04) 
0 (0) 
26 (79) 
2 (06) 
5 (15) 
09 (60) 
03 (20) 
03 (20) 
08 (31) 
14 (51) 
04 (15) 
<0.001 
National Tobacco Control Program (NTCP) 
Objectives: 1) To bring about greater awareness about the harmful effects of tobacco use and about the Tobacco control Laws; and 2) To 
facilitate effective implementation of the Tobacco Control Laws. 
Can the pharmacist play a role in National Tobacco Control Program (NTCP)? 
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   Yes  
   No 
   Do not know  
99 (77) 
22 (17) 
08 (06) 
52 (95) 
03 (05) 
0 (0) 
28 (85) 
03 (09) 
02 (06) 
09 (60) 
03 (20) 
03 (20) 
10 (38) 
13 (50) 
03 (12) 
<0.001 
National Program for Health Care of the Elderly (NPHCE) 
Objective is to provide separate, specialized and comprehensive health care to the senior citizen at various level of State health care 
delivery system including outreach services. 
Can the pharmacist play a role in National Program for Health Care of the Elderly (NPHCE)? 
   Yes  
   No 
   Do not know  
93 (72) 
25 (19) 
11 (09) 
53 (96) 
01 (02) 
01 (02) 
25 (76) 
04 (12) 
04 (12) 
08 (53) 
04 (27) 
03 (20) 
07 (27) 
16 (62) 
03 (12) 
<0.001 
 Chi-square test was used. 
 * < 0.05 is considered significant. 
 
  
 119 
 
10 DISCUSSION 
 
The results of this study suggest that most of the pharmacy students are not learning enough 
about NPHPs and health policies in pharmacy programs in India. Among those six assessed 
pharmacy curriculums, the US and Indian PharmD programs contained most public health and 
patient care aspects and Indian DPharm and BPharm programs contained least. A sample of 
final year Indian pharmacy students participating in the classroom survey exhibited positive 
attitude on pharmacists’ involvement in NPHPs and also opined it is important to take part in 
national health policies and NPHPs. At the same time, their perceived competences varied 
according to the curriculum with PharmD students being best prepared. The pilot survey on 
physicians’ perceptions indicated that Indian physicians are willing to collaborate with 
pharmacists and are comfortable to involve them in the health care team.  
 
10.1  Public Health and Patient Care Aspects in Indian Pharmacy Curricula: A Comparison 
between DPharm, BPharm, and PharmD Programs (I) 
 
The leading pharmacy programs in India, DPharm and BPharm, are industry focused and not 
pharmacy practice, patient care and public health oriented (I,II). Indian BPharm curriculum 
contains a significant amount of industry-oriented teaching and training and is ill equipped to 
do full justice in the community pharmacy and primary care settings.  
 
Indian PharmD is evidently a clinical- and community-based program265 and is on par with the 
PharmD in USA, where pharmacists are learning more clinical practice-based aspects (I, II). The 
Indian PharmD program does not have much focus on community pharmacy practice settings 
but has enough emphasis on clinical and hospital pharmacy practice. This can be balanced by 
reducing some hours in pharmaceutical sciences in the program and adding some Advanced 
Pharmacy Practice Experiences (APPEs) as in the USA, so that there is scope for the students to 
learn more community pharmacy aspects, on which the focus is lacking in the current 
curriculum. 
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As the Indian curriculum for DPharm and PharmD are prescribed by the PCI,266 uniform 
standards are being maintained throughout the country. At the same time, such regulations are 
creating barriers to bring innovation and creativity to the curriculum development. For 
example, in the USA, even though all PharmD programs are accredited by the Accreditation 
Council for Pharmacy Education (ACPE), there is quite a lot of variation in curricular structures 
and coverage in different universities. Still, the pharmacists in the USA are able to deliver 
patient focused clinical pharmacy services under PharmD degree.267  
 
Indian DPharm curriculum is not comparable with other curriculums in the study (I,II). 
Lengthwise, DPharm program is too short in comparison to other programs. Out of total 1500 
hours of entire DPharm program length, only 175 hours of core area 3, social/behavioral/ 
administration sciences, and 125 hours of core area 4, clinical sciences, are covered. It is 
understandably not possible to accommodate and train with required knowledge and skills and 
develop attitude that are needed to produce patient care-oriented pharmacists (“good 
pharmacists”268) in two years during DPharm program. There is no effective clinical pharmacy 
practice presently being taught in DPharm program and has no focus on pharmaceutical care 
(I). Therefore, Diploma pharmacists are not equipped for patient care activities, as knowledge 
and training acquired during the course is limited, with very little practical exposure.269  
 
Curriculum evaluation and reforms were least prioritized for both DPharm and BPharm 
programs in India (I, II), which may be one of the several reasons for not developing patient 
care-oriented pharmacy practice in India. As the PharmD is a newly introduced program in 
India, it is important to evaluate the results of the program and make necessary reforms 
frequently as it is being practiced in developed countries, for example, the University of 
Helsinki in Finland.270 Three years after the introduction of the reformed curriculum at the 
University of Helsinki, the results of the reform were evaluated. 271  These assessment 
procedures have been an integral part of the faculty’s quality assurance program. This was 
done by creating discussion forums among the faculty members, institutions, deans, and with 
the help of students and professional associations as stakeholders.272  
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In India, DPharm holders are the mainstays of pharmacy practice.273 However, National 
Commission on Macroeconomics and Health (NCMH) report from India stated that “most of the 
diploma-trained pharmacists, who are at best equivalent to pharmacy assistants or technicians 
in developed and many developing countries (such as Ghana, Fiji, and Nigeria), perform tasks 
normally reserved for registered pharmacists. The knowledge and expertise of most diploma 
holders are inadequate for community practice”.274 This challenge is addressed by training 
new PharmD graduates in India, started in 2008.275  
 
The migration of health sector workers is primarily comprised of three main professions: 
nurses, followed by physicians, and pharmacists.276 To meet the manpower requirements with 
the same competency level as PharmD graduates with equal distribution throughout the 
country, it would take several decades of maintaining admission enrollment per year. As per 
the National Knowledge Commission’s Report to the Nation2006–2009,277 “Medical education 
cannot be stand-alone. It requires support of trained nurses, pharmacists, paramedic workers.” 
In this direction, the Commission has recommended “gradual phasing out of untrained 
pharmacists should be considered.” 
 
The diploma in pharmacy should no longer be the minimum qualification for pharmacist 
registration in India.278 India should not continue with all different types of programs with wide 
variation. This will create a huge knowledge gap within the profession in those individuals with 
the same professional titles. This increases the chance for inter-professional disputes. 
Therefore, it is important that the statutory authorities act quickly in cooperation with 
professional associations. When the USA adopted PharmD as the national professional degree, 
existing pharmacists with BPharm/BS in Pharmacy were provided with sufficient 
opportunities to obtain additional education,279 but obtaining a PharmD degree was not 
mandatory in order to continue to practice pharmacy. The University-framed modules for 
part-time and distance/e-learning process enhances the existing pharmacists’ knowledge and 
qualifications. India should work out a similar process to address the knowledge gaps.280 
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One of the educational challenges is that teachers in Indian pharmacy schools are not trained 
for providing the clerkship, internship, and fellowship components of a PharmD program.281 
Clerkship is the gateway to the world of real pharmacy practice. 282  The institutions, 
associations and regulatory authorities should focus on training the teachers on clerkship, 
internship, and fellowship components and chartering the activities in the curriculum.283 
 
10.2  Public Health and Patient Care Aspects in Indian Pharmacy Curricula: A Comparison 
with USA, Finland and Denmark (II) 
The option for community pharmacy and health care orientation in addition to current industry 
orientation in Indian pharmacy curricula is supported by the existing deployment needs. 284,285 
Nevertheless, Curriculum evaluation and reforms were least prioritized for both DPharm and 
BPharm programs,286 which may be one of the several reasons for not developing the 
curriculums to support patient care oriented pharmacy practice in India. 
 
Indian DPharm program could be converted similar to Finnish 3-year BSc(Pharm) program 
which is practice-oriented university degree with quite a good proportion of social, behavioral 
and administrative sciences, and electives.287 Also the obligatory 6-months internship is 
designed to support development of pharmacy practice competences, particularly, patient 
counseling and medication management skills. 288,289 Another option could be to restructure 
DPharm program similar to Danish pharmaconomist (pharmacy assistant) program.290 It is a 3-
year vocational program mostly based on workplace training coordinated by a training center 
(Pharmakon) run by the Danish pharmacy owners association (Danmarks Apotekerforeningen). 
Danish pharmacies provide cognitive services guided by a protocol for their delivery.291 The 
services can be provided by pharmacists and pharmaconomists.292 The pharmaconomist cannot 
own or run a pharmacy, but can perform most of the pharmacist’s duties with some limitations, 
such as medication reviews, dosage corrections and interventions in the prescriptions, which 
should be done in cooperation with the registered pharmacist. Pharmaconomists can operate 
pharmacy outlets or medicine delivery facilities 293  as can also Finnish BSc pharmacists. 
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However, this issue is addressed by PCI by introducing Bachelor of Pharmacy (Practice) in 
2014.294  
 
The current ACPE standards allow US colleges and schools to pursue the development of 
student experiences that will utilize best practices in service learning, plus fulfill the need of 
introductory practice experiences.295 To gear up future pharmacists’ new roles, introduction of 
community service in the Indian pharmacy curriculum for DPharm and BPharm courses is 
suggested. This can be achieved through advanced pharmacy practice experiences (APPEs) as 
being practiced in USA, where students can be inspired, empowered, and take notice of what is 
lacking in the scope of practice of a pharmacist, in hopes that they will one day be driven to 
seek ways to enact changes within the profession.  
 
10.3  Role of Pharmacists in National Public Health Programs in India: A Survey on Pharmacy 
Students’ Perceived Knowledge and Attitude (III) 
 
Overall results suggest students’ positive overview on pharmacists’ involvement in NPHPs (III). 
It is clear from the results that both DPharm and PharmD students were showing more interest 
and motivated to learn about NPHPs than BPharm students. DPharm generally is the mainstay 
of pharmacy practice in India with over 42,000 admissions per year of the total of 100,000296, 
while PharmD has been adding to it by providing approximately 5,000 graduates with even 
more comprehensive clinical skills since 2008.297 Therefore, it is important to focus on these 
two programs when developing pharmacists’ competences in patient care and public health 
aspects. BPharm curriculum is industry oriented with more pharmaceutical sciences and less 
pharmacy practice and patient care aspects.298   
 
This study revealed a gap between “pharmacy students’ willingness to be involved in NPHPs 
and students’ perceived competencies to actually be involved in NPHPs” (III). Findings of this 
study are in line with a systematic review from UK which showed that most pharmacists viewed 
public health services as important, but pharmacists’ confidence in providing public health 
services was on the whole average to low.299 Pharmacy curriculum and training with better, 
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well-designed focus on NPHPs would help future pharmacists to prepare better. Introduction 
of NPHPs to internship programs would also improve students’ understanding of 
implementation of NPHPs in clinical practice and how pharmacists can contribute. There are 
encouraging results from USA indicating that time devoted to public health discussions during 
an Advanced Pharmacy Practice Experience (APPE) has substantial impact on pharmacy 
students’ knowledgebase and interest in public health.300  
 
HIV/AIDS control, RNTCP, Pulse Polio, NPCB and NTCP were top five National Public Health 
programs that the responding students knew about and felt that they have a role to play (III). In 
addition to these top five programs, more than 60% of the students showed interest in most of 
the other six programs involved in the survey. This means that if the pharmacists are trained in 
NPHPs, they can be utilized widely to supplement the limited health workforce in Indian public 
health concerns. Following paragraphs will briefly discuss pharmacists’ potential contributions 
to those NPHPs that were ranked among top five by the responding pharmacy students.  
 
10.3.1  HIV/AIDS Control Program  
HIV/AIDS control program was the most well-known among the responding students (III). This 
may be because of Indian Pharmaceutical Association’s (IPA) initiatives since 2000 in creating 
awareness on the roles and opportunities for pharmacists in HIV/AIDS care and prevention. 
Among the initiatives there has been National Pharmacy Week 2000 with the theme 
“Pharmacists to fight against HIV/AIDS”; prepared “guiding principles for pharmacists”;301 
trained -trainers, in-service pharmacists, and training programs in schools. IPA had also several 
endorsements and statements to promote pharmacists role in HIV/AIDS. WHO-India 
recommended integrating pharmacists in National AIDS Control Organization’s (NACO) 
programs such as in procurement, storage, distribution and proper use of Antiretroviral ARV 
medicines.302 In line with this, as a mandatory training, pharmacists working in Antiretroviral 
Therapy (ART) centers and Link ART centers (LAC) were being trained by the Department of 
AIDS Control.303 An extension of such training for pharmacists working in private pharmacies 
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and students/interns would increase the impact in several folds, which is supported by 83% 
percent of students’ interest to take active part in HIV/AIDS Control program (III). 
 
10.3.2  Revised National Tuberculosis Control Program (RNTCP) 
Eighty three percent of the responding students were willing to take part in RNTCP (III). 
According to a previous research, pharmacists can be key players in prevention and treatment 
of tuberculosis by promoting adherence, assessing patients of risk factors for resistant disease, 
providing information about disease control and prevention, and monitoring for effectiveness, 
adverse effects, and drug interactions.304 Private pharmacies play a key role in influencing 
patients’ treatment choices and in guiding them to appropriate health care facilities.305 
Providing continuing education on TB control to diploma-trained community pharmacists can 
improve case detection and rational use of anti-TB medicines.306 Because of which, Ministry of 
Health took a step forward in utilizing the community pharmacies and pharmacist workforce by 
preparing a training module for community pharmacists jointly with IPA.307 For the first time in 
2010, RNTCP guidelines mentioned “pharmacists” as specialists with expertise in managing 
Multi-Drug-Resistant Tuberculosis (MDR-TB),308 which is very motivating for the profession in 
the country.  
 
10.3.3  Pulse Polio and Universal Immunization Programs 
Eighty percent of the respondents knew Pulse Polio and Universal Immunization programs and 
about 70% were willing to take part in these programs (III). National Vaccine Policy suggests 
that it is important to have experts from pharmacy to reduce time lag from availability of a 
vaccine to its use in National Immunization Programs.309 Internationally, the provision of 
immunization services involving pharmacists trained and certified to administer vaccines, 
utilizing agreed protocols and collaborative arrangements, is now well accepted in countries 
such as the USA, UK, Ireland and Portugal.310 Such success stories can be adopted by Indian 
pharmacists to take initiatives by taking up pilot project to create evidence to become part of 
health care team.  
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10.3.4 National Tobacco Control Program (NTCP)  
In this survey, 90% of the responding pharmacy students were willing to take active role in 
Tobacco Control (III). This is quite similar result as was obtained in a previous study in 2003 
(92.5%).311-312 This acknowledges that pharmacists have a continuous interest in promoting 
smoking cessation. Smoking is among the most important risk factors jeopardizing public 
health. Thus, pharmacists’ are easily accessible healthcare professionals to be involved in NTCP. 
Potential for Indian pharmacy students and pharmacists to make a definitive contribution to 
public health protection though NTCP should be utilized by the government of India. 
 
10.3.5  National Program on Control of Blindness (NPCB)  
Though 72% of the responding students showed enthusiasm to take active role in NPCB (III), 
there is no documented evidence on pharmacist involvement in NPCB as there is on HIV/AIDS 
control program, RNTCP and NTCP. Therefore, it is important to take initiatives by the 
professional bodies to find out how pharmacists can contribute in NPCB and create evidence.  
 
The above experiences and examples show that there are many ways that the Indian 
government can utilize pharmacists’ expertise in different public health programs. As pharmacy 
students seem to be interested in contributing to NPHPs, it is important that professional 
organizations, such as IPA and the Pharmacy Council of India will cooperate with pharmacy 
schools in curriculum development and shaping new public health roles and services for 
pharmacists. The Pharmacy Council of India, responsible statutory body for regulation of 
profession and practice of pharmacy, is also promoting pharmacists’ role in public health.313  
 
10.4  Pharmacists in National Public Health Programs in India: A Pilot Study Highlighting 
Physicians’ Perceptions (IV) 
This small-scale pilot study indicates that Indian physicians are willing to collaborate with 
pharmacists and are comfortable to involve them in the health care team (IV). The same 
positive trend was found in the physicians’ general opinions on: i) interaction and cooperation 
with pharmacists; ii) pharmacists’ involvement in NPHPs; and iii) pharmacists’ role in 11 major 
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individual NPHPs in India. The survey also revealed differences in opinions between junior and 
senior physicians:  the longer the physicians’ practice experience was, the less favorable they 
were for pharmacists’ involvement in NPHPs.  
 
Differences in opinions between junior and senior physicians concerning pharmacists’ 
involvement in NPHPs can be related to pharmacists’ qualifications in India. Most of the 
pharmacists practicing in community pharmacies in India are DPharm holders with 2 years 
education314 and without continuing education.315 Physicians with more than 10 years practice 
experience may build their perceptions of pharmacists’ skills and knowledge on these least 
trained professionals that use the same title as, e.g., PharmDs who have three times longer 
training which is also more clinically oriented.316 Thus, upcoming PharmD graduates with 6 
years education (training initiated in 2008) focused mainly towards clinical and community 
aspects317 should be able to change collaborative practice models and physicians’ perceptions 
in the future.  
 
World Health Organization (WHO) and its partners recognize interprofessional collaboration in 
education and practice as an innovative strategy.318 Strong working relationships between 
pharmacists and physicians are needed to optimize patient care. A study from Canada reveals 
that community pharmacists and physicians agree that collaborative practice can optimize 
patient outcomes and would like to collaborate more.319  
 
Physicians who participated in this survey had opined that pharmacists can take an important 
role in all the NPHPs (IV). This provides pharmacists huge opportunities to contribute to public 
health and patient care. However, practicing pharmacists need proper continuing education for 
being prepared for more patient-oriented practice. Some suitable continuing education is 
already available, e.g., implementation of National Health Mission is providing a course for BSc 
in Community Health for mid-level clinical care provider, including pharmacists.320 Such courses 
for in-service pharmacists would provide opportunities to improve their competencies and 
collaborative networks. The Planning Commission of India has approved schemes for "Setting 
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up of college of pharmacy in government medical colleges" to facilitate quality education and 
ensure availability of skilled competent workforce to the society.321 This initiative in long run, 
provides better understanding of physician expectations provide collaborative opportunities 
for the pharmacists.  
 
To create such evidence, pharmacists need to make strategies with the help of professional 
associations. It is also important to conduct a separate study to understand reasons for these 
differences. 
 
As per the survey results, Pulse Polio, HIV/AIDS, Tuberculosis-, Tobacco Control and Leprosy 
Eradication programs were the top five NPHPs where physicians perceived that pharmacists can 
play an important role (IV). It is also important to note that, none of the other selected 
programs were completely ignored by the respondents (>65% positive response for all other 
programs). If pharmacists are trained in NPHPs, this untapped potential of one million 
pharmacists can be utilized to supplement the health workforce in India to meet challenges in 
public health sector. Therefore, it is important to conduct a large scale study to understand the 
needs of training that is required for the pharmacists to make them part of NPHPs.  
 
Policy makers in India are yet to realize full potential of pharmacists’ role in NPHPs. Physicians 
in this survey clearly indicated that pharmacists can play an important role in the major health 
programs and the physicians are willing to collaborate. A Malaysian study suggests that General 
Physicians (GPs) support the extension of community pharmacists’ role in patient care 
activities,322 which is almost the same as in this study.  
 
As both the pharmacists and physicians want pharmacists’ involvement in NPHPs, now 
pharmacy professionals have to find ways to make pharmacists as part of public health 
providers. A live example for such initiatives comes from South Africa. Over the past few years, 
a range of initiatives to recruit and retain health professionals we taken, which includes 
mandatory one-year community service in public sector facility to all pharmacists willing to 
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become registered pharmacist with the South African Pharmacy Council. Similar initiatives in 
collaboration with Pharmacy Council of India will improve pharmacists’ image in society and 
with policy makers. 
 
Though the physicians are welcoming, it is also important that pharmacists are prepared and 
learn about the NPHPs, either through training programs or in the curriculum, or both. In recent 
years, pharmacists and professional associations have been actively promoting the pharmacist’s 
role in public health. There are examples of pharmacists taking initiatives to be a part of 
national health programs, such as the Revised National Tuberculosis Control Program (RNTCP). 
For the first time, the RNTCP guidelines have mentioned the word “pharmacist” as a specialist 
with expertise in managing Multi-Drug-Resistant Tuberculosis (MDR-TB)323 which is a step 
forward. Teaching more clinical practice would be helpful in pharmacists taking a larger role in 
national health programs such as malaria and leprosy eradication programs, diabetes, 
HIV/AIDS, and family and welfare programs. In a published study, dispensing practices for 
tuberculosis and knowledge about the national tuberculosis program of 300 pharmacies were 
assessed. Although 95% of pharmacists were not aware of the existence of the tuberculosis 
program, majority (97%) were willing to learn and contribute toward tuberculosis control.324 
Hence, creating awareness on NPHPs and the opportunities available for pharmacists should be 
actively promoted by professional associations and pharmacy schools, so that pharmacists take 
initiatives in NPHPs. 
 
10.5  Role of Professional Associations in Strengthening Pharmacists’ Position in NPHPs 
Productive partnerships could be public-private-professional organizational collaborations. For 
example, All India Organisation of Chemists and Druggists (AIOCD) with its approximately 
700,000 members and Indian Pharmaceutical Association with 10,000 members operating in 17 
state branches and 33 local branches could be potential resources to disseminate information 
on various NPHPs. The NPHP coordinators could utilize this vast network to create awareness 
and better image about the roles of pharmacists in NPHPs. 
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11  STUDY LIMITATIONS 
 
 National and International curriculum comparison of pharmacy programs (I, II) 
The strength of this study was use of national curricula for DPharm and PharmD from PCI, and 
for BPharm program the AICTEs’ model curriculum (individual universities have freedom to 
modify the curriculum). Selection of University of Florida curriculum to represent entire USA is 
a limitation, as all the US universities follow the ACPE guidelines, but they can modify the 
curriculum as per their needs. Thus, limitation of the national level comparison study was that 
there was no opportunity to study curricula variations in different universities (I, II).  
In the International comparison study (II), selection was limited to four countries form three 
WHO regions. A wider range of selection from Western Pacific, Eastern Mediterranean Regions 
and African Regions would have given more insights. Particularly, inclusion of UK and Australian 
curricula could have provided more insights in public health and patient care orientation in 
pharmacy curricula, and thus, enriched our analysis. However, the comparison was limited to 
India, USA, Finland and Denmark on the basis of the reasons given in the Methods Section. 
 Pharmacist role in NPHPs – students’ perceptions (III) 
The strength of this classroom survey was that there is equal number of participants from the 
three different pharmacy programs. Classroom survey method facilitates inclusion of all 
students which decreases the influence of selection bias on results. 
One of the major limitations is the number of colleges and students’ participation, as the study 
was limited to five colleges in South India (III). Therefore, it can be considered as a pilot study to 
test the method and get some insights in pharmacy students’ knowledge and attitude on 
NPHPs. A national level study with larger random sample of students from entire India would 
give more insights to the situation. Every year, there is a possibility for over 100,000 admissions 
in over 1800 pharmacy colleges in India.8 Reaching all these students to organize such a large 
study by using random sampling would only be possible by taking initiatives by Pharmacy 
Council of India or Indian Association of Colleges of Pharmacies. Such a large study would be 
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useful for professional bodies to start negotiations with policy makers to include pharmacists in 
national health policies and NPHPs to make pharmacists a part of health care team. 
 Pharmacist role in NPHPs – physicians perceptions (IV) 
The strength of this survey was that there was statistically comparable and valid number of 
participants from all the groups of the physicians with different levels of experience. There are 
over 885,000 registered physicians practicing in the country. One of the limitations is number of 
physicians participating in this study which is limited to 129 (IV). As this study was conducted 
only in South India, it can be considered as a pilot study to test the method and get some 
insights in physicians’ perceptions on pharmacist role in NPHPs. A larger national level study 
covering all parts of India would give more insights to the situation.   
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12  RECOMMENDATIONS  
To develop patient care and public health aspects, curriculum development teams and 
statutory authorities in India should start thinking of including these aspects in curricula at all 
levels. As part of the solution, it would be useful to have an alternative curriculum line focusing 
on patient care and pharmacy practice aspects in Indian DPharm and BPharm programs (I). In 
2014, PCI has addressed this issue by introducing Bachelor of Pharmacy (Practice). This gives a 
positive scope for the development of the profession. If pharmacists are included in National 
Health and Pharmaceutical Policies, it is likely that increased exposure to public health services 
will have more positive perceptions of health care professionals and the common public on 
pharmacists image. As suggested in WHO resolution WHA 47.12, it is high time to recognize 
key role of pharmacists in public health care which should reflect in curriculum content.325 
Poor enforcement of regulations in pharmacy sector is seen at all levels in India.326 Along with 
brining the new regulations, the regulatory bodies taking stringent steps towards enforcement 
of the regulations is hoped to change the face of the profession.  
 
The curriculum plays a major role in developing and changing the face of the profession. 
DPharm and BPharm curriculums in India are not preparing pharmacists to take part in public 
health, patient and pharmaceutical care services, and to become a part of health care team. 
The PharmD program is covering most of the care and service aspects and giving hope to the 
current situation. 
 
The research reveals that the student pharmacists are also motivated to learn more about 
NPHPs and be part of NPHPs (III). The research also reveals that physicians are willing to 
cooperate and accepting pharmacists taking important role in NPHPs (IV). The pharmacists 
representing organizations can utilize these findings to make arguments to provide a platform 
for pharmacist workforce in NPHPs at national level.  
  
 133 
 
13  POLICY IMPLEMENTATIONS  
 
This study is first of its kind in India, providing evidence to curriculum development teams, 
professional associations, statutory bodies and policy makers for making plans to utilize the 
pharmacist workforce in NPHPs and health policies. Curriculum development teams and 
statutory authorities in India should start thinking of including public health aspects, NPHPs in 
curricula at all levels. This study will also be helpful to statutory authorities and curriculum 
reform committees in India and other countries where pharmacists’ role is continuing to evolve 
towards inclusion of public health and patient care. 
 
This study will be useful to make new policies and bring reformations in pharmacy education at 
all levels. An example of reforms is as India developed a separate curriculum for BPharm 
(practice) to foster practicing pharmacists’ skills.  
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14 CONCLUSIONS 
 
 The curriculum plays a major role in developing and changing the face of the profession. 
The Indian pharmacy programs do not have the same length and knowledge levels in 
patient care and public health, but the graduates from all three programs obtain the same 
title as pharmacists.  The PharmD curriculum contains more clinical subjects and patient 
oriented services than industrial aspects.  
 The US and Indian PharmD programs contain most and the Indian DPharm and BPharm least 
public health and patient care aspects of all the six pharmacy programs which were 
assessed. It would be useful to have an alternative curriculum line focusing on patient care 
and pharmacy practice aspects in Indian DPharm and BPharm programs. 
 Students exhibited positive attitude on pharmacists’ involvement in NPHPs, although their 
different student groups, PharmD and DPharm students being most positive towards 
pharmacists’ involvement. The study also revealed the need for increasing contents 
supporting NPHPs to all pharmacy programs, particularly to BPharm program. 
 The pilot study among physicians indicates that Indian physicians are willing to collaborate 
with pharmacists and are comfortable to involve them in the health care team. The survey 
also revealed differences in opinions between junior and senior physicians: the longer 
physicians’ practice experience was, the less favorable they were for pharmacists’ 
involvement in NPHPs. 
 Larger scale studies are needed in the future to learn more about pharmacists’ role in 
patient care and public health in India and how it can be supported by pharmacy education. 
As it is suggested in WHO resolution WHA 47.12, it is high time to recognize the key role of 
pharmacists in public health care which should reflect to curriculum content.327  
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A survey to assess pharmacy students’ knowledge and attitude on National Public Health Programs 
 
General description: This survey is to be completed by final year DPharm, BPharm and PharmD students 
from any college in India. The main objective of this survey is to compare the knowledge levels and 
attitudes of final year DPharm, BPharm and PharmD students towards their role as pharmacists in public 
health and patient care. 
 
Demographics  
Name:          College name:  
Age:   Gender: Male Female  
Geographical region:  North South        East West 
Educational program:            DPharm  BPharm                          PharmD 
 
Assessment of pharmacy students’ knowledge in National Public Health Programs 
This section covers questions related to National Public Health Programs. The respondents MUST answer 
ALL questions. Please answer independently, without taking help or opinions from others. 
 
1. Have you studied about National Health Policy in your pharmacy curriculum? 
            Yes   No  Do not know   Do not remember 
2. Have you studied pharmaceutical policy in your pharmacy curriculum? 
            Yes   No  Do not know   Do not remember 
3. Do you know the national public health programs in India? 
            Yes, I know well          Yes, I know to some extent  
            Yes, I have heard about, but do not know contents         No, I have never heard about them 
  
4. Name all the National Public Health Programs that you know: 
 
 
 
 
5. Have you received lectures or completed any courses that provided information on national public 
health programs? 
Yes, I have received lectures during my basic studies    
 Yes, I have received at least one course in continuing education 
 Yes, I have studied about national health programs as self-study 
 I have not received any training on national health programs 
       Other comments:  
 
6. Is the amount of time devoted to learn public health aspects sufficient? (Basic pharmacy studies) 
            Yes, it is sufficient   No, not sufficient No opinion  
       Other comments:  
 
7. Based on your pharmacy education, do you have adequate knowledge to take part in national public 
health programs? 
            Yes            No         No opinion                 Not necessary for pharmacists  
       Other comments:   
 
8. Have you studied about disease prevention and dissemination of information in National Public Health 
Programs? 
            Yes   No  Do not know  
       APPENDICES  
 
Appendix 1: Questionnaire to assess pharmacy students’ knowledge and attitude on NPHPs 
 
166 
 
  
9. Is it necessary for the pharmacists to know about national public health programs? 
            Yes   No  No opinion 
 
 
Assessment of pharmacy students' attitude on National Public Health Programs 
 
Assessment of pharmacy students’ attitude on importance and participation of National Public Health Programs. 
This section covers questions to assess attitude of DPharm, BPharm and PharmD students on National Public Health 
Programs. The respondents MUST answer ALL the questions. Please answer the questions independently, without 
taking help or opinions from others. 
 
10. Do you think that it is important to include National Public Health Programs in normal training program 
for pharmacists? 
            Very important         Important                   Moderately 
            Of little importance         Unimportant  
 
11. Do you feel that your current knowledge about public health programs in the country is sufficient? 
            Very much sufficient          Sufficient                    Neutral  
            Not sufficient         Totally insufficient   
 
12. Do you feel you have an important role to play in public health programs? 
            Very important         Important                   Moderately 
            Of little importance         Unimportant  
 
13. During your pharmacy education program, have you ever involved in any public health program(s)? 
            Yes                No 
       If your answer is YES, please describe in which program you have participated and in which way: 
 
 
14. Have you ever involved in any public health program(s) during your internship? 
            Yes                No 
       If your answer is YES, please describe in which program you have participated and in which way: 
 
 
15. Are you willing to take up a professional role in public health program? 
            Yes   No  Do not know  
 
16. Do you want to learn or learn more about Public Health programs in your curriculum? 
            Yes, I want to learn              Yes, I want to learn more               No, it is not relevant  
            No do not want to learn         Do not know  
       If your answer is YES, please mention which program you want to learn / learn more: 
 
 
17. Where do you plan to work after graduation? 
Please select top two priorities (write 1 and 2 in the relevant boxes below):
     Community Pharmacy 
     Hospital Pharmacy 
     Drug Manufacturing Industry 
     R&D 
     Clinical Research 
     Regulatory affairs in industry 
Regulatory officer in government  
Marketing 
Higher studies 
Teaching 
Work abroad  
Any other, please specify 
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Knowledge in individual National Public Health Programs 
Assessment of pharmacy students’ knowledge in different National Public Health Programs (e.g. HIV/AIDS, TB, 
Pulse Polio, Blindness and Deafness Control Programs, Tobacco Control, Universal Immunization Program, etc.). 
This section covers questions related to individual National Public Health programs. The respondents MUST answer 
ALL the questions. Please answer the questions independently without taking help or opinions from others. 
 
18. Major programs in communicable diseases:  
  
  
Program  
Do you know about 
the program 
Do you have a 
role to play 
Are you willing 
to take part 
What kind of role? 
(please describe) 
Yes  No Yes No Yes No 
HIV/AIDS control program 
NACO envisions an India where every 
person living with HIV has access to 
quality care and is treated with dignity. 
Effective prevention, care and support for 
HIV/AIDS is possible in an environment 
where human rights are respected and 
where those infected or affected by 
HIV/AIDS live a life without stigma and 
discrimination. 
       
Revised National 
Tuberculosis Control 
Program (RNTCP) 
The objective of TB control Program is to 
achieve and maintain cure rate of at least 
85% in new sputum positive pulmonary TB 
patients, and to achieve and maintain 
detection of at least 70% of such cases. 
Directly Observed Treatment is highlight of 
this program. 
       
National Vector Borne 
Disease Control program 
(NVBDCP):  
The objective of the program is to prevent 
and control Malaria, Dengue, Lymphatic 
Filariasis, Kala-azar, Japanese Encephalitis 
and Chikungunya in India. 
       
National Leprosy 
Eradication Program (NLEP) 
Highlights of the program:  
Early detection & complete treatment of 
new leprosy cases. Carrying out house hold 
contact survey in detection. Early diagnosis 
& prompt MDT, through routine and special 
efforts. Information, Education & 
Communication (IEC) activities in the 
community to improve self reporting to 
Primary Health Centre (PHC) and reduction 
of stigma. Intensive monitoring and 
supervision at Primary Health 
Centre/Community Health Centre. 
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19. Major programs in non-communicable diseases:  
 
  
Program  
Do you know about 
the program 
Do you have a 
role to play 
Are you willing 
to take part 
Mention your role as 
pharmacist? (please describe) 
Yes  No Yes No Yes No 
National Mental Health 
Program (NMHP)  
Objectives: 1. To ensure the availability 
and accessibility of minimum mental 
healthcare for all in the foreseeable 
future, particularly to the most vulnerable 
and underprivileged sections of the 
population; 2. To encourage the 
application of mental health knowledge in 
general healthcare and in social 
development; and 3. To promote 
community participation in the mental 
health service development and to 
stimulate efforts towards self-help in the 
community. 
       
National Program for Prevention 
and Control of Deafness 
(NPPCD) 
Highlights: 1. To prevent the avoidable 
hearing loss on account of disease or injury. 
2. Early identification, diagnosis and 
treatment of ear problems responsible for 
hearing loss and deafness.  
3. To strengthen the existing inter-sectoral 
linkages for continuity of the rehabilitation 
programme, for persons with deafness.  
       
National Program for Control of 
Blindness (NPCB) 
Highlights: 1. To reduce the backlog of blindness 
through identification and treatment of blind at 
primary, secondary and tertiary levels. 2. 
Prevention of visual impairment; through provision 
of comprehensive eye care services and quality 
service delivery. 
3. To enhance  community awareness on eye care 
and lay stress on preventive measures;  
4. To secure participation of Voluntary 
Organizations/Private Practitioners in eye Care 
       
        
Pulse Polio program 
Objectives: Children in the age group of 0-
5 years administered Polio drops during 
the national and sub-nationals 
immunization rounds. About 172 million 
children are immunized during each 
National Immunization Day. 
       
Universal Immunization 
Program (UIP)  
Objective: Protection of children from life 
threatening conditions by providing 
vaccination. Under UIP, following vaccines 
are provided: 1. BCG, 2. DPT, 3. OPV (Oral 
Polio Vaccine), 4. Measles, 5. Hepatitis B, 6. 
TT (Tetanus Toxoid), etc. 
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20. Other important National Public Health Programs:  
 
 
Thank you for participating in this important survey. We will share the results of the study. 
If you have any questions, please feel free contact us by e-mail: prassu117@gmail.com 
Program  
Do you know about 
the program 
Do you have a 
role to play 
Are you willing 
to take part 
What kind of role? 
(please describe) 
Yes  No Yes No Yes No 
National Tobacco Control 
Program (NTCP) 
Types of benefits of NTCP:  
1.To bring about greater awareness about 
the harmful effects of tobacco use and 
about the Tobacco Control Laws and 2.To 
facilitate effective implementation of the 
Tobacco Control Laws. 
       
National Program for Health 
Care of the Elderly (NPHCE) 
Objective is to provide separate, specialized 
and comprehensive health care to the 
senior citizens at various level of State 
health care delivery system including 
outreach services. 
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A survey to assess Physicians’ perception on pharmacist role in National Public Health Programs 
 
General description: This survey is to be completed by family physicians/specialists/surgeon doctors 
practicing in any type of practice setting in any part of India. The objective of this survey is to characterize 
physician perceptions on the role of pharmacists in public health and patient care aspects. 
 
Definition: In this study the National Public Health Programs means that major programs that are being 
carried out by the Ministry of Health and Family Welfare, the Government of India. The programs that we 
are focusing in this survey are: HIV/AIDS, Revised National TB Control Programme, National Vector Borne 
Disease Control Programme, National Leprosy Eradication Programme, National Mental Health Programme, 
National Programme for Prevention and Control of Deafness, National Programme for Control of Blindness, 
Pulse Polio Programme, Universal Immunization Programme, National Tobacco Control Programme and 
National Programme for Health Care of the Elderly. 
 
Demographics 
Name:        Type of practice setting: 
Age:    Gender: Male Female  Email: 
Geographical region: North South     East  West 
Highest Medical qualification:     MBBS  MS/MD              Other 
 
Please select the year group in which you obtained your highest medical qualification 
Year of    2004-2014     1990-1999    1980-1989    1970-1979    <1970 
 
How many years have you been practicing:  < 5     5-10     11-15     > 15 
 
Current designation:  Family doctor     Medical oficer    CMO      Surgeon      Other  
 
1. Is there a pharmacy attached or close to your practice? 
      Yes    No  
 
2. Do you refer your patients with prescription to a pharmacy in your practice area to buy their medicine? 
      Yes   No 
 
3. Do you contact your pharmacy frequently for professional matters? 
      Yes    No  
 
4. On an average, please estimate the frequency of your interactions with a pharmacist: 
  Every day    More than once/week   Once a week 
  > Once/month    Once a month  Less than once/month 
 
5. Do you think that your pharmacist is knowledgeable? 
      Yes    No  
 
6. Do you think that your pharmacist is service oriented? 
      Yes    No  
 
7. Do you think the pharmacy / your pharmacist is providing patient counseling on medicine, 
administration, dosage, side efects etc., to supplement your counseling, is at a satisfactory level? 
      Very much suficient      Suficient          Neutral 
      Not suficient      Totaly insuficient  
 
Physicians’ perception on pharmacist role in national public health and patient care 
This section covers questions related physicians’ perception on pharmacist role in National Public Health 
Programs. The respondents MUST answer ALL questions. 
 
8. Do you see the pharmacist as a mere vendor/dispenser of prescription drugs? 
      Yes   No  Do not know 
 
9. Your perception on pharmacist role in National Public Health Programs: 
      Positive Neutral  Negative     No  opinion  
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10. Do you feel pharmacists have an important role to play in public health programs? 
   Yes, very important   Yes, moderately important  
 No, not important   No opinion   
       Other comments:  
 
If yes please answer question no. 11. If no, please go to question no. 12.  
 
11. What kind of role pharmacist can play in public health and patient care? (Select one or more) 
             Disease prevention          Dissemination of information 
             Patient counseling on correct use of medicine                  Improve patient adherence 
             Dispensing prescriptions                  Pharmacovigilance  
             Help to select medication (medical representative)         Providing drug information to physicians  
             Patient care services e.g. check on inhalation technique           Participating in health campaigns 
             Pharmacoeconomics            No, pharmacists has no role to play  
       Other roles, please mentions here:  
 
12. Do you think it is important to include pharmacists in National public health programs? 
   Yes, very important   Yes, moderately important  
 No, not important   No opinion   
       Other comments:  
 
13. Do you feel that pharmacists’ current knowledge on various health public programs is sufficient? 
            Very much sufficient          Sufficient                    Neutral  
            Not sufficient         Totally insufficient   
 
Physicians’ opinion on pharmacist role in individual National Public Health Programs  
 
This section covers questions related to the assessment of physicians’ perception on the role of 
pharmacists in individual national health programs that are being implemented by the Government of India 
(e.g. HIV/AIDS, TB, Pulse Polio, Blindness and Deafness Control Programs, Tobacco Control, Universal 
Immunization Program, etc.). The respondents MUST answer ALL the questions.  
 
Major programs in communicable diseases 
14. Can the pharmacist play a role in HIV/AIDS Control Program?  
            Yes   No  Do not know  
If your answer is YES, please select one or more example roles  
            Disease prevention          Dissemination of information 
            Patient counseling                   Improve patient adherence 
            Dispensing prescriptions          Drug management  
       Other roles: 
 
15. Can the pharmacist play a role in Revised National Tuberculosis Control Program (RNTCP)? 
            Yes   No  Do not know  
If your answer is YES, please select one or more example roles  
            Disease prevention          Dissemination of information 
            Patient counseling                   Improve patient adherence 
            Dispensing prescriptions          Drug management  
       Other roles: 
 
16. Can the pharmacist play a role in National Vector Borne Disease Control program (NVBDCP)?  
[In prevention and control of Malaria, Dengue, Lymphatic Filariasis, Kala-azar, Japanese Encephalitis and Chikungunya in India] 
            Yes   No  Do not know  
If your answer is YES, please select one or more example roles  
            Disease prevention          Dissemination of information 
            Patient counseling                   Improve patient adherence 
            Dispensing prescriptions          Drug management  
       Other roles: 
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17. Can the pharmacist play a role in National Leprosy Eradication Program (NLEP)? [Information, Education and 
Communication activities in the community to improve self reporting to Primary Health Centre and reduction of stigma] 
            Yes   No  Do not know  
If your answer is YES, please select one or more example roles  
            Disease prevention          Dissemination of information 
            Patient counseling                   Improve patient adherence 
            Dispensing prescriptions          Drug management  
       Other roles: 
 
Major programs in non-communicable diseases 
18. Can the pharmacist play a role in National Mental Health Program (NMHP)? 
            Yes   No  Do not know  
If your answer is YES, please select one or more example roles  
            Disease prevention          Dissemination of information 
            Patient counseling                   Improve patient adherence 
            Dispensing prescriptions          Drug management  
       Other roles: 
 
19. Can the pharmacist play a role in National Program for Prevention and Control of Deafness (NPPCD)?  
[To prevent the avoidable hearing loss on account of disease or injury. Early identification, diagnosis and treatment of ear 
problems responsible for hearing loss and deafness. To strengthen the existing intersectoral linkages for continuity of the 
rehabilitation program, for persons with deafness]  
            Yes   No  Do not know  
If your answer is YES, please select one or more example roles  
            Disease prevention          Dissemination of information 
            Patient counseling                   Improve patient adherence 
            Dispensing prescriptions          Drug management  
       Other roles: 
 
20. Can the pharmacist play a role in National Program for Control of Blindness (NPCB)?  
[To enhance community awareness on eye care and lay stress on preventive measures]  
            Yes   No  Do not know  
If your answer is YES, please select one or more example roles  
            Disease prevention          Dissemination of information 
            Patient counseling                   Improve patient adherence 
            Dispensing prescriptions          Drug management  
       Other roles: 
 
21. Can the pharmacist play a role in Pulse Polio program?  
            Yes   No  Do not know  
If your answer is YES, please select one or more example roles  
            Disease prevention          Dissemination of information 
            Patient counseling                   Improve patient adherence 
            Dispensing prescriptions          Drug management  
       Other roles: 
 
22. Can the pharmacist play a role in Universal Immunization Program (UIP)? 
            Yes   No  Do not know  
If your answer is YES, please select one or more example roles  
            Disease prevention          Dissemination of information 
            Patient counseling                   Improve patient adherence 
            Dispensing prescriptions          Drug management  
       Other roles: 
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Other important National Public Health Programs 
 
23. Can the pharmacist play a role in National Tobacco Control Program (NTCP)?  
            Yes   No  Do not know  
If your answer is YES, please select one or more example roles  
            Disease prevention          Dissemination of information 
            Patient counseling                   Improve patient adherence 
            Dispensing prescriptions          Drug management  
       Other roles: 
 
24. Can the pharmacist play a role in National Program for Health Care of the Elderly (NPHCE)?  
            Yes   No  Do not know  
If your answer is YES, please select one or more example roles  
            Disease prevention          Dissemination of information 
            Patient counseling                   Improve patient adherence 
            Dispensing prescriptions          Drug management  
       Other roles: 
 
General perception of physicians on pharmacists and the pharmacy profession   
This section covers general questions related to the physician opinion on pharmacist and pharmacy 
profession and inter-professional collaboration between pharmacists and physicians.  
 
25. Please rate your comfort with pharmacist roles described above: 
            Very comfortable  Somewhat comfortable Uncomfortable  
 
26. Do you have any barriers to collaborate with pharmacists as a part of health care team?  
            Very comfortable  Somewhat comfortable Uncomfortable  
 
27. Do you see pharmacists as a part of health care team?  
            Yes   No  No opinion   
 
28. Please indicate any comments/ideas/improvements needed for pharmacist roles in national public 
health: 
 
 
 
Thank you for participating in this important survey. We will share the results of the study. 
If you have any questions, please feel free contact us by e-mail: prassu117@gmail.com 
 
 
  
